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Abstract 
1: The ring-opening of aziridine-2-carboxylates dominates their reactivity, providing diverse, 
biologically relevant compounds. Less is known about the chemistry of NH-aziridine-2-carboxylates, 
owing to multi-step preparation, and lack of N-functionality to aid ring-opening. Building on the 
recent disclosure of an NH-aziridination methodology applicable to enones, the substrate scope was 
expanded to include enoates. Aziridination provided access to NH-aziridine-2-carboxylates in a single 
step from readily available starting materials. Treatment of the resulting aziridine-2-carboxylates with 
nucleophiles proceeded with high regio- and stereoselectivity, providing access to natural and un-
natural amino acid derivatives (Scheme 1).  
 
Scheme 1: The synthesis and ring-opening of aziridine-2-carboxylates 
2: Identification of kinase protein-substrate sets is crucial to further understand cellular processes, but 
is challenging with known methodology. Previous study had proposed a new methodology, 
incorporating two known strategies, bump-hole inhibition and photo-affinity labelling. Novel C3-aryl 
pyrazolo[3,4-d]pyrimidines were designed for the purpose (Fig. 1), although preparation of the 
compounds had proved challenging, with several key steps in the synthesis of analogues low-yielding 
and lengthy. A new synthetic route was developed, using hydrazone allylation to establish the α-tert-
amine functionality of the pyrazolo[3,4-d]pyrimidines. A late-stage oxidative cleavage was used to 
re-connect with the original synthetic strategy, to provide access to the C3-hydro analogues. 
Application of the revised route to the synthesis of the target compounds, using an alternative enol 
ether for C3-aromatic installation, provided access to two novel pyrazolo[3,4-d]pyrimidines for 
testing.  
 
 
Fig. 1: C3-aryl pyrazolo[3,4-d]pyrimidines  
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Stereochemical Notation 
Throughout this thesis, the pictorial representation of stereochemistry is consistent with the 
conventions proposed by Maehr.
1
 Uniform solid wedges and broken lines represent relative 
stereochemistry, whilst narrowing of the solid wedge or broken line at one terminus illustrates 
absolute configuration. Where relative stereochemistry is pictured, the compound has been prepared 
as a racemate. Conversely, absolute configuration is given where a compound has been prepared as a 
single enantiomer. 
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Abbreviations 
Ac  acetyl 
ADP  adenosine diphosphate 
aq.  aqueous 
Ar  aryl 
atm  atmospheres 
ATP  adenosine triphosphate 
Bn  benzyl 
Boc  tert-butyloxycarbonyl 
br  broad 
Bu  butyl 
Bz  benzoyl 
cat.  catalytic/catalyst 
Cbz  benzyloxycarbonyl 
CI  chemical ionisation MS 
d  doublet/day(s) 
DABCO 1,4-diazabicyclo[2.2.2]octane 
dba  dibenzilydeneacetone 
de  diastereomeric excess 
DMAP  4-dimethylaminopyridine 
DMF  dimethylformamide 
DMSO  dimethylsulfoxide 
Dpp  diphenylphosphinyl 
dr  diastereomeric ratio 
EDG  electron donating group 
ee  enantiomeric excess 
EI  electron impact MS 
eq./equiv. molar equivalent(s) 
ES  electrospray MS 
er  enantiomeric ratio 
Et  ethyl 
EWG  electron withdrawing group 
h  hour(s) 
HMBC  heteronuclear multiple bond coherence 
HMPA  hexamethylphosphoramide 
HRMS  high resolution mass spectrometry 
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Hz  Hertz 
IPA  isopropyl alcohol 
i
Pr  isopropyl 
IR  infra-red 
J  coupling constant 
LG  leaving group 
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M  molar 
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Me  methyl 
MLn  metal-ligand complex 
min  minute(s) 
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MS  mass spectrum/mass spectrometry/molecular sieves 
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m/z  mass/charge ratio 
N-  amino- 
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n
Bu  normal-butyl 
NMR  nuclear magnetic resonance 
NMM  N-methylmorpholine 
NMO  N-methylmorpholine N-oxide 
NMP  N-methylpyrrolidine 
Ns  4-nitrobenzenesulfonyl 
o  ortho 
p  para 
petrol  petroleum ether (40-60 °C) 
Ph  phenyl 
ppm  part(s) per million 
Pr  propyl 
PTC  phase transfer catalyst 
q  quartet 
R  alkyl group 
Rf  retention factor 
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r.t.  room temperature 
s  second(s), singlet 
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t  triplet 
T  temperature 
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t
Bu  tert-butyl 
Tf  triflyl/trifluromethanesulfonyl 
THF  tetrahydrofuran 
THP  tetrahydropyran 
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1.1 Introduction 
The aziridine-2-carboxylate, of the general structure shown (Scheme 2), is an important architecture 
for the synthetic chemist. Further to being an interesting target in its own right, the motif is highly 
susceptible to nucleophilic ring-opening chemistry.
2, 3
 Accordingly, access to a diverse array of 
compounds from this common intermediate is possible, depending on the regio- and stereoselectivity 
of nucleophilic addition. Although the same is true of the aziridine motif in general, ring-opening of 
aziridine-2-carboxylates can lead to structures of particular biological importance (Scheme 2). By 
way of example, nucleophilic attack at C3 leads to amino acid derivatives,
4, 5
 whilst opposing 
regioselectivity yields β-amino acids.6 Conjugate nucleophilic addition to a vinyl 
aziridine-2-carboxylate could provide access to the vinyl glycine motif. Diastereomers of all these 
products can arise, often dependent on the mechanism of nucleophilic attack.
7
 
 
Scheme 2: Biologically important ring-opening products 
The high propensity of aziridine-2-carboxylates, and also aziridines, to undergo ring-opening, can be 
attributed to the electrophilicity of the carbon atoms of the aziridine; indeed, several structural 
features of the motif contribute to this. Firstly, the three membered heterocycle is highly strained and 
a thermodynamic advantage is achieved on ring-opening. The internal bond angles are constrained to 
60° instead of the preferred 109.5°, and unfavourable eclipsing interactions exist between the 
aziridine substituents. This ring-strain causes an increase in the p-character and thus weakening of the 
CN aziridine bonds, and in turn, an increase in s-character of the nitrogen lone-pair.
8
 Accordingly, the 
aziridine nitrogen is less basic than analogous larger-ring or acyclic aliphatic amines, so nucleophilic 
chemistry is less common.
9
 
 
N-substitution of an aziridine also affects the electrophilicity of the motif, with aziridines classified as 
activated or non-activated, dependent upon this substitution.
10
 Activated aziridines bear N-substitution 
that is able to stabilise negative charge build-up at nitrogen during ring-opening (Fig. 2).
9
 The 
electron-withdrawing nature of such a substituent also further polarises the aziridine CN bonds. Both 
result in the increased electrophilicity of the carbon atoms. Non-activated aziridines generally require 
12 
 
initial activation with Lewis or Brønsted acid. Examples of non-activated aziridines include N-alkyl 
and N-unfunctionalised (NH) aziridines (Fig. 2). 
 
Fig. 2: Examples of N-functionality of aziridine-2-carboxylates 
The majority of protocols to access aziridine-2-carboxylates yield N-functionalised aziridines.
11
 
Synthetic methods available require protection of the aziridine nitrogen during synthesis (vide infra) 
and the ease of subsequent ring-opening chemistry makes N-functionalised aziridines attractive 
targets. However, a key disadvantage is the usual requirement for N-deprotection, either of the 
aziridine, or of the resulting amine product following ring-opening. This adds a synthetic step, and 
can be low yielding; in particular, the sensitive nature of the aziridine means that the CN bonds can be 
cleaved.
12
 One solution is to directly synthesise NH-aziridine-2-carboxylates, so the problematic 
deprotection step is not required. Additionally, this would lead to more efficient ring-opening 
chemistry. However, a limited number of methods to access NH-aziridine-2-carboxylates exist. 
Consequently, little is known about their synthetic use, including their propensity to participate in 
ring-opening reactions. If successful, ring-opening could provide direct access to a diverse range of 
biologically important structures from a common aziridine-2-carboxylate. 
 
The review that follows aims to highlight some of the common and very successful methodologies to 
access aziridine-2-carboxylates. However, the selected examples will also be used to illustrate the lack 
of applicability of the majority of current methods to the synthesis of NH-aziridine-2-carboxylates. 
Only examples involving synthesis of the aziridine ring are included, rather than functionalisation of a 
pre-existing aziridine substrate. A full review of the area is not intended, rather a discussion of 
particularly relevant examples and methods; for a more detailed analysis, the reader is directed 
towards several reviews.
13-15
 
1.1.1 Synthetic methods to aziridine-2-carboxylates 
Aziridine syntheses can be grouped into two main classes; addition and cyclisation processes 
(Scheme 3). Addition processes can be further sub-divided into a) addition of carbenoids to imines 
and b) addition of a nitrene, nitrenoid or nucleophilic nitrogen to alkenes.
15
 Ring-contraction, for 
example of a 1,2,3-triazole with loss of nitrogen, can also lead to aziridine formation, although this 
class of reactions is not covered in this overview. 
13 
 
 
Scheme 3: Classical synthetic methods to aziridines 
1.1.1.1 Cyclisation processes 
Cyclisation processes to form aziridines involve the intramolecular substitution of a β-leaving group 
by a nitrogen nucleophile. This is the oldest class of aziridine-forming reaction; indeed the first 
reported synthesis of aziridine by Gabriel in 1888 occurred from the cyclisation of a 1,2-amino 
alcohol.
16
 Synthesis of aziridine-2-carboxylates via cyclisation is facile and widely exploited.
11
 
Common substrates for this chemistry include 1,2-amino- and 1,2-azido alcohols, with displacement 
of the alcohol functionality usually occurring after activation, for example, with sulfonylation or 
Mitsunobu chemistry.
17, 18
 Substrate synthesis is facile but stepwise, often involving alkene 
epoxidation and subsequent ring-opening with the required nitrogen nucleophile. 1,2-Haloamines are 
also frequently used, with the advantage that prior activation of the leaving group is not necessary. 
Haloamines are commonly derived from the parent amino alcohols (Fig. 3). 
 
Fig. 3: Common substrates for cyclisation chemistry 
β-Halogen-displacement methodology was used by Boukhris to synthesise a range of N-alkoxy 
aziridine-2-carboxylates. The aziridines were isolated in good yields from the displacement of 
chloride and bromide by N-alkoxy amines (Scheme 4).
19
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Scheme 4: Boukhris’ N-alkoxy aziridines 
Secondary amines are common intramolecular nucleophiles, leading to N-functionalised aziridines. 
Electron-rich secondary amines assist cyclisation by increasing the nucleophilicity of the nitrogen 
through inductive effects. An electron-withdrawing group on the amine increases the acidity of the 
amine proton, facilitating removal in aziridine formation.
9
 The interesting azaspiropentane 6 was 
synthesised following cyclisation of N-benzylated chloroamine 4. The reactive acrylate 3 was 
prepared and used as a solution in THF, whereupon addition of benzylamine provided the unstable 
chloroamine 4. Cyclobutene 5 was the intended target, but on treatment of this compound with 
triethylamine, the spiro-aziridine 6 proved to be the only isolable product, in 14% yield (Scheme 5).
20
 
 
Scheme 5: Azaspiropentane synthesis 
However, primary amines are also suitable nucleophiles, leading directly to 
NH-aziridine-2-carboxylates.
17, 18
 These products can also be accessed from β-azido alcohols. 
Staudinger chemistry reveals the primary amine nucleophile, which then displaces the alkoxy group. 
This reactivity was exploited by Goodman et al. to access tri-substituted NH-aziridine-2-carboxylates 
from the ring-opening of a cyclic sulfate. The starting sulfate 7 was synthesised using Sharpless 
dihydroxylation of benzyl tiglate, followed by reaction with thionyl chloride and oxidation. 
Nucleophilic substitution with azide occurred with complete inversion at the α-stereocentre, and 
treatment with acid yielded the required 1,2-azido alcohol 8 as a single enantiomer. PPh3 mediated 
ring-closure provided the trans-aziridine 9 in 91% yield (Scheme 6).
21
 
 
Scheme 6: Ring-closure of a chiral azido-alcohol 
15 
 
As shown, one advantage of cyclisation methodology is that the precursors are often accessible in 
enatiomerically pure form.
22
 The stereochemistry of the aziridine product is set in the cyclisation step, 
owing to the anti- relationship between the nitrogen nucleophile and leaving group necessary for the 
intramolecular substitution. Enantioenriched amino and azido alcohols in particular are accessed using 
established chemistry, for example enantioselective epoxidation of an α-β-unsaturated ester followed 
by ring-opening with azide or the required amine. 
 
A further example of asymmetric aziridine synthesis occurs in Wandless‟ synthesis of the natural 
product phomopsin. The interesting 3-alkynyl aziridine-2-carboxylate 12 was obtained from the 
cyclisation of the corresponding 1,2-amino alcohol 11, which itself could be prepared in five steps 
from chiral Weinreb amide 10. The cyclisation step proceeded in 99% yield, and aziridine 12 was 
isolated in 29% overall yield in 6 steps from the Weinreb amide (Scheme 7).
23
 
  
Pannecoucke was able to determine the diastereoselectivity of a prior reduction step, on accessing 
cis-aziridines using cyclisation methodology (Scheme 7). 1,2-Amino selenyl compounds were 
prepared as single diastereomers by 
1
H NMR following reduction of α-seleno-imines. Cyclisation 
afforded cis-aziridines exclusively, allowing the configuration of the 1,2-amino selenyl esters to be 
determined as syn (Scheme 7). 1,2-Amino selenyl esters with the opposite regiochemistry were 
synthesised using an alternative route, and successfully subject to cyclisation.
24
 
 
Scheme 7: Stereoselective syntheses of aziridine-2-carboxylates 
The Gabriel-Cromwell reaction 
A well established reaction to synthesise aziridine-2-carboxylates that is a combination of both 
cyclisation and addition processes is the Gabriel-Cromwell reaction (Scheme 8). This involves the 
addition of a nitrogen nucleophile to an α-halo enoate to establish a 2-haloamine motif. 
Tautomerisation and cyclisation then occur to provide the aziridine-2-carboxylate.  
16 
 
 
Scheme 8: Gabriel-Cromwell reaction 
NH-Aziridine-2-carboxylates are synthesised with Gabriel-Cromwell chemistry, on using ammonia as 
the nitrogen nucleophile. Cardillo and co-workers were able to access trans-NH-aziridines in good 
yields and high er (>9:1) on treating an auxiliary-derived chiral enamide with ammonia in DMSO 
(Scheme 9). A mechanism to support the origin of asymmetry was suggested. Initial attack of 
ammonia occurs on the top face of α-bromo enamide 13, although the authors make no comment on 
the preferred conformation of the enamide prior to addition. Subsequent formation of 
hydrogen-bonded enolate 14 is suggested, which is favoured in the aprotic polar solvent. Protonation 
to provide α-bromo β-amino amide 15 occurs preferentially from the less hindered bottom face, 
setting up the required stereochemistry for ring-closure to the trans-aziridine. Cleavage of the 
auxiliary of 15 with lithium benzyloxide provides the benzyl-ester NH-aziridine-2-carboxylate 16 
(Scheme 9).
25
 
 
Scheme 9: Origin of stereoselectivity in Cardillo’s Gabriel-Cromwell aziridine synthesis 
Cyclisation processes allow access to aziridine-2-carboxylates bearing diverse substitution at carbon 
and nitrogen. Aziridines can be accessed as single enantiomers, following the use of readily accessed 
chiral substrates. The main disadvantage is that syntheses of aziridine-2-carboxylates by this method 
requires multiple steps when the overall route from readily available starting materials is considered. 
Thus, the chemistry is time consuming and usually occurs in low overall yield. Direct addition 
methodologies are now more desirable, with the aim of providing aziridine-2-carboxylates in a single 
step from readily available substrates. 
1.1.1.2 Addition processes 
Addition to imines 
The addition of a carbenoid to an imine is a widely exploited methodology for the direct synthesis of 
aziridine-2-carboxylates. Carbenoids can be considered as carbene equivalents that display tempered 
17 
 
reactivity. Examples include carbanions bearing an ipso-leaving group, and metallo-carbenoids, 
commonly depicted as species bearing a metal-carbon double bond (Fig. 4).  
 
Fig. 4: Comparing carbenes and carbenoids 
The aza-Darzens reaction provides a good example of this chemistry (Scheme 10). Deprotonation of 
an α-halo-acetate with strong base generates a carbenoid intermediate, which undergoes addition to an 
imine. Ring-closure furnishes an aziridine-2-carboxylate. Nucleophilic addition of the carbanion is 
irreversible, so the geometry of the aziridine product is set at this step, proceeding through the lowest 
energy transition state. Ring-closure is stereospecific, owing to the required anti- relationship between 
the amide anion and halide leaving group for intramolecular nucleophilic substitution. 
 
Scheme 10: The aza-Darzens reaction 
Asymmetric induction in the aza-Darzens reaction has been realised through using chiral alkyl and 
aryl sulfinimines by Davis (Scheme 11). Lithiation of methyl α-bromoacetate at -78 °C, followed by 
reaction with the chiral sulfinimines afforded N-sulfinyl aziridine-2-carboxylates with excellent 
cis-diastereoselectivity (de 82-98%). However, isolated yields of some aziridines were poor, 
rationalised as being due to the suspected instability and self dimerisation of the lithium enolate of 
methyl α-bromoacetate. As a result, an in situ trapping method was developed, whereby the 
sulfinimine and α-halo enolate were mixed prior to treatment with LiHMDS (Scheme 11). This 
method provided aziridines in increased yields, but poorer diastereoselectivity (de 41-90%). 
Stereocontrol is proposed to arise from a chair-like transition state, with co-ordination of the imine 
nitrogen, acrylate oxygen and sulfinyl oxygen with the lithium (Scheme 11). Co-ordination of the 
sulfinyl oxygen in the chair transition state accounts for the excellent diastereoselectivity observed 
with respect to the auxiliary. Oxidation of the N-sulfinyl aziridines with mCPBA provided the 
corresponding N-tosyl aziridines in excellent yields, which were subjected to ring-opening chemistry. 
Additionally, cleavage of the N-sulfinyl group was possible in good yields, providing access to 
NH-aziridine-2-carboxylates.
26, 27
 The aziridination and ring-opening methodology was applied 
towards the synthesis of the antibiotic (+)-thiamphenicol. An intermediate in the route could be 
accessed in 49% yield over three steps, starting from an enantiopure sulfoxide.
28
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Extension of Davis‟ methodology was reported by Stockman et al. (Scheme 11). Chiral imines 
derived from Ellman‟s tert-butanesulfinamide 17,29 were reacted with lithiated α-bromoethylacetate, 
to give the corresponding aziridines in moderate to good yields (49-86%), and excellent de‟s (>98%, 
c.f. 41-90% in Davis‟ in situ method). The reaction was cis-selective (>90:10) in accordance with 
Davis‟ findings, but a slight drop in diastereoselectivity was observed for electron-poor substrates and 
heteroaromatics. N-tert-Butylsulfiniyl ketimine substrates displayed poorer reactivity but gave 2,2,3-
trisubstituted aziridines, with excellent de‟s (>96%) observed for ketimines bearing aromatic 
functionality at carbon.
30
 
 
Scheme 11: Aza-Darzens chemistry to N-sulfinyl aziridine-2-carboxylates 
α-Diazoacetates are commonly used as metallo-carbenoid precursors in aza-Darzens-like chemistry 
(Scheme 12). Carbenoid formation is driven by loss of nitrogen from the starting material, promoted 
by heat, light or the metal catalyst.  
 
Scheme 12: α-Diazoacetates in aza-Darzens-like chemistry 
An early publication in this field from Espenson et al. used catalytic methylrhenium trioxide to 
generate the carbenoid derived from ethyldiazoacetate. Addition to aryl imines provided 
trans-aziridine-2-carboxylates in yields of 87-96%, with variation of the aryl imine. A 
rhenium-carbenoid was tentatively suggested as the active species (Scheme 13).
31
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Scheme 13: Re(CH3)O3 catalysed aziridine formation 
Detailed research into this reaction has led to the publication of seminal work from Wulff et al. An 
enantioselective protocol employing boronate VAPOL-derived catalysts provided cis-aziridine-2-
carboxylates in good yield (Scheme 14).
32
 Subsequent investigation revealed that VANOL-derived 
catalysts were also suitable for the transformation.
33
 Initially N-benzhydryl protection was found to be 
necessary for good levels of enantiocontrol, but hydrogenolytic removal in the presence of Pearlman‟s 
catalyst led to ring-opening of aryl-substituted aziridines. Although this presented a simple synthesis 
of enantioenriched amino acid derivatives, NH-aziridines were the desired targets. Substitution of 
N-benzhydryl with the acid labile N-dianisylmethyl (DAM) in the methodology provided access to 
NH-aziridine-2-carboxylates on protecting-group cleavage, with no ring-opening observed.
34
 
 
Scheme 14: Wulff’s asymmetric synthesis of N-DAM aziridines 
Following Wulff‟s Lewis acid-mediated protocol, an attractive Brønsted acid-catalysed methodology 
was described by Johnston et al. to access aziridine-2-carboxylates. The authors highlight the relative 
ease of catalyst removal using a basic wash, in comparison to column chromatography required for 
removal of the VANOL- and VAPOL-derived Lewis acids. However, a limitation of the procedure is 
lack of asymmetric induction, in contrast with Wulff‟s methodology. Initial optimisation found that 
Brønsted acids with low pKa‟s provided decreased reaction times, and that polar solvents were the 
optimum media for aziridination. Addition of ethyldiazoacetate to a range of N-benzhydryl aldimines 
in the presence of TfOH in CH3CH2CN, provided good yields of aziridine-2-carboxylates in high cis-
diastereoselectivity (Scheme 15). Yields and diastereoselectivity were found to decrease with more 
electron-rich aliphatic aldimine substrates. Further experimentation revealed that the electron-poor 2-
20 
 
pyridyl-substituted aldimine underwent complete conversion to the corresponding aziridine in 30 min. 
in excellent cis-diastereoselectivity (Scheme 15). Chelation of the proton between the imine and 
pyridine nitrogen atoms was suggested to rationalise the increased reaction rate.
35
 
 
Scheme 15: Brønsted acid-catalysed aza-Darzens reaction 
Fluoronium salts have also been used as catalysts in aza-Darzens-like chemistry by Bew et al. Eight 
N-PMP aziridines were synthesised in good yields from aromatic and aliphatic aldimines (Scheme 
16). The aziridination was cis-selective, although diastereoselectivity was moderate for three 
substrates. The fluoronium ion was the presumed catalyst, activating the aldimine substrate to 
nucleophilic attack, in an analogous manner to Brønsted acid-catalysis. Indeed, a control experiment 
in the absence of a fluoronium salt produced no aziridine. N-fluoropyridinium triflate was found to be 
the optimum fluoronium source for aziridination; other fluoropyridinium catalysts tested provided 
decreased yields of aziridine. One example of an N-TMS aldimine undergoing aziridination was 
described, providing direct access to an NH-aziridine following cleavage of the N-TMS group on 
chromatographic purification on silica (Scheme 16).
36
 
 
Scheme 16: Fluoronium-catalysed aziridination 
The addition of carbenoid reagents to imines is a rapid method to access aziridine-2-carboxylates, in 
high stereoselectivity if desired. However, the developed chemistry often proceeds under strongly 
basic or acidic conditions, or in the presence of metal catalysts, which are not appropriate for 
NH-imine substrates. Thus synthesis of NH-aziridine-2-carboxylates via this method requires a final 
deprotection step, and cannot be classified as direct with respect to these substrates. 
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Addition to alkenes 
Nitrene and nitrenoid reagents 
Initial forays into aziridine-2-carboxylate synthesis from alkene substrates utilised nitrenes. An early 
communication from Atkinson et al. described a chiral alkene aziridination using 
N-aminobenzimidazole 18 (Scheme 17). Oxidation of this reagent, followed by treatment with methyl 
acrylate, provided the N-aminated aziridine as a mixture of stereoisomers. α-Methylene-γ-
butyrolactone underwent aziridination with an improved steroisomeric ratio, and introduction of a 
gem-dimethyl group to the α-methylene-γ-butyrolactone substrate saw 19 produced as a single 
diastereomer. The configuration of the major diastereomer was confirmed by X-Ray crystallography, 
allowing a transition state model to be suggested.
37
 A second-generation aminating agent 20 was 
developed, using an N-aminoquinazolone, which allowed control of aziridine stereochemistry through 
the presence or absence of an acid catalyst.
38
 The group applied the N-aminoquinazolone catalyst to a 
range of α,β-unsaturated esters, isolating aziridine-2-carboxylates in moderate to good yields. Access 
to either aziridine diastereomer was possible through the presence or lack of TFA (Scheme 17).
39
 
Both aminating agents 18 and 20 were synthesised as racemates. However, a later communication 
describes the synthesis of a third generation aminoquinazolone as a single enantiomer, for the 
asymmetric synthesis of aziridine-2-carboxylates.
40
 
 
Scheme 17: Nitrene-aziridination methodology 
Notwithstanding this elegant chemistry, nitrene methodologies commonly suffer from lack of 
selectivity and functional group compatibility, due to the harsh conditions required for their 
generation. Nitrenoid reagents
41, 42
 with tempered reactivity were generated from PhI=NTs and iron or 
manganese catalysis and first used for aziridination by Manusy.
43
 The chemistry was subsequently 
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developed into a synthetically useful method with considerable substrate scope by Evans et al., using 
copper catalysis.
44
 
 
Evans identified both Cu(I) and Cu(II) complexes as efficient promoters of alkene aziridination using 
PhI=NTs. Asymmetric aziridination was realised through the use of C2-symmetric chrial 
bis-oxazoline ligands. Cinnamate esters were a particularly useful class of substrates, leading to N-
tosyl aziridine-2-carboxylates. Optimisation of conditions specifically for these substrates, using bis-
oxazoline 21 led to excellent ee‟s (94-97%) with only the trans diastereomers observed (Scheme 18). 
A transfer hydrogenation protocol was developed, demonstrating the synthetic utility of the aziridine-
2-carboxylates as precursors to N-tosylated phenylalanine derivatives. In one case, the phenylalanine 
derivative 22 was used to assign the absolute stereochemistry of its aziridine precursor.
45
 Scott and co-
workers subsequently reported similar methodology using a copper biaryl Schiff base complex for 
enantioinduction (Scheme 18).
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Scheme 18: Asymmetric aziridination and transfer hydrogenation 
Recent developments in copper-nitrenoid chemistry have led to the disclosure of a CH-activation 
protocol using a similar combination of reagents. Chan et al. were able to effect the aziridination of 
thirteen 2-alkyl-β-ketoesters in >61% yields, using Cu(OTf)2 and PhINTs in the presence of 1,10-
phenanthroline and 4Å molecular sieves (Scheme 19). Two mechanisms were suggested for the 
aziridination. Both involve the initial formation of a chelated copper enolate 23. In the first pathway, 
dual-nitrene insertion into the allylic CH bond and at the α-position of the β-ketoester via a radical 
pathway, forms aziridine intermediate 24. Collapse of the copper enolate followed by a second ring-
closure generates the aziridine product 25. The second pathway involves addition of copper enolate 23 
to the electrophilic iodine species, to give hypervalent iodine species 26. A cyclic mechanism 
generates olefin 27. Addition of TsN=Cu to the alkene as detailed in the literature provides aziridine 
25.
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Scheme 19: ‘CH-activation’ to aziridine-2-carboxylates 
N-Tosyl aziridines are common products in nitrenoid aziridination methodologies, owing to the 
stabilisation of the nitrenoid through electronic and steric effects. The high affinity of copper for 
nitrogen means that N-protection is required, and consequently, nitrenoid methodologies cannot be 
used to synthesise NH-aziridine-2-carboxylates directly. 
Nucleophilic nitrogen 
A milder method for generating aziridine-2-carboxylates from alkenes arises from the stepwise 
addition-elimination of a nitrogen nucleophile bearing a leaving group (Scheme 20). The increased 
nucleophilicity of nitrogen with respect to carbon means that initial deprotonation of the nucleophile 
is not necessary, thus avoiding the strongly basic conditions associated with analogous carbon-based 
reagents (cf. aza-Darzens chemistry). trans-Aziridines are the common products of this methodology, 
owing to bond rotation in the intermediate enolate allowing ring-closure to occur through the 
lowest-energy transition state. 
 
Scheme 20: Nucleophilic nitrogen bearing a leaving group for aziridination 
N-Chloro-N-sodiocarbamates
48
 have been used in the phase-transfer catalysed aziridination of a 
chiral-auxiliary bearing enamide by Minikata. The chiral quaternary ammonium salt 28 was used as a 
matched ion pair for the chiral enolate of 29 following conjugate addition of the amine. The 
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menthol-derived auxiliary was found to be the most effective for high dr, with subsequent cleavage 
using DMAP in MeOH providing the N-Cbz-aziridine-carboxylic ester 30 in 78% yield (Scheme 21). 
Conjugate addition of the carbamate to the enamide is followed by stereoselective ring-closure, 
arising from a preferred conformation of the catalyst and the chiral enamide. The report focussed on 
optimisation of reaction conditions, such as catalyst, auxiliary and solvent. Substrate scope was not 
reported.
49
 
 
Scheme 21: Example of Minikata’s diastereoselective aziridination 
Calcium oxide-mediated addition of ethyl nosyl carbamate to α,β-unsaturated esters has been used to 
furnish N-ethyl carbonate protected aziridines in moderate to good yields (57-72%) (Scheme 22). 
Deprotection of the aziridines with NaOMe in MeOH provided the NH-aziridine-2-carboxylates, 
although no yields were reported.
50
 α-Ylidene γ-lactones were also susceptible to aziridination, 
resulting in spiro-aziridines.
51
 The addition of ethyl nosyl carbamate to 2-(trifluromethyl)acrylates 
required strong base (NaH) for cyclisation. Under the CaO-mediated conditions, the adduct could be 
isolated, providing evidence for the stepwise addition-cyclisation mechanism.
52
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Scheme 22: N-ethyl carbonate aziridines from electron-poor alkenes 
Addition-elimination to enoates provides an attractive potential route to NH-aziridine-2-carboxylates, 
through the use of a primary amine bearing a leaving group. However, such methodology has not 
been described in the literature, aside from two examples from Armstrong.
53
 Protocols for the 
synthesis of NH-aziridines from enones via this chemistry are more readily available, and provide 
precedent for the applicability of this chemistry to enoates. 
1.1.2 NH-aziridines via addition to electron-poor alkenes 
Hydroxylamines are a class of reagents that have been used with success for this chemistry. 
O-Sulfonyl hydroxylamines were used by Hamelin to effect NH-aziridination of electron-deficient 
alkenes. Evidence for a stepwise mechanism arose from the isolation of an addition product in the 
absence of Et3N to facilitate ring-closure (Scheme 23).
54
 Interestingly, retention of olefin geometry 
was observed in a separate report, on reaction of electron-rich olefins with the analogous 
p-tosylhydroxylamine, implying a concerted nitrene-like mechanism.
55
 Methoxyamine has also been 
used similarly by Seko, with the intermediate adduct isolated prior to aziridine ring-closure (Scheme 
23). However, the scope of the procedure was limited, with only two enone substrates reported, and 
poor diastereoselectivity observed.
56
 An enantioselective protocol utilising chiral iminium catalysis 
has also been developed by Córdova (Scheme 23). Nucleophilic addition of acetylated 
hydroxylamines to enals in the presence of the Jørgensen-Hayashi catalyst 31 provided chiral 
aziridines in good yields and ee‟s.57 The methodology has recently been adapted to access terminal 
aziridines from the corresponding enals.
58
 
26 
 
 
Scheme 23: Hydroxylamines in NH-aziridination 
A hydrazine has been used in an analogous manner, detailed in a short communication from Harvey. 
The method was developed to access NH-aziridine-2-acrylanilide 34, as established methodology had 
not been successful. Treatment of acrylanilide 32 with dimethyl hydrazine afforded the conjugate 
addition compound 33. Selective methylation of the tertiary amine and base-mediated ring closure 
provided aziridine 34 (Scheme 24).
59
 
 
Scheme 24: Dimethylhydrazine as a reagent for nucleophilic aziridination 
More recently, similar methodology employing nitrogen ylides has allowed the transformation of 
Harvey‟s methodology into a one-step protocol. Nitrogen-sulfur and nitrogen-nitrogen ylides have 
been used, with the key difference that the nitrogen or sulfur leaving group is pre-charged, negating 
the methylation step required in Harvey‟s chemistry (Scheme 25). 
 
Scheme 25: A nitrogen-nitrogen ylide in aziridination 
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Furukawa and Oae were the first to use free diphenyl sulfinimine for ylide-mediated aziridination. 
Mixtures of trans-NH-aziridines and vinyl amines were produced following treatment of unsaturated 
1,4-dicarbonyl compounds with the reagent, in modest to good yields (Scheme 26). Reaction of 
dimethylmaleate led to the trans-aziridine, and complete isomerisation of the recovered starting 
material. No isomerisation was observed in the absence of diphenyl sulfinimine, indicating 
reversibility of the initial conjugate addition.
60, 61
 The methodology was used by Spry at Eli Lily, in 
the synthesis of C2-spiraziridino-cephalosporins (Scheme 26). Selectivity was observed for the 
γ,δ-olefin of an α,β,γ,δ-unsaturated ester, presumably due to steric encumbrance surrounding the 
α,β-system, and the added electron-withdrawing properties of the vinyl sulfoxide of the γ,δ-olefin.62 
 
Scheme 26: Diphenylsulfinimine in the synthesis of NH-aziridines 
Following Harvey‟s discovery, work from Ikeda led to the generation of a dimethyl hydrazine-derived 
ylide 35 in situ (Scheme 27). Whilst Harvey reported the primary amine as the nucleophilic site of the 
reagent, complimentary reactivity was observed by Ikeda. Reaction of dimethylhydrazine with 
methyloxirane proceeded through the initial attack of the tertiary amine at the unsubstituted 
epoxide-carbon. The quaternary amine was generated, followed by an intramolecular deprotonation to 
give ylide 35. Once synthesised, the ylide was used in situ, forming the NH-aziridines from a range of 
chalcones in 67-89% yield. Complete diastereoselectivity for the trans-aziridines was observed.
63
  
 
Scheme 27: Ikeda’s ylide for aziridination 
Xu et al. identified an isolable ylide precursor 36 on the amination of DABCO with 
hydroxylamine-O-sulfonic acid (HOSA). Treatment of thirteen α,β-unsaturated ketones with the 
reagent in the presence of base led to the derived aziridines in >76% yield (Scheme 28). Electron-
poor (nitro-substituted) chalcones were a limitation of the methodology, with low isolated yields of 15 
and 17%. Electron-rich styryl derivatives were unsuccessful substrates in the aziridination, suggestive 
of a nucleophilic stepwise mechanism, as opposed to nitrene reactivity.
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Scheme 28: Hydrazinium nitrate precursor for ylide-promoted aziridination 
Following Xu‟s methodology, Armstrong and co-workers discovered that nitrogen ylides bearing the 
N-methylmorpholine scaffold were effective promoters of aziridination (Scheme 29). Optimisation of 
the aziridination of chalcone provided a 95% yield, identical to that observed by Xu, but under more 
amenable reaction conditions, using MeCN and NaOH.  Two syntheses of the ylide precursor were 
developed, bearing nitrate and iodide counterions. Electron-poor substrates provided better yields with 
the nitrate salt 37, whilst electron-rich performed optimally using the iodide salt 38, under modified 
conditions. Aziridination proceeded with complete trans-diastereoselectivity.
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Scheme 29: N-methylmorpholinium salts in NH-aziridination 
The method was further developed to involve in situ generation of the ylide (Scheme 30). 
O-(diphenylphosphinyl)hydroxylamine (DppONH2) 39 was found to effect the in situ amination of 
NMM and subsequent formation of chalcone-derived aziridine in an excellent 88% yield. No 
aziridination occurred in the presence of DppONH2 alone, and the secondary amine morpholine did 
not promote aziridination, providing support for the proposed aminimine pathway. Following 
optimisation, a range of α,β-unsaturated ketones were aziridinated in yields of >62%, superior to those 
observed using the hydrazinium salt chemistry. Reactions typically took place in 10-24 h.
66
 Two 
tert-butyl enoate substrates were also tested, with the aziridine of tert-butyl acrylate isolated in 80% 
yield. tert-Butyl cinnamate proved to be the most challenging substrate tested; an isolated yield of just 
32% was obtained after 40 h. The poor yield was attributed to the electron-rich substrate slowing the 
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nucleophilic aziridination. Investigation into enantioselective aziridination has highlighted quinine as 
the most effective promoter. The enantiomer shown was generated in 56% ee, using quinine under 
slightly modified conditions.
53, 67, 68
 The in situ methodology has since been applied to 
α,β,γ,δ-unsaturated ketones, providing good yields of vinyl-aziridines in excellent 
trans-diastereoselectivity and excellent regioselectivity for the α,β-olefin.69 
 
Scheme 30: Development of in situ aziridination 
1.2 Project aims 
Owing to the relative dearth of methodology to access NH-aziridine-2-carboxylates, the opportunity to 
develop the in situ aziridination for enoate substrates using Armstrong‟s methodology was realised. 
This would potentially allow expedient access to NH-aziridine-2-carboxylates from readily available 
starting materials, presenting an attractive alternative to current stepwise methodologies. Following 
this, the susceptibility of the non-activated NH-aziridines to nucleophilic ring-opening could be tested. 
If ring-opening was successful, it would be possible to access a range of biologically relevant 
structures from a common aziridine-2-carboxylate intermediate. 
 
Thus, the aims of the project were: 
- To optimise the in situ Armstrong methodology for enoate substrates, and examine the scope 
of the reaction; 
- To subject the resulting NH-aziridine-2-carboxylates to nucleophilic ring-opening, to 
establish susceptibility to nucleophilic attack. 
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1.3 Results and Discussion  
1.3.1 Optimising the enoate aziridination 
1.3.1.1 Reagent synthesis 
trans-tert-Butyl cinnamate 42a was selected as the initial substrate for aziridination optimisation. The 
substrate was considered the more synthetically useful of the two tert-butyl enoate substrates reported 
in the original paper,
69
 but the derived aziridine had only been isolated in 32% yield. Prior to 
commencing optimisation studies, a robust synthesis of the substrate was required, due to the high 
cost of the commercially available material. The ready availability of trans-cinnamic acid 40a 
prompted a synthesis beginning with this reagent. Formation of cinnamoyl chloride 41a was facile; on 
treatment of the starting acid with oxalyl chloride, complete conversion was observed by TLC 
analysis after 1 h. The volatiles were removed in vacuo, the acid chloride re-dissolved in THF and 
treated with commercial KO
t
Bu (1 M in THF). After 16 h., work-up and chromatographic purification 
provided trans-tert-butyl cinnamate 42a in 80% yield on a 7 mmol scale (Table 1, entry 1). Brief 
optimisation revealed that KO
t
Bu (1 M in THF) was the most effective reagent for generation of the 
tert-butyl ester; re-dissolution of the acid chloride in tert-butanol and treatment with solid KO
t
Bu 
caused complete hydrolysis to the starting acid (entry 2) and a considerably lower yield was observed 
on using commercial KO
t
Bu (s) in THF (entry 3). Subsequent scale-up of the cinnamate synthesis 
provided the product in comparable yield (entries 4 and 5). 
Table 1: trans-tert-Butyl cinnamate synthesis 
 
Entry Scale (mmol) Solvent Form of KO
t
Bu Isolated yield (%) 
1 7 THF 1M in THF 80 
2 24 t-BuOH (s)
a 
-
b 
3 7 THF (s) 50 
4 17 THF 1M in THF 73 
5 24 THF 1M in THF 91 
Reactions performed at a concentration of 0.7 M. a 1.05 eq. KOtBu b Complete hydrolysis to cinnamic acid observed by 1H 
NMR analysis of the crude reaction mixture. 
It was decided to initially validate the aziridination of trans-tert-butyl cinnamate by repeating the 
literature procedure. In order to do this, the aminating agent DppONH2 (39)
70, 71
 had to first be 
synthesised. Following the published protocol,
53
 phosphinyl chloride 43 in dioxane was added at -5 
°C to a stirred solution of hydroxylamine hydrochloride, pre-treated with aqueous sodium hydroxide 
(Scheme 31). The crude product was filtered and dried in vacuo before purification by slurrying in 
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aqueous sodium hydroxide and rigorous drying in vacuo. Although isolated in low yield, the 
aminating agent was judged of sufficient purity by NMR analyses (
1
H and 
31
P) to be used in the 
aziridination. More recently, an alternative synthesis of the aminating agent has been published.
72
 The 
procedure differs in that Et2O is used in place of dioxane, and mechanical stirring is required for 
complete mixing of the biphasic reaction. The Schotten-Baumann conditions allow considerably 
improved recovery of DppONH2. Subsequent preparations of DppONH2 were carried out following 
this procedure, which provides the reagent in high purity, and reproducible quantitative yield.  
 
Scheme 31: DppONH2 synthesis 
With the aminating agent and cinnamate in hand, the first aziridination reaction could be carried out. 
Repeating the reported procedure, NMM was added dropwise to a suspension of the aminating agent 
in CH2Cl2 and stirred for 30 min., before the sequential addition of NaOH and trans-tert-butyl 
cinnamate. Work-up and analysis of the 
1
H NMR spectrum of the crude material revealed a 35% 
conversion to aziridine 1a with starting cinnamate the only other compound observable. Purification 
by column chromatography provided a 31% isolated yield of the aziridine as the single 
trans-diastereomer, comparable with the literature value of 32% (Scheme 32).  
 
Scheme 32: Repeat of literature conditions for tert-butyl cinnamate aziridination 
In order to speed up analysis during optimisation, it was decided to use the conversion observed by 
1
H 
NMR of the crude material as a guide to the success of changes made to the reaction conditions. The 
conversion was calculated by measuring the integrals of three sets of selected peaks relating to both 
tert-butyl cinnamate and aziridine 1a and inserting the values into (Equation 1). Three sets of peaks 
were compared for increased accuracy (Table 2), all with good chemical shift separation and no 
overlap with other signals. 
 
(Equation 1) 
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Table 2: Signals integrated to obtain conversion value 
tert-Butyl cinnamate Chemical shift (ppm) Aziridine 1a Chemical shift (ppm) 
PhCH 7.60 PhCHNH 3.17 
C(O)CH 6.42 C(O)CHNH 2.50 
C(CH3)3 1.55 C(CH3)3 1.50 
1.3.1.2 The catalytic cycle 
To begin optimisation of the aziridination of tert-butyl cinnamate, the catalytic cycle of the 
aziridination was first considered (Scheme 33). The cycle begins with amination of NMM by 
DppONH2, which generates the hydrazinium species 44. Under basic conditions, the presumed active 
intermediate, aminimine 45 is formed, which adds in a conjugate fashion to the substrate. Ring-
closure yields the aziridine and regenerates NMM.
53
 Previous studies have shown that a tertiary amine 
is required for aziridination; the reaction does not proceed if a secondary amine is used, and 
DppONH2 alone does not generate the aziridine.
67, 73
 It is thought likely that the cycle proceeds under 
general base catalysis and that existence of the aminimine is transient. Hydrazinium salts have been 
isolated and characterised in previous work and the hydrazinium species has been observed by 
1
H 
NMR (in d6-DMSO), on treatment of NMM with DppONH2.
67, 74
 However, there is limited evidence 
for the existence of the aminimine. An attempt has been made to measure the pKa of the aminated 
hydrazinium salt of NMM using potentiometric titrations, to establish whether hydroxide and alkoxide 
bases used in the aziridination would be strong enough to effect deprotonation to form the 
aminimine.
67
 A pKa value of greater than 12.5 was indicated, although a precise value could not be 
established, owing to the upper limit of the equipment (pH = 12.5).  
 
The heterogenous nature of the aziridination has prevented any detailed kinetic studies, but 
circumstantial evidence suggests that the cyclisation step is rate-limiting. Original optimisation 
studies tested several tertiary amine promoters, and found that cyclic tertiary amines with lower pKa 
values provided higher yields of aziridine. This could be related to the leaving-group ability of the 
tertiary amine in the final cyclisation step. Additionally, a clear trend in relative reactivity for electron 
rich and electron poor enones has not been observed, which suggests that the addition step is not 
rate-limiting.  
 
Considerable effort in previous optimisation identified that DABCO, quinuclidine, NMP and NMM 
were the most favourable tertiary amine promoters for aziridination. Optimum solvents included 
MeCN, CH2Cl2, THF and DMF, and hydroxide or alkoxide bases were found to be most suitable.
73
 
These results were considered along with the catalytic cycle, in the optimisation of enoate-specific 
aziridination conditions. However, it was also realised that all previous studies had been carried out 
using enone substrates. The differing electronic properties of the two substrate classes could have 
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considerable implication on the catalytic cycle, and consequently, the optimum reagents for 
aziridination. 
 
Scheme 33: Catalytic cycle for Armstrong aziridination 
1.3.1.3 Towards a homogeneous aziridination 
The heterogeneous nature of the reaction was highlighted as a possible cause for the low conversions 
to aziridine 1a observed. Consequently, increasing the dissolution of the inorganic components, 
namely DppONH2 and NaOH, was a first priority in optimisation. 
Solvent choice 
A range of anhydrous solvents were selected and tested under the published aziridination conditions. 
The polar solvent MeCN was chosen, which had been used with success for other substrates in the 
reported methodology, along with the alternative chlorinated solvents, dichloroethane and CDCl3 
(selected in the absence of anhydrous CHCl3). The reaction remained heterogeneous in all three 
solvents, and no conversion to aziridine was observed (Table 3, entries 2-4). Quantitative recovery of 
starting cinnamate was observed by 
1
H NMR analyses of the spectra of the crude material. It was 
observed that increasing the volume of solvent used led to increased dissolution of the inorganics and 
improved magnetic stirring. Consequently, further reactions were carried out at a decreased 
concentration of 0.03 M (with respect to the cinnamate), with the polar solvents MeOH, THF and 
diethyl ether, and also DMSO tested. DMSO and MeOH were the only two solvents in which the 
reaction components dissolved completely, but no conversion to aziridine was observed in either, nor 
was any conversion observed in the ether solvents (entries 5-8). Interestingly, the only solvent apart 
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from CH2Cl2 to provide any conversion to aziridine 1a was toluene, in an identical 35% (entry 9).  
Due to the lower cost and higher volatility of CH2Cl2, further optimisation was carried out in this 
solvent. The phase transfer catalyst TBAB was included in two experiments in CH2Cl2, at 10 mol% 
and 100 mol% loadings (entries 10 and 11), but lower conversion to aziridine 1a was observed in both 
experiments, and so the additive was omitted in further optimisation.  
Table 3: Screen of solvents 
 
Entry Solvent 
1
H NMR conversion (%) 
1
a 
CH2Cl2
 
35 
2
a 
MeCN 0 
3 Dichloroethane 0 
4 CDCl3 0 
5
b 
DMSO 0 
6
b 
MeOH 0 
7
b 
THF 0
c 
8
b 
Et2O 0
c 
9
b 
Toluene 35 
10
b,d
 CH2Cl2 17 
11
b,e
 CH2Cl2 32 
Reactions performed on 0.12 mmol scale of tert-butyl cinnamate. a 0.49 mmol scale. b Carried out at a concentration of 0.03 
[M]. c Degradation observed by 1H NMR analysis of crude material. d TBAB (100 mol%) added. e TBAB (10 mol%) added. 
Base choice 
It was suggested that the low conversions to aziridine observed might be due to instability of the 
reagents to the NaOH. To establish whether the aminating mixture (NMM and DppONH2 pre-stirred 
in CH2Cl2 for 30 min.) was undergoing degradation under the reaction conditions, a reaction was set 
up using the standard conditions, and a second portion of aminating mixture was added to the 
aziridination after 20 h. An identical 35% conversion was obtained, which was inconclusive. 
Subsequent experimentation involved pre-stirring the aminating mixture with NaOH for set time 
intervals, prior to the addition of the cinnamate, reasoning that lower yields could indicate poor 
stability of the aminating agent to hydroxide. Interestingly, a time delay of 20 min. between NaOH 
and substrate addition was found to improve the conversion from 35 - 47% (Table 4, entry 1 vs. 2). It 
was suggested that this time delay could allow some initial deprotonation of the hydrazinium to occur 
thus increasing the rate of nucleophilic attack. However, stirring the aminating mixture with NaOH 
for a considerably longer time period (160 min.) prior to cinnamate addition did lead to decreased 
conversion (23%) (entry 3), suggesting that the aminating mixture is unstable when exposed to 
hydroxide for this longer time period. Optimisation therefore continued including 20 min. between 
base and substrate addition. 
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If the increased conversion observed with the 20 min. delay prior to NaOH addition was due to some 
initial hydrazinium deprotonation, then it was reasoned that a stronger base could allow a further 
increase in conversion to aziridine. KO
t
Bu has enjoyed previous success in the aziridination 
methodology, when used as a commercial 1 M solution in THF.
67
 Additionally, any transesterification 
with the reagent would regenerate the tert-butyl ester. Substituting KO
t
Bu (1 M in THF) for NaOH 
under the optimised conditions led to a low conversion of 3% (entry 4), but with a good mass 
recovery of tert-butyl cinnamate obtained. The result suggested that the aminating mixture was 
unstable to the more strongly basic KO
t
Bu. Some evidence for this hypothesis was obtained on 
repeating the reaction with sequential addition of KO
t
Bu and tert-butyl cinnamate, and with increased 
equivalents of NMM and DppONH2 with respect to KO
t
Bu. In this case, conversion to the aziridine 
was a respectable 45% (entry 5). Treatment with LiO
t
Bu under these modified conditions led to a 
lower conversion of 35% (entry 6). NaO
i
Pr, synthesised in situ from NaH and 
i
PrOH, had been used 
with success by a co-worker in the aziridination of sensitive α-enolisable substrates.67 These 
conditions, albeit slightly modified, were tested in the aziridination of tert-butyl cinnamate. 
Conversions were below the optimum 47%, whether the base and ester were added sequentially, or 
the 20 min. delay between addition of reagents was included (entries 8 and 9). 
 
Given this, attention was re-focussed on the optimum conditions that had provided the 47% 
conversion to aziridine, ensuring that the base was the sole variable in further testing. On testing solid 
KO
t
Bu, a 15% conversion to aziridine was observed (entry 7). Consequently, further investigation 
into tert-butoxide bases was halted, given the poorer conversions observed with the reagents. An 
alternative hydroxide base, KOH, was selected but gave a low conversion to aziridine of 18% (entry 
10). Two weaker bases, K2CO3 and Hünig‟s Base, provided no conversion to aziridine when 
substituted for NaOH (entries 11 and 12); seemingly both were too weakly basic to effect 
deprotonation and drive the aziridination forward. Finally, the aziridination was attempted using 
NaOH with mild heating, to try to increase the conversion further. However, reactions performed at 
25 °C and 30 °C led to decreased conversions, possibly due to poor stability of the aminating agent at 
increased temperatures (entries 13 and 14). Reactions at temperatures of 40 °C and above led to a 
decrease in diastereoselectivity, along with impurity formation. Of the bases tested, NaOH had 
provided the optimum conversion to aziridine, and so was selected for continuing testing of other 
variables. 
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Table 4: Screen of bases 
 
Entry Base 
1
H NMR conversion (%) 
1
a,h 
NaOH 35 
2 NaOH 47 
3
b 
NaOH 23 
4 KO
t
Bu (1M in THF) 3 
5
a,g 
KO
t
Bu (1M in THF) 45 
6
a,g 
LiO
t
Bu (1M in THF) 35 
7
c 
KO
t
Bu (s) 15 
8
d 
NaO
i
Pr 20 
9
a,d 
NaO
i
Pr 30 
10 KOH 18 
11 K2CO3 0 
12 Hünig‟s Base 0 
13
e 
NaOH 35 
14
f 
NaOH 38 
Reactions performed on 0.12 mmol scale of tert-butyl cinnamate. a tert-butyl cinnamate and base added sequentially. b 160 
min. between addition of tert-butyl cinnamate and NaOH. c KOtBu (s) purchased. d NaOiPr (4 eq.) synthesised in situ from 
NaH and iPrOH; performed at [0.06M]. e Hotplate set at 25 °C throughout reaction. f Hotplate set at 30 °C throughout 
reaction. g NMM (2 eq.), DppONH2 (2 eq.), NaOH (3 eq.). 
h Performed at [0.06 M]. 
1.3.1.4 Investigating reagent stoichiometry 
Next, reagent stoichiometry was considered, reasoning that this could have a considerable effect on 
the catalytic cycle, particularly due to the heterogeneous nature of the reaction. An increase in the 
stoichiometry of NaOH from 2 to 4 eq. provided a slightly better conversion of 50% (Table 5, entry 1 
vs. 2). Interestingly, no conversion to aziridine was observed on using commercial NaOEt under 
analogous conditions (entry 3), providing further evidence that the aminating mixture is unstable to 
alkoxide base. A large excess of NaOH (20 eq.) only led to a slightly detrimental effect on the 
conversion (47%, entry 4).  Since the optimum conversion observed to this point was 50%, it was 
suggested that a sub-stoichiometric loading of reagents could allow for increased conversion (as long 
as the CH2Cl2 was still saturated) due to lower quantities of insoluble inorganics in the reaction 
mixture. An excess of insoluble reagents could hinder aziridination, causing inefficient stirring and 
fewer productive molecular collisions. However, decreased conversions were observed for two 
reactions employing sub-stoichiometric loadings of NMM and DppONH2 (entries 5 and 6). Increasing 
the equivalents of aminating agent and NMM also led to poorer conversions (37 and 33%, entries 7 
and 8), whilst an excess of tertiary amine alone was found to provide a similar conversion of 36% 
(entry 9). The optimum conversion of 50% had been observed in this study on using 4 eq. of NaOH, 
and so this stoichiometry was used for further experimentation. 
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Table 5: Optimum reagent stoichiometry 
 
Entry Equivalents of reagent 
1
H NMR conversion (%) 
 NMM DppONH2 NaOH  
1 1.04 1.04 2 47 
2 1.04 1.04 4 50 
3
a 
1.04 1.04 4 0 
4 1.04 1.04 20 47 
5 0.8 0.8 2 25 
6 0.6 0.6 2 30 
7 1.04 2 3 37 
8 2 2 3 33 
9 10 1.04 2 36 
Reactions performed on a 0.12 mmol scale. a Reaction performed using NaOEt instead of NaOH. 
1.3.1.5 The effect of concentration 
With the newly optimised conditions, it was decided to investigate concentration more fully. Initial 
experiments had shown that a lower concentration of 0.03 M in comparison to the literature 0.06 M 
provided an increase in conversion to aziridine 1a (Table 4, entry 1 vs. 2). An average of conversions 
in three experiments at this concentration was taken to ensure reproducibility, with a value of 47% 
obtained. Performing the aziridination at concentrations below 0.03 M gave similar conversion values, 
and so it was decided to test the chemistry at increased concentrations. Interestingly, a clear trend of 
conversion increasing with concentration could be observed (Graph 1). At a concentration of 0.06 M, 
an average conversion of 56% was obtained. This was the concentration used in the published 
aziridination protocol, with the key differences at this point being the increased NaOH stoichiometry 
(2 to 4 eq.) and the inclusion of the 20 min. time period between the addition of the base and the 
substrate to the aminating mixture. At concentrations of 0.12 M and greater, the conversion was 
observed to level off (Graph 1); indeed, at 0.48 M the heterogeneous reaction became too 
concentrated for efficient magnetic stirring. As better stirring was observed at 0.24 M, this was the 
selected concentration for further optimisation. An average conversion of 61% was observed on 
performing the reaction at this concentration. The increased conversions observed at higher 
concentrations suggest that good solubility of the reagents is not critical for good conversions in the 
aziridination.  
38 
 
Graph 1: tert-Butyl cinnamate aziridination: Concentration vs. 
1
H NMR
 
Conversion 
 
  
1.3.1.6 Alternative tertiary amines 
Having established that increased concentration led to improved conversions to aziridine, alternative 
tertiary amine promoters were tested at 0.24 M. DABCO was trialled initially, owing to the success of 
isolated aminated salts of the reagent in the preceding aziridination methodology.
65
 No conversion to 
aziridine was observed (Table 6, entry 2), suggesting either that amination of DABCO with 
DppONH2 had not occurred, or that tert-butyl cinnamate was unreactive to the DABCO-derived 
hydrazinium. The DABCO-derived hydrazinium salt has been used with success on a range of 
chalcones, although no tert-butyl cinnamates.
65
 Interestingly, Et3N provided a conversion of 32% to 
aziridine, albeit significantly lower than the 61% obtained using NMM (entry 1 vs. 3). This result 
showed that a rigid cyclic structure is not a necessary feature of the tertiary amine promoter in order 
for aziridination to occur. N-Methyl piperidine was tested, as a structural analogue of NMM. The 
amine provided a 41% conversion to aziridine (entry 4) - 20% lower than the reaction promoted by 
NMM. This suggested that the increased electronegativity of the oxygen atom in the morpholine ring, 
in comparison to the carbon atom in the analogous piperidine, is beneficial for high conversions in the 
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aziridination. Quinuclidine had been tested in the aziridination under the dilute conditions (0.03 M in 
substrate), in the hope that this more nucleophilic tertiary amine might speed up the rate of amination, 
and hopefully, overall conversion to the aziridine. However, only a 10% conversion to aziridine was 
observed, considerably lower than the 47% optimum observed using NMM under these conditions 
(entry 5 vs. 6). The cinchona alkaloid quinine has been used as a chiral tertiary amine in the 
aziridination of chalcone, yielding the aziridine in 56% ee.
53
 If quinine could be used as tertiary amine 
promoter for the aziridination of tert-butyl cinnamate, then the possibility for enantioinduction would 
arise. Quinine was substituted for NMM under the optimum conditions, but on work-up, no 
conversion to aziridine was observed by analysis of the 
1
H NMR spectrum of the crude material 
(entry 7). A second experiment, employing the conditions developed for enantioselective aziridination 
was carried out.
53
 The reaction was left for the extended time of 40 h. (c.f. 16 h. for chalcone using the 
published conditions) due to the lower reactivity of the substrate. However, using quinine as amine 
promoter, in the presence of NaH/
i
PrOH, with sequential addition of the substrate and base led to no 
conversion to aziridine, and considerable degradation by 
1
H NMR analysis of the crude material 
(entry 8). It is likely that the strongly basic conditions are incompatible with the tert-butyl cinnamate. 
Given that NMM displayed considerably superior conversions in the aziridination in comparison to 
other amines tested, it was decided to halt further investigation into alternative tertiary amines. 
Table 6: Alternative tertiary amine promoters 
 
Entry Tertiary amine promoter 
1
H NMR conversion (%) 
1 NMM 61 
2 DABCO 0 
3 Et3N 32 
4 N-Methyl piperidine 41 
5
a 
NMM 47 
6
a 
Quinuclidine 10 
7 Quinine 0 
8
b 
Quinine 0
 
Reactions performed on a 0.12 mmol scale. a Performed at [0.03 M]. b Quinine (1.04 eq.), DppONH2 (1.04 eq.), NaH (2 eq.), 
iPrOH (2 eq.) used.53 
1.3.1.7 The effect of water 
It was suggested that the equivalent of water produced in each catalytic cycle could be deactivating 
the aminimine via proton transfer, causing the ylide to become too transient to effect aziridination. To 
test this hypothesis, a drop of water (ca. 50 μL, 2.8 mmol) was added to a reaction. Although the 13% 
conversion was significantly lower than the optimum 47% under the same conditions without water 
added (Table 7, entry 1 vs. 2), it was interesting to see that the large excess of water (>20 eq.) did not 
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prevent aziridination altogether. Given the decreased conversion to aziridine in the presence of water, 
drying agents were added to three reactions (performed at lower concentrations to aid magnetic 
stirring). The addition of MgSO4 (20 mg) provided a lower conversion of 45% than the 63% in the 
analogous reaction lacking the additive (entry 3 vs. 4). Similarly, lower conversions of 47% and 43% 
were observed on the addition of molecular sieves, cf. 56% in their absence (entries 6 and 7 vs. 5). 
The lower conversions were attributed to poorer magnetic stirring resulting from the addition of 
insoluble drying agents to the heterogeneous reaction mixture. 
Table 7: The effect of water on the aziridination 
 
Entry Concentration [M] Additive Quantity (mg) 
1
H NMR conversion 
(%) 
1
a 
0.03 none - 47 
2
a 
0.03 H2O ca.50 (1 drop) 13 
3 0.12 none - 63 
4 0.12 MgSO4 20 45 
5 0.06 none - 56 
6 0.06 4Å Mol sieves (powdered) 200 47 
7 0.06 4Å Mol sieves (pellets) 200 43 
Reactions performed on a 0.12 mmol scale. a Reaction performed using NaOH (2 eq.). 
1.3.1.8 Scaling-up the aziridination 
At this point, it was decided to perform a larger-scale aziridination of tert-butyl cinnamate using the 
optimised conditions, in order to bring through material for ring-opening experiments. 14 mMol of 
tert-butyl cinnamate was subjected to the optimum conditions at the increased concentration of 0.48 
M, with the large volume of solvent used on this scale meaning that magnetic stirring was efficient at 
this higher concentration. Work-up of the reaction and 
1
H NMR analysis of the crude material 
revealed a 68% conversion to aziridine 1a, with no other products evident by 
1
H NMR. 
Disappointingly, chromatographic purification on silica provided a 50% isolated yield of aziridine, 
considerably lower than the conversion value (Table 9, entry 1). The discrepancy between conversion 
and isolated yield required investigation. The starting cinnamate was also recovered in 26%, and the 
„conversion‟ to aziridine calculated based on recovered starting material was 66%, comparable with 
the 
1
H NMR conversion. A second large scale (10 mmol) aziridination scale provided a similar 
conversion (67%) and yield (50%), proving reproducibility (Table 9, entry 2). The similarity between 
the conversion values based on recovered starting material and 
1
H NMR analysis provided some 
evidence that the starting cinnamate and aziridine were stable on silica gel; another possibility was 
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that both were undergoing degradation to the same extent, which seemed less likely. Thus it was 
decided to focus attention on the work-up procedure, to try to account for the loss in mass observed.  
 
The work-up procedure for the aziridination involves quenching the reaction with NH4Cl (sat. aq.), 
followed by extraction of the aqueous phase three times with CH2Cl2. The combined organics are then 
dried over MgSO4 and concentrated in vacuo, and the remaining volatiles are removed under high 
vacuum for a brief period (ca. 10 min.). A portion of purified aziridine was subjected to the standard 
work-up conditions, and re-isolated. A poor mass recovery of 56% was obtained, which was verified 
on repeating the experiment using a different batch of aziridine (Table 8, entries 1 and 2). Reasoning 
that the mildly acidic wash could be causing decomposition of the aziridine, distilled water was used 
in place of NH4Cl (sat. aq.), yet a similar mass recovery was obtained (entry 3). Subjecting the 
aziridine to high vacuum for 30 min. provided a quantitative return of starting material, showing that 
the aziridine was not volatile at room temperature under high vacuum (ca. 0.1 mm Hg, entry 4). 
MgSO4 was next identified as a potential cause of the reduced mass recovered, due to its Lewis acidic 
nature. Substituting MgSO4 with the non-Lewis acidic Na2SO4 in the work-up procedure resulted in a 
quantitative return of aziridine, suggesting that the drying agent could be the cause of the low 
recovered mass (entry 5). 
Table 8: Stability of aziridine to work-up conditions 
 
Entry Work-up conditions Mass recovery (%) 
 
Aqueous wash Drying agent  
1
a 
NH4Cl MgSO4 56 
2
a 
NH4Cl MgSO4 61 
3
b 
H2O MgSO4 54 
4
c 
- - Quantitative 
5
a 
NH4Cl Na2SO4 Quantitative 
All experiments perfomed on 0.12 mmol of aziridine. CH2Cl2 used for aqueous extraction. 
a NH4Cl (sat. aq.) used. 
b Distilled 
water used. c Aziridine subjected to high vacuum for 30 min. 
An aziridination was performed on 0.5 mmol scale, substituting Na2SO4 for MgSO4 in the work-up 
procedure. Despite a good 
1
H NMR conversion of 61%, only a 28% yield of aziridine was isolated 
(Table 9, entry 3 vs. 1). Additionally, there was a considerable discrepancy between the 
1
H NMR 
conversion and the conversion calculated based on the isolated yields, (61% vs. 48%). The lower 
value obtained following work-up indicated that the aziridine was unstable to the conditions used. In 
order to confirm that the discrepancy was not due to purification on silica gel, the reaction was 
repeated, purifying on basic alumina. Only 39% of aziridine was isolated, and the discrepancy 
between conversion values was again observed (55% vs. 63%, entry 4). Due to poorer isolated yields, 
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it was decided to cease investigation into alternative work-up conditions. Attention was instead turned 
to the stability of the cinnamate and aziridine to the reaction conditions, to see if the loss in mass 
could be accounted for. 
Table 9: Alternative work-up and purification conditions in the aziridination 
 
Entry Drying 
agent 
1
H NMR 
conversion (%) 
Isolated yield (%) Total isolated 
yield
a
 (%) 
Conversion
b 
(%) 
   Aziridine Cinnamate   
1
c,e 
MgSO4 68 50 26 76 66 
2
c,f 
MgSO4 67 50 30 80 63 
3
c,d 
Na2SO4 61 28 30 58 48 
4
d,g 
Na2SO4 63 39 32 71 55 
a Combined yield (%) of starting material and product. b Calculated using isolated yields of aziridine and cinnamate. c 
Purification by column chromatography on silica. d Performed on 0.5 mmol scale. e Performed on 10.0 mmol scale. f 
Performed on 14.0 mmol scale.  g  Purification by column chromatography on basic alumina.  
1.3.1.9 Investigating reagent and product stability 
tert-Butyl cinnamate was first subjected to treatment with the aziridination reagents in various 
combinations. Standard aziridination conditions were used, except for the selected omitted reagents 
detailed (Table 10). Treatment with NaOH led to a quantitative mass recovery of tert-butyl cinnamate 
after work-up, demonstrating stability of the reagent to NaOH under the conditions (entry 1). The 
combination of NMM and NaOH yielded a lower recovered mass, of 80% (entry 2). Interestingly, 
NMM alone gave an identical mass recovery (entry 3), indicating that the cinnamate is unstable to the 
tertiary amine. Stirring the cinnamate with the aminating agent led to a quantitative recovery of 
starting material (entry 4), whilst a loss in recovered mass was observed on stirring with the aminating 
agent in the presence of NaOH (entry 5). This last result is particularly important in its own right; the 
aminating agent does not effect aziridination in the absence of the tertiary amine, suggestive that the 
aminimine pathway is in operation. 
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Table 10: Stability of tert-butyl cinnamate to aziridination reagents 
 
Entry Reagent Mass recovery (%) 
 NMM NaOH DppONH2  
1    Quantitative 
2    80 
3    80 
4    Quantitative 
5    60 
tert-Butyl cinnamate stirred with selected aziridination reagents under otherwise standard conditions.  = Reagent included 
in experiment.  = Reagent omitted from experiment. 
Similar experiments were performed to test the stability of the aziridine to the reaction conditions 
(Table 11). An initial result was pleasing; stirring in the presence of NaOH returned a quantitative 
yield of aziridine (entry 1). However, treatment with other reagents led to worrying mass recoveries. 
It appeared that NMM was a factor in the poor mass recoveries observed, which were all below 30% 
on treatment with the reagent (entries 2-4). In all control experiments, only starting material was 
observed by 
1
H NMR analysis of the crude reaction mixture. 
Table 11: Stability of aziridine to aziridination reagents 
 
Entry Reagent Mass recovery 
(%) 
1
H NMR conversion to 
tert-butyl cinnamate (%) 
 NMM NaOH DppONH2   
1    Quantitative N/Aa 
2    17 N/Aa 
3    30 2 
4    8 3 
Aziridine stirred with selected aziridination reagents under otherwise standard conditions.  = Reagent included in 
experiment.  = Reagent omitted from experiment. a Not applicable. 
Interestingly, a very small level of conversion to tert-butyl cinnamate was observed in the presence of 
NMM and NaOH (entries 3 and 4). It was suggested that the aziridination could be reversible, with 
attack of the NMM at the aziridine nitrogen, and ring-opening to form enolate 46. Collapse of the 
enolate could then generate tert-butyl cinnamate, with loss of the aminimine ylide 45 (Scheme 34). 
tert-Butyl cinnamate was only generated in the presence of NaOH; NMM alone did not effect the 
transformation, suggesting that basic conditions were necessary for aminimine stability. However the 
unusual nature of this mechanism was realised, with no examples of nitrogen nucleophiles attacking 
aziridine on nitrogen identified following a literature search.  
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Scheme 34: Suggested mechanism for formation of tert-butyl cinnamate from aziridine 
As a test of this mechanistic proposal, which leads to the production of the NMM aminimine, the 
reaction was performed in the presence of chalcone, a known successful aziridination substrate, as an 
ylide trap. Chalcone was added to aziridine 1a in CH2Cl2 in the presence of NMM and NaOH 
(Scheme 35). However, after 40 h., work-up and analysis of the 
1
H NMR spectrum showed no 
conversion to the chalcone-derived aziridine 47. 
 
Scheme 35: Aziridine 1a as the aminating agent 
An alternative mechanism in the presence of DppONH2 was suggested; electrophilic amination of the 
aziridine nitrogen, followed by ring-opening and loss of diimide could generate tert-butyl cinnamate, 
although this did not provide an explanation for observation of the reagent in the absence of 
DppONH2.  
 
Owing to the poor mass recoveries observed on earlier treatment of the aziridine with NMM, it was 
suggested that avoidance of the reagent could lead to increased yields of aziridine. A previous screen 
of tertiary amines (vide supra) had revealed that NMM was considerably superior for the 
methodology. Additionally, it seemed likely that DppONH2 was incompatible with the aziridine; a 
considerable drop in recovered mass was observed upon inclusion of the reagent in a control reaction 
(Table 11, entry 3 vs. 4). These considerations prompted investigation into the use of alternative 
aminating agents and tertiary amines which might be more appropriate for the aziridination of 
tert-butyl cinnamate. 
1.3.1.10 An alternative aminating agent  
Oxaziridines 
Oxaziridines are successful nitrogen transfer agents, and several literature examples exist of their use 
as a source of electrophilic nitrogen.
75
 Oxaziridine 48 has been used by Ellman et al. as an 
electrophilic aminating agent, in the synthesis of O-alkyl oximes.
76
 Treatment of potassium alkoxides 
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with 48 led to the formation of O-alkyl hydroxylamines, with di-tert-butyl ketone 50 generated as the 
by product (Scheme 36).  
 
Scheme 36: Ellman’s synthesis of O-alkyl hydroxylamines using di-tert-butyl oxaziridine 
It was suggested that a nucleophilic tertiary amine could react with 48 in an analogous fashion, to 
provide aminimine 45 required for the aziridination protocol. If successful, alternative tertiary amines 
could be used, circumventing the stability problems observed with NMM. Furthermore, the proposed 
mechanism for amination would not require a base to drive the aziridination forward (Scheme 37). 
 
Scheme 37: Proposed catalytic cycle using di-tert-butyl oxaziridine as aminating agent 
Synthesis and reactivity  
Ellman‟s procedure was adapted for the synthesis of oxaziridine 48. mCPBA was added over 1 h. to 
the commercial di-tert-butyl imine in CH2Cl2 at 0 °C. Removal of CH2Cl2 in vacuo provided the crude 
product. Washing with NaHCO3 (sat. aq.) removed the mCBA by-product, and the oxaziridine was 
isolated in 88% purity by 
1
H NMR, with a contaminant tentatively assigned as di-tert-butyl ketone 50. 
Kugelrohr distillation improved the purity from 88 to 93%, although the similar volatilities of the 
ketone and oxaziridine at low pressure meant that pure oxaziridine could not be isolated. Additionally, 
chromatographic purification was not possible due to the instability of the oxaziridine on silica.  The 
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1
H NMR spectra of the starting imine 49 and the oxaziridine were similar, and so 
13
C NMR was used 
as a better indication of product formation; re-hybridisation of the imine sp
2
 carbon to the sp
3
 carbon 
of the oxaziridine was marked by a shift from 194 ppm to 85 ppm. 
 
To validate the aminating ability of oxaziridine 48, O-menthol oxime 51 was synthesised according to 
Ellman‟s procedure (Scheme 38). Menthol was treated with washed KH in anhydrous DMPU, before 
the addition of oxaziridine 48 at -40 °C. After 2 h., benzaldehyde was added, and following work-up 
and chromatographic purification, menthol-oxime 51 was isolated in 37% yield. Although 
considerably lower than the literature value of 78%, formation of the oxime validated the use of 
oxaziridine 48 as an electrophilic nitrogen transfer agent. 
 
Scheme 38: Synthesis of O-menthol oxime using oxaziridine 48 
Having established the electrophilic nature of the oxaziridine in the presence of an alkoxide, the 
aminating ability of the oxaziridine with a weaker nucleophile was tested. This would establish 
precedent for use of the oxaziridine in the aziridination chemistry, with an amine or nucleophilic 
reagent with a similar pKa. The analogous penta-methylene oxaziridine has been observed to react 
with p-nitro benzene thiol (52) to give thiooximes in good yield, along with a small amount of 
disulfide (Scheme 39).
75
 The literature conditions were repeated, substituting the penta-methylene 
oxaziridine for di-tert-butyl oxaziridine 48. Disappointingly, formation of thiooxime 54 was not 
observed, but a 13% yield of the disulfide 55 was obtained (Scheme 39). TLC analysis of the starting 
thiol had not indicated the presence of the disulfide. It was suggested that initial amination of the thiol 
to give sulfinimine 53 was occurring, but that subsequent imine formation was significantly retarded 
owing to the hindered ketone. Instead, unstable sulfinimine 53 reacts with a second thiol molecule to 
generate disulfide 55 (Scheme 39). The tentatively assigned ketone 50 was observed by 
1
H NMR 
analysis of the crude reaction mixture, although this could not be regarded as proof of the suggested 
pathway, owing to the initial presence of the ketone as an impurity in the oxaziridine. 
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Scheme 39: Reaction of p-nitrobenzene thiol with oxaziridines 
Oxaziridine-promoted aziridination 
As the proposed mechanism for disulfide formation involved the desired nucleophilic attack at the 
oxaziridine nitrogen, it was decided to test the oxaziridine as the aminating agent in the aziridination. 
Chalcone was selected as an initial substrate, as one of the most successful in the aziridination 
methodology. As a base is not required for the proposed aziridination pathway, NaOH was omitted. 
NMM was selected as an initial tertiary amine, owing to success in the enone aziridination. If 
aziridination of chalcone was observed, the incompatibility of the reagent with the tert-butyl 
cinnamate derived aziridine would be borne in mind for further experimentation. An excess of NMM 
was used, to maximise the rate of ylide formation, and the reaction was carried out in CH2Cl2 
(0.12 M).  Disappointingly, chalcone and oxaziridine were the only products observed by 
1
H NMR 
analysis of the crude reaction mixture upon work-up after 20 h. at r.t. Ellman‟s use of the polar aprotic 
DMPU in the oxaziridine methodology, led to substitution of CH2Cl2 with this solvent. No aziridine 
formation was observed, with recovered starting material again observed in the 
1
H NMR spectrum of 
the crude material. At this point, it was decided to perform an NMR experiment to establish whether 
any interaction of the NMM with the oxaziridine could be observed. Interestingly, the oxaziridine 
di-tert-butyl singlet was split into a broad doublet on addition of NMM in CDCl3. The splitting did 
not appear to increase with time; the same 
1
H NMR profile was observed both 5 min. and 2 h. after 
addition of NMM. The oxaziridine-NH peak also sharpened considerably on treatment with NMM. 
Increased equivalents of NMM caused the splitting to become increasingly complex, although no 
other change to the spectrum was observed. Importantly, neither di-tert-butyl ketone peaks nor any 
changes to the NMM signals were observed, indicating that the aminimine ylide was not forming.  
 
To explain the observed changes to the 
1
H NMR spectrum, a non-covalent interaction between the 
NMM and oxaziridine-NH was suggested. Hydrogen-bonding between the tertiary amine and the 
oxaziridine-NH could slow inversion at the oxaziridine nitrogen, causing the diastereotopic 
relationship of the two tert-butyl groups to become observable by 
1
H NMR (Fig. 5). Further evidence 
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for this hypothesis lay in the sharpening of the oxaziridine-NH peak on treatment with the tertiary 
amines; the slower barrier to inversion at nitrogen would cause the nitrogen-proton to have a more 
defined environment, and a sharper signal. A pronounced singlet splitting was also observed in the 
presence of DMAP (Fig. 5). 
1
H NMR analysis of the oxaziridine in d4-MeOH showed a similar 
splitting of the tert-butyl singlet, presumably due to hydrogen-bonding with the solvent. Removal of 
the solvent in vacuo and re-analysis of the specimen by 
1
H NMR in CDCl3 saw the split signal revert 
to a singlet. 
 
 
Fig. 5: Oxaziridine tert-butyl 
1
H NMR signal splitting on treatment with DMAP 
Although the hypothesised hydrogen-bonding interaction was not desirable for ylide formation, it was 
suggested that the interaction could be reversible, so ylide formation could still be realised. Further, if 
ylide formation was itself reversible and a small amount of the ylide existed in equilibrium, the 
presence of the chalcone substrate (56) might promote the collapse of the oxaziridine. DMAP was 
trialled initially as the tertiary amine promoter. However, two reactions at r.t. and 40 °C led to 
returned starting material, with some degradation to unidentified products observed at 40 °C (Table 
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12, entries 3 and 4). Treatment of the oxaziridine with either NMM or DMAP at higher temperatures, 
in an attempt to force the collapse of the strained ring, led to degradation to unidentified products as 
observed by 
1
H NMR analysis.  
Table 12: Conditions attempted for oxaziridine-promoted aziridination 
 
Entry Tertiary amine Solvent Temperature 
1 NMM CH2Cl2 r.t. 
2 NMM DMPU r.t. 
3
a 
DMAP CHCl3 r.t. 
4
a,b 
DMAP CHCl3 40 
All reactions performed on 0.12 mmol scale, for 20 h, using 3.3 eq. R3N. 
a 2.2 eq. DMAP used. b Reaction performed for 30 
h. 
Pentamethylene oxaziridine 57 has reportedly been used as a direct nitrogen source for the 
aziridination of electron-rich olefins.
77
 To see whether oxaziridine 48 would display analogous 
reactivity, α-methyl styrene was treated with the reagent under the literature conditions. Both 
conventional and microwave heating were tested, but no aziridination was observed (Scheme 40). 
Given the lack of reactivity observed towards the selected olefins, it was decided to test an alternative 
aminating agent, with reported success for the aziridination of chalcone substrates. 
 
Scheme 40: Attempted aziridination of an electron-rich olefin 
 An alternative ylide 
Nitrogen-nitrogen ylide 35, generated in situ from dimethyl hydrazine and propylene oxide, has been 
used by Ikeda to effect the aziridination of chalcone substrates (vide supra).
63
 Previous work in the 
group had led to a modified synthesis of the ylide, avoiding benzene as a toxic solvent, and negating 
the need for a pressurised reaction vessel.
78
 According to this, propylene oxide was treated with 
dimethyl hydrazine in iso-propanol at r.t. After 24 h., chalcone was added in toluene, and heated to 50 
°C for 20 h. Recrystalisation from methanol provided the trans-aziridine 47 in 31% yield (lit. 48%
78
) 
(Scheme 41).  
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Following the successful aziridination of chalcone, tert-butyl cinnamate was subjected to the reaction 
conditions. Disappointingly, aziridine 1a was not observed, with some degradation to unidentified 
products observed by 
1
H NMR analysis of the crude reaction mixture. The scope presented in the 
literature is limited to chalcones,
63
 and perhaps the failure to aziridinate tert-butyl cinnamate is 
evidence of the substrate dependence of the procedure.  
 
Scheme 41: Ikeda’s ylide for aziridination 
Due to the lack of success of these alternative aminating agents in the aziridination of tert-butyl 
cinnamate, it was decided to return to the optimised aziridination protocol using DppONH2 and 
NMM. Although substrate instability to NMM had been observed, an improved isolated yield of 50% 
(cf. lit. 32%) had been obtained on a 14 mmol scale, and good recovery of the unreacted cinnamate 
meant that re-submission of the reagent to the reaction conditions would be possible.  
1.3.2 Probing the substrate scope  
1.3.2.1 Alternative esters 
It was decided to examine the substrate scope of the enoate aziridination, initially with respect to the 
ester moiety. It was suggested that using an ester moiety that was more electron-poor and ketone-like 
than the tert-butyl ester could increase substrate reactivity, drawing on the considerable success of 
enones in the methodology. However, it was realised that such substrates would be more reactive and 
would not benefit from the steric hindrance of the tert-butyl ester, therefore increasing the likelihood 
of 1,2-attack and ester hydrolysis. Alternative esters were selected using pKa values (in DMSO) as an 
approximate guide to the electron density at the carbonyl centre. 
 
Phenyl cinnamate 59 was selected as the initial alternative to tert-butyl cinnamate. It was realised that 
phenoxide (pKaH ca. 10) is a considerably better leaving group than tert-butoxide (pKaH ca. 19), and 
that the susceptibility of phenyl cinnamate to hydrolysis would be much increased in comparison to 
tert-butyl cinnamate. However, the delocalisation of the ester lone-pair into the aromatic system 
renders the substrate more „ketone-like‟ than tert-butyl cinnamate, which was hoped to be 
advantageous for aziridination. Phenyl cinnamate was first synthesised from benzaldehyde and the 
commercially available phosphorane 58. Heating at reflux in THF for 16 h. provided 59 in 
comparable yield on 0.5 and 1.0 mmol scales (Scheme 42). Treatment under the optimised 
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aziridination conditions led to complete consumption of phenyl cinnamate in 20 h. as judged by TLC 
analysis. On chromatographic purification, no aziridine was observed. Instead, a compound 
containing the morpholine scaffold was isolated. Analytical data were not conclusive as to the identity 
of the product, with both morpholinium salt 60 and tert-amide 62 (from base-mediated Stevens‟ 
rearrangement of the former) considered as possibilities (Scheme 42). In order to conclusively prove 
the identity of the product, the tert-amide 62 was synthesised via an alternative route. 
N-Aminomorpholine was added to cinnamoyl chloride to give the secondary amide 61 in 46%. 
Deprotonation of 61 with KO
t
Bu followed by reaction with dimethyl sulfate led to the isolation of 
tert-amide 62 in 8% yield, following purification (Scheme 42). Comparison of 
1
H NMR data showed 
that the product of the attempted aziridination of phenyl cinnamate was the cationic morpholinium 60; 
the 
1
H NMR shifts of the cation were considerably downfield by comparison with the tert-amide. 
Hydroxide was tentatively suggested as the counterion, as DppO
-
 was not observed by 
1
H NMR 
analysis. Benzyl cinnamate (pKaH of benzyloxide ca. 15) was also subjected to the aziridination 
conditions, and interestingly, morpholinium 60 was again isolated in 21% yield. 
 
Scheme 42: Identification of morpholinium addition product 
The constrained conformation of lactones prevents the stabilising anomeric effect present in esters, so 
it was rationalised that the increased reactivity of the former could improve yields in the aziridination. 
To probe lactone reactivity in the aziridination, the five- and six- membered α-benzilydene lactones 
63 and 64 were selected for testing. pKaH values of ca. 15 were suggested for both lactones, and it was 
hoped that each would be less susceptible to hydrolysis than phenyl cinnamate. 
 
The enolate of γ-butyrolactone was prepared using NaOMe generated in situ, and condensed with 
benzaldehyde.
79
 Work-up after 1 h. at 0 °C followed by chromatographic purification provided the 
lactone 63 in 24% yield as a single diastereomer (Scheme 43). An attempt to prepare the six-
membered analogue using the chemistry described resulted in the isolation of hydroxy acid 65, also as 
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a single stereoisomer, in 73% yield (Scheme 43). Pleasingly, refluxing in toluene in the presence of 
MgSO4 according to the literature procedure gave a quantitative yield of lactone 64 (Scheme 43).
80
 
E-Diastereoselectivity was assigned for both compounds, through correlation with 
1
H NMR shifts 
from literature syntheses of the compounds. Additionally, the E-diastereomer is likely the 
thermodynamic product in each case, to avoid eclipsing interactions between the aromatic and 
carbonyl functionalities.  
 
Scheme 43: Synthesis of α-benzilydene lactones 
Formation of spiro-aziridine 66 from lactone 63 was attempted using the optimum conditions (Table 
13, entry 1). Consumption of starting material was observed by TLC analysis after 3 h., but 
1
H NMR 
analysis of the crude reaction mixture indicated complete degradation to unidentified products, and 
hydrolysis of lactone 63 was assumed. However, none of the corresponding hydroxy acid was 
observed by 
1
H NMR, despite acidification and extraction of the aqueous phase during work-up, 
owing to the likely aqueous solubility of the compound. A control experiment lacking NMM (entry 2) 
showed consumption of the starting lactone by TLC analysis after 40 h., supporting the hypothesis, 
although instability of the lactone to the ylide was suggested, given the increased rate of substrate 
consumption in the presence of NMM. Decreasing the equivalents of NaOH to one in the aziridination 
led to a good mass recovery of starting material, although no aziridination was observed (entry 3). It 
was reasoned that the lactone might exhibit better stability to a less nucleophilic base, and so KO
t
Bu 
was substituted for NaOH in the aziridination. However, the lactone proved to be unstable to this 
reagent; poor mass recovery and complete degradation to unidentified products by 
1
H NMR was 
observed when either four or one equivalents were used in the aziridination (entries 4 and 5). Lactone 
64 also proved to be susceptible to basic hydrolysis, although no degradation was observed in the 
attempted aziridination of this substrate. Instead, 78% conversion to the hydroxy acid 65 was 
observed by 
1
H NMR analysis of the crude reaction mixture, after 3 h. under the aziridination 
conditions, with no spiro-aziridine 67 observed (entry 6).  
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Table 13: Attempted formation of spiro-aziridines 
 
Entry Compound number Base (eq.) 
1 63 NaOH (4) 
2
a,b 
63 NaOH (4) 
3 63 NaOH (1) 
4 63 KO
t
Bu (4) 
5 63 KO
t
Bu (1) 
6
c 
64 NaOH (4) 
All reactions performed on 0.24 mmol scale at [0.06 M]. a No NMM added. b 40 h. was required for complete consumption 
of the starting lactone. c 78% conversion by 1H NMR analysis to hydroxy acid; performed at [0.24 M]. 
Commercial ethyl cinnamate was next tested, reasoning that ethoxide (pKaH ca. 16) was only a 
slightly better leaving group than tert-butoxide. Potentially, the former could be slightly more prone 
to hydrolysis, but exhibit increased reactivity in the aziridination. Disappointingly, after 20 h., loss of 
starting material was observed by TLC, with no new non-baseline product spots observed. A poor 
mass recovery was obtained following work-up, with 
1
H NMR analysis showing ethyl cinnamate 
along with considerable degradation. It seemed that ester hydrolysis was occurring faster than 
addition of the aminimine, resulting in the lack of aziridination and low mass recovery observed. Due 
to the lack of successful aziridination of lower esters and lactones, it was decided to cease 
investigation into alternative ester groups at this point. 
 
It was reasoned that an amide (pKaH ca. 35) would be less susceptible to basic hydrolysis, and so 
commercial cinnamamide (68) was subjected to the aziridination conditions (Scheme 44). The 
increased electron density at the carbonyl centre would likely render the amide substrate less reactive, 
but possibly lead to an improved total mass recovery of starting material and product by limiting 
direct addition to the carboxyl group. The susceptibility of the amide protons to deprotonation was 
also realised, which would deactivate the substrate further still to aziridination. Unfortunately, 
quantitative recovery of starting material was observed, proving that cinnamamide was not susceptible 
to aziridination under these conditions.  
 
Scheme 44: Attempted aziridination of cinnamamide 
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1.3.2.2 Conjugated oxazoles 
Alternative unsaturated electron-poor systems that have previously been tested by co-workers include 
α,β-unsaturated nitrates, aldehydes, sulfones and nitriles.68, 73 To this point, the only substrates that 
have been used with success in the aziridination are enones and tert-butyl enoates. Aiming to expand 
the substrate scope further, it was decided to test the aziridination potential of substrates bearing 
electron-poor heteroaromatics instead of the carbonyl functionality. Oxazoles and isoxazoles were 
selected for investigation, due to the availability of literature syntheses of both heteroaromatics 
bearing styryl functionality at different positions on the ring. Styryl functionality was selected in order 
that the olefin substitution at the aromatic terminus was unchanged. 
 
Literature procedures were followed for the synthesis of substrates 70 and 74 (Scheme 45). Van 
Leusen oxazole synthesis was used to access compound 70.
81
 TOS-MIC and cinnamaldehyde (69) 
were heated to reflux in MeOH in the presence of K2CO3. Work-up and chromatographic purification 
provided 70 in moderate yield (34%). Isoaxzole 74 was synthesised, albeit in poor yield (14%), by 
condensing enaminone 73 with hydroxylamine hydrochloride in refluxing ethanol.
82
 The starting 
enaminone 73 was the product of benzylidene acetone (71) condensation with 
bis(dimethylamino)methoxymethane 72 in the presence of catalytic H2SO4, adapting the published 
procedure.
83
 CH-activation of oxazole to form 75 is described in several recent literature accounts.
84, 85
 
Unfortunately, attempts to repeat these resulted in the isolation of starting material in all cases, with 
no evidence of product formation by TLC and 
1
H NMR analysis. 
 
Scheme 45: Synthesis of oxazole isomers 
Owing to their wider substrate scope, the published aziridination conditions were initially applied to 
substrates 70 and 74, as opposed to the newly-developed enoate-specific conditions.
53
 Attempted 
aziridination of oxazole 70 in dichloromethane led to quantitative recovery of starting material. 
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Acetonitrile was also tested as a reaction solvent, although clean recovered starting material was again 
isolated. Isoxazole 74 showed complete conversion to a single product by TLC analysis, after 16 h. 
under aziridination conditions. Work-up and chromatographic purification yielded nitrile 76 in 91% 
(Scheme 46). The product had presumably arisen from deprotonation of isoxazole 74 by NaOH, 
followed by ring-opening by elimination and protonation of the resulting enolate.  
 
Scheme 46: Base-mediated rearrangement to nitrile 76 
It seemed from experimentation to this point that the optimised enoate aziridination conditions were 
only applicable to tert-butyl esters. Although a limitation of the chemistry, tert-butyl esters are a 
synthetically useful functionality, with the advantage over other esters that they undergo facile 
deprotection under acidic conditions. With this in mind, it was decided to investigate the effect of 
altering the substituent at the aromatic terminus of tert-butyl cinnamate.  
1.3.2.3 Furfuracrylates 
tert-Buyl enoates bearing a furan ring at the 3-position were considered interesting targets, following 
examination of a sub-unit of the natural product Muramycin. Muramycin is a structurally challenging 
target that has been shown to exhibit considerable antibiotic activity.
86, 87
 Analogues are likely to have 
similar properties, and a simple synthetic strategy to access these would be desirable. It was envisaged 
that the ribose unit and a range of derivatives could be established using oxidative transformations on 
the furan ring. The furan amino-acid could potentially arise from the hydrolysis of aziridine 77a 
(Scheme 47).  
 
Scheme 47: Retrosynthesis of muramycin sub-unit 
Whilst it was recognised from the outset that the electron-rich nature of the furan ring would likely 
make the unsaturated alkene less electrophilic than in tert-butyl cinnamate, the potential synthetic 
utility of the aziridine product prompted the preparation and testing of tert-butyl furfuracrylate 79a. 
The substrate was synthesised in good yield (88%), using the previously-developed esterification 
chemistry (Scheme 48). Disappointingly, the substrate proved to be unreactive to aziridination, with 
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recovered starting material and a small amount of degradation to unidentified products observed by 
1
H NMR analysis of the crude reaction mixture. 
 
Scheme 48: Synthesis and attempted aziridination of tert-butyl furfuracrylate 
It was reasoned that introduction of electron-withdrawing substituents on the furan ring might 
increase the susceptibility of the substrate to aziridination. The 5-nitro substituted analogue 78b was 
suggested, as reduction of the nitro-group in a subsequent step could provide a functional amine 
handle for the introduction of the cyclic urea moiety present in Muramycin. Gilman and Wright 
describe the selective nitration of furfuracrylic acid 78a at the 5-position to give nitro-derivative 
78b,
88
 but unfortunately attempts to repeat the syntheses resulted in either return of starting material, 
or degradation to unidentified products by TLC and 
1
H NMR analysis of crude reaction mixtures. As 
the nitro-furfuraldehyde 80b is commercially available, a Wittig route was devised. Combination of 
the aldehyde with the commercial phosphorane 81 in THF for 2.5 h., followed by solvent removal and 
chromatographic purification, led to isolation of the crystalline trans-diastereomer 79b in 88% 
(Scheme 49). 
 
Scheme 49: Synthetic routes to tert-butyl furfuracrylate derivatives 
With the nitro-analogue 79b in hand, an aziridination reaction was attempted using the optimised 
enoate conditions. TLC and 
1
H NMR analysis of the crude reaction mixture upon work-up showed 
considerable degradation to unidentified products, and a low recovered mass was noted. The 
difference in reactivities observed for tert-butyl furfuracrylate 79a and the nitrated analogue 79b 
under the aziridination conditions suggested that it might be possible to tune the reactivity of the 
substrate through selection of the appropriate furyl substituent. The chloro-derivative 79c was mooted 
as an analogue with intermediate electronic properties. Additionally, a halogen at this position would 
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present the opportunity for cross-coupling chemistries for the introduction of the pendant cyclic urea 
later in the synthesis. Synthesis of the chloro-derivative 79c was facile; utilising the Wittig route 
developed for the synthesis of the nitrated furfuracrylate provided the product in 71% isolated yield 
(Scheme 49). Subjection of the chloro-furfuracrylate 79c to the optimised enoate aziridination 
conditions pleasingly led to isolation of the derived aziridine 77c, albeit in a low yield of 11% (Table 
14, entry 1). Aziridine 77c was considerably more sensitive than the tert-butyl cinnamate derived 
analogue 1a; no degradation has been observed of the latter after storage for 12 months at room 
temperature under air, but the former was observed to undergo complete degradation to unidentified 
products by 
1
H NMR analysis after 5 days under the same conditions. It was also noted that the mass 
recovery of the crude product was low (48% calculated as a percentage of starting tert-butyl 
furfuracrylate mass, entry 1). Hypothesising that the poor mass recovery and low isolated yield could 
be attributed to substrate and/or product sensitivity to NaOH, a second aziridination was attempted, 
using 1 equiv. of the reagent for a shorter reaction time of 26 h. A lower conversion of 12% was 
observed, in comparison with the 39% conversion under the standard conditions (entry 1 vs. 2). 
However, the improved mass recovery (80%) prompted the shorter reaction time to be maintained and 
4 eq. of NaOH to be re-introduced in a third experiment. Pleasingly, a 32% conversion, comparable 
with the initial result (39%) was observed, with a quantitative mass recovery (entry 3). A final 
aziridination, quenched after 16 h., led to a slightly diminished conversion (80%), but purification of 
the crude product from this reaction led to the isolation of aziridine 77c in an improved 35% yield 
(entry 4). Aziridine 77c displayed some interesting spectroscopic properties. The quaternary 
chloro-substituted C2-furyl carbon proved elusive in the 
13
C NMR spectrum. Instead, an HMBC 
experiment showed a 
2
J correlation between the C3-furyl proton and the C2-carbon, allowing the shift 
of the C2-carbon to be identified (see Scheme 49 for numbering system). 
Table 14: Aziridination of 5-chloro-tert-butyl furfuracrylate 79c 
 
Entry NaOH 
(eq.) 
Time (h.) Crude mass 
recovery (%)
a 
1
H NMR conversion 
(%)
b 
Isolated yield 
(%) 
1 4 40 48 39 11 
2 1 26 80 12 n.d 
3 4 20 Quant. 32 n.d 
4
c 
4 16 80 27 35 
All reactions performed on 0.11 mmol scale. a Calculated as a percentage of the mass of starting tert-butyl furfuracrylate. b 
Calculated using the relative intergrals of tert-butyl ester peaks in starting ester and product aziridine. c Performed on 0.22 
mmol scale. 
Although initial optimisation of the 5-chloro furfuracrylate aziridination had been promising, it was 
decided to postpone further investigation along with potential access to the muramycin subunit due to 
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the low yields and instability of the aziridine product. The observed dependence of the tert-butyl 
furfuracrylate aziridination on the electronic properties of the aromatic system led to refocus of 
investigative efforts on a similar study using tert-butyl cinnamate derivatives. 
1.3.2.4 tert-Butyl cinnamates 
Eight trans-tert-butyl cinnamate substrates bearing either electron-withdrawing or electron-donating 
groups at varying positions on the phenyl ring were selected for study. Five para-substituted examples 
were chosen, so that the electronic effect of substituents on the yield of the aziridination could be 
directly compared, without the added variables of ring-position and sterics. para-Substituents ranged 
from electron-withdrawing nitro- to electron-donating methyl- and methoxy-. para-Halo substitution 
was also selected, as the derived aziridine would bear functionality for further elaboration via 
cross-coupling. meta-Methoxy substitution was chosen, to observe the effect of moving the donating 
group out of conjugation with C3, the site of nucleophilic attack. ortho-Nitro and ortho-chloro 
tert-butyl cinnamates would provide an indication of the effect of steric bulk near the reacting 
C3-carbon, comparable with the para-substituted derivatives. 
Substrate synthesis 
Six of the substrates were synthesised using the esterification chemistry described for tert-butyl 
cinnamate (Table 15, entry 1-6). Synthesis was straightforward with the exception of the ortho-nitro 
substrate; a further portion of oxalyl chloride was required for full conversion to the acid chloride, and 
the tert-butyl ester 42g was isolated in a poor 13% yield (entry 6). The para-iodo derivative 42h was 
isolated in good yield (79%) via the Wittig chemistry used to access furfuracrylates 77b and 77c  
(entry 7).  
  
59 
 
Table 15: Synthesis of tert-butyl cinnamates  
 
Entry X Method Compound number Isolated yield (%) 
1 p-OCH3 A 42b 65 
2 p-NO2 A 42c 63 
3 p-CH3 A 42d 79 
4 p-Cl A 42e 84 
5
a 
m-OMe A 42f Quant. 
6
a,b 
o-NO2 A 42g 13 
7
c 
p-I B 42h 79 
All reactions performed on 2 mmol scale. a Performed on 4 mmol scale. b 2 x 1.05 eq. portions of oxalyl chloride required for 
full conversion to acid chloride. c Performed on 0.11 mmol scale. 
ortho-Chloro tert-butyl cinnamate 42i proved to be the most challenging substrate to synthesise. The 
esterification chemistry was not a viable route, due to the limited availability of the starting acid. 
Wittig reaction from ortho-chloro benzaldehyde (82) led to a 5:1 mixture of trans:cis isomers, which 
were inseparable from both each other, and from unreacted starting aldehyde (ca. 50% of the crude 
product by relative integration of 
1
H NMR signals) (Scheme 50). Treatment of the mixture with 
NaBH4 in MeOH led to complete reduction of the aldehyde after 1 h. at r.t., allowing separation of the 
resulting alcohol from the isomers via column chromatography. However, the second purification led 
to erosion of the cinnamate trans:cis selectivity to 5:2 (Scheme 50). An alternative synthesis was 
sought, to provide the trans-cinnamate 42i selectively, due to the observed difficulty in separation of 
the isomers.  
 
Scheme 50: Mixtures of products following Wittig chemistry of o-Cl benzaldehyde 
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The Heck coupling is known to provide olefins in excellent trans selectivity. 1-Chloro-2-iodo benzene 
(83) and tert-butyl acrylate (84) were the required coupling partners, with the added advantage that 
the olefin is considered „activated‟ with respect to Heck chemistry. As the synthesis of this cinnamate 
had not previously been reported in the literature, two palladium catalysts and two bases were selected 
that have enjoyed success in Heck chemistry, and combinations of the reagents tested. Three reactions 
were carried out in sealed tubes, heating to 115 °C. Pleasingly, the required product was isolated from 
all reactions (Table 16, entries 1-3), with no cis isomer observed by 
1
H NMR analysis of the crude 
reaction mixture. The optimum set of conditions, employing PdCl2(PPh3)2 in Et3N as solvent, provided 
the product 42i in 80% isolated yield (entry 2). A decrease in the reaction temperature to 95 °C saw a 
considerable drop in yield to 35% (entry 4). Re-introduction of the higher temperature (115 °C) and 
moderate scale-up led to an identical yield of 80% (entry 5). 
Table 16: Optimisation of Heck route to trans-o-chloro tert-butyl cinnamate 
 
Entry Pd catalyst Base Isolated yield (%) 
1 PdCl2(PPh3)2 Cs2CO3 20 
2 PdCl2(PPh3)2 Et3N
a 
80 
3 Pd2(dba)3 Cs2CO3 42 
4
b,c 
PdCl2(PPh3)2 Et3N 35 
5
b 
PdCl2(PPh3)2 Et3N
a 
80 
All reactions performed on 0.2 mmol scale with 0.2 eq. catalyst. a Base used as reaction solvent in place of PhMe. b 
Performed on 0.8 mmol scale c Performed at 95 °C. 
Susceptibility to aziridination 
With the purified trans-tert-butyl cinnamates in hand, testing of the substrates in the aziridination 
could begin. However, it was first decided to subject the crude mixture of cis- and trans-ortho-chloro 
cinnamates, 42i and 42j to the aziridination. Acyclic cis-enones and enoates have not been tested in 
the aziridination, as accessing such substrates in high diastereoselectivity is synthetically challenging. 
According to the proposed mechanism, the geometry of the starting alkene should not be reflected in 
the aziridine product; the intermediate prior to aziridine formation can undergo free rotation about the 
C2-C3 bond, leading to the most stable trans- configuration as observed (Scheme 51). Subjecting a 
cis-enoate to the aziridination would test this hypothesis, and provide further mechanistic 
understanding.  
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Scheme 51: trans-Selectivity in the aziridination 
Accordingly, the optimised enoate aziridination conditions were applied to the isomeric mixture. 
Analysis of the 
1
H NMR spectrum of the crude product showed complete consumption of the 
trans-cinnamate 42i, which appeared to have undergone complete conversion to the trans-aziridine.  
Interestingly, it appeared that none of the cis- isomer 42j had reacted; the relative integrals of the cis- 
and trans-isomers in the starting mixture were identical to those of the trans-aziridine and cis-
cinnamate in the crude product.  
 
The apparent lack of conversion of the cis-cinnamate 42j to aziridine indicated that the substrate was 
unreactive to the initial nucleophilic addition of the aminimine. If this step was occurring without 
subsequent ring-closure, then isomerisation to the trans-cinnamate would be expected, due to the 
reversible nature of the addition.  
 
The other interesting feature of the reaction was the apparent complete conversion of the 
trans-cinnamate to aziridine, which has not previously been observed in enoate aziridination using 
this methodology. Following chromatographic purification, the aziridine was isolated in 35% yield, 
calculated using the mass of the isomeric mixture. Assuming non-reactivity of the cis-product 42j in 
the mixture, an extrapolated yield of 51% was calculated, based on the percentage of trans-cinnamate 
in the starting mixture. Wondering whether the increased quantities of reagents used with respect to 
the trans-cinnamate were responsible for the yield (higher than the 50% observed with tert-butyl 
cinnamate), brief experimentation was carried out using increased reagent quantities with tert-butyl 
cinnamate. 
 
The quantities of reagents used with respect to the trans-cinnamate were calculated to be 3 eq. each of 
NMM and DppONH2, and 11 eq. of NaOH. tert-Butyl cinnamate was subjected to the aziridination, 
using the increased quantities, at the lower concentration of 0.12 M, to aid magnetic stirring of the 
heterogeneous reaction mixture. An optimum conversion of 78% was observed by 
1
H NMR analysis 
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of the crude reaction mixture after 40 h., translating into an isolated yield of 60% after 
chromatographic purification (Table 17, entry 1). The large excess of NaOH (11 eq.) was found to be 
necessary; an analogous reaction using 6 eq. led to a considerably lower conversion of 60% (entry 2). 
Further increase of reagent stoichiometries to 5 eq. of tertiary amine and aminating agent each, and 20 
eq. of NaOH provided complete conversion of starting cinnamate to aziridine, although a slight drop 
in isolated yield (56%) was observed (entry 3).  
Table 17: Optimisation of super-stoichiometric aziridination conditions 
 
Entry NMM 
(eq.) 
DppONH2 
(eq.) 
NaOH 
(eq.) 
Concentration 
[M] 
1
H NMR 
conversion (%) 
Isolated yield 
(%) 
1 3 3 11 0.12 78 60 
2 3 3 6 0.12 60 n.d.
a
 
3 5 5 20 0.09 Quant. 56 
All reactions performed on 0.12 mmol scale of substrate. a Not determined. 
In the interests of time, further optimisation of these super-stoichiometric conditions was ceased. It 
was decided to test both these conditions and the previously optimised conditions on each of the 
tert-butyl substrates synthesised. The previously observed sensitivity of the furfuracrylates arising 
from electronic properties, led to the rationale that electron-poor substrates might be sensitive to the 
super-stoichiometric conditions.  
 
The aziridination of the tert-butyl cinnamate substrates showed that isolated yields were largely 
dependent on the electronic properties of the aromatic in the substrate. Cinnamates with electron-rich 
aromatics gave low yields that were only marginally improved on application of the 
super-stoichiometric conditions B (Table 18, entries 2, 4, 6). The milder set of conditions (A) were 
found to be more appropriate for cinnamates with electron-poor aromatic systems (entries 3, 5, 8); this 
effect was particularly marked for the p-NO2 system, where a good isolated yield of aziridine 1c 
(76%) under conditions A was reduced to a meagre 9% using super-stoichiometric conditions B (entry 
3). Reduced yields were observed for ortho-substituted cinnamates in comparison to their 
para-substituted analogues (for example, entry 3 vs. 8). Despite this, a moderate yield (47%) was still 
obtained for the ortho-chloro cinnamate 1i under the super-stoichiometric conditions (entry 9). 
Moving the donating para-methoxy group out of conjugation into the meta-position, provided only a 
small difference in isolated yield of the derived aziridine 1f (entry 2 vs. 6). The result indicates that 
the yield of aziridine is affected by the overall electron density of the aromatic system rather than 
conjugation effects. As described previously, the aziridination of tert-butyl cinnamate itself was 
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higher yielding (60%) under the super-stoichiometric conditions B, and this yield was further 
increased on moderate scale-up, to provide aziridine 1a in 65% (entry 1). Interestingly, electron-poor 
cinnamates were observed to provide better yields in the aziridination than electron-rich. This is 
suggestive that the initial addition step of the catalytic cycle is rate limiting in the enoate aziridination. 
This opposes circumstantial evidence obtained from the study of enone reactivity in the aziridination, 
which indicated that the cyclisation step was rate-limiting for these substrates. 
Table 18: Aziridination of tert-butyl cinnamates 
 
Entry Ar Aziridine number Isolated yield of aziridine (%) 
   Conditions A Conditions B 
 
1 
 
1a 
 
50
a 
 
60 (65)
b 
 
2 
 
1b 
 
33
c
 
 
39 
 
3 
 
1c 
 
76
e 
 
9 
 
4 
 
1d 
 
34
e 
 
36
 
 
5 
 
1e 
 
53
f
 
 
19 
 
6 
 
1f 
 
23
 
 
32 
 
7 
 
1h 
 
33
g 
 
29
h 
 
8 
 
1g 
 
40
 
 
4 
 
9 
 
1i 
 
24
 
 
47 
Reactions performed between 0.12 and 0.24 mmol scale. a 10.0 mmol scale, b 3.0 mmol scale, c 0.71 mmol scale. Reactions 
performed at d [0.17 M]; e [0.12 M]; f [0.03 M]; g [0.15 M]; h [0.08 M]. 
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The strong dependence of the enoate aziridination on the electronic properties of the aromatic system 
had been established. With that, it was decided to test enoate substrates bearing non-aromatic 
functionality at the β-position, to see whether any considerable difference in reactivity could be 
observed. 
1.3.2.5 Dienoates 
The successful aziridination of α,β,γ,δ-unsaturated ketones (dienones) has previously been reported 
using the methodology, under slightly modified conditions.
69
 The derived aziridines are formed in 
excellent trans diastereoselectivity, with the aziridination completely regioselective for the α,β-olefin. 
Two α,β,γ,δ-unsaturated esters (dienoates) were tested as part of the substrate scope, with no 
conversion to the resulting aziridines observed. However, the dienoates had not been subjected to the 
conditions used for enoate aziridination in the original paper,
53
 or the newly optimised enoate 
conditions. Accordingly, two tert-butyl dienoate substrates were selected as comparable with 
tert-butyl cinnamate; compound 88, with an allyl moiety at the β-position, and compound 87, with a 
styryl group at this position. The compounds were synthesised using Wittig chemistry, from the 
commercial phosphorane 81 and crotonaldehyde (86) or cinnamaldehyde (85) respectively. The crude 
dienoates were mixtures of diastereomers, with the major isomer the trans,trans-product, 87a or 88a 
in each case. Chromatographic purification allowed separation and isolation of all diastereomers 
(Scheme 52).  
 
Scheme 52: Synthesis of dienoates 87 and 88 
Initially, dienoate 88a was subjected to aziridination. Application of both the moderate conditions (A) 
and the super-stoichiometric conditions (B) led to either no or very low conversions to aziridine, from 
comparison of 
1
H NMR integrals in the spectrum of the crude product (Table 19, entries 1 and 2). 
Additionally, the mass recovery from both reactions was poor; ca. 25% of the mass of the starting 
dienoate. Concluding that the mass loss was likely due to instability of dienoate 88a to the reaction 
conditions, attention was turned to the aziridination of dienoate 87a. Improved reactivity was 
observed, with a 16% conversion to aziridine 89 on application of the super-stoichiometric conditions 
(B) (entry 4). Aziridine 89 was isolated in low yield (4%), following chromatographic purification, 
nonetheless providing sufficient material for the regiochemistry of aziridination to be confirmed at the 
α,β-olefin. A 4J correlation between the γ-CH and the carbonyl carbon was observed using HMBC 
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spectrometry, with the same γ-CH correlating to the aromatic signals. trans-Diastereoselectivity was 
confirmed through the coupling constants of the aziridine-CH protons. The isolated aziridine 89 was 
observed to undergo degradation after 12 h. at room temperature, with 
1
H NMR analysis showing 
considerable formation of unidentified products. Interestingly, the published aziridination conditions 
provided no conversion to aziridine, highlighting the necessity of the enoate-specific conditions for 
improved substrate scope (entry 5).  
 
Following the previous observation that cis-cinnamates appeared unreactive to the aziridination, the 
cis,trans-isomer 87b was subjected to the super-stoichiometric conditions (B) found to be optimum 
for aziridination of the trans,trans-isomer 87a. Analysis of the 
1
H NMR spectrum of the crude 
material showed no conversion to aziridine, and 3% isomerisation to the trans,trans-compound 87a, 
with the cis,trans-starting material 87b the main compound observed (entry 6). Additionally, mass 
recovery of the crude material was quantitative. To establish whether this isomerisation was being 
caused specifically by reversible addition of the aminimine, a control experiment was performed. The 
cis,trans-dienoate 87b was treated with NaOH in the absence of tertiary amine and aminating agent, 
with 4% isomerisation to the trans,trans dienoate 87a observed by 
1
H NMR after 40 h (entry 7). This 
indicated that the isomerisation observed under the aziridination conditions was likely due to 
reversible nucleophilic addition of hydroxide, and that addition of the aminimine to dienoate 87b had 
not occurred. 
Table 19: Aziridination of dienoates 
 
Entry Dienoate Conditions
a 
Product ratio (%)
b 
   Starting dienoate Aziridine 
1 88a A 100 0 
2 88a B 99 1 
3 87a A 96 4 
4 87a B 84 (52) 16 (4) 
5 87a -
c 
100 0 
6
 
87b B 97
d
 0 
7 87b -
e 
96
d 
0 
All reactions performed on 0.11 mmol scale. Isolated yields in parentheses. a Conditions A: DppONH2 (1.04 eq.), NMM 
(1.04 eq.), NaOH (4 eq.), CH2Cl2 (0.24 M); Conditions B: DppONH2 (3 eq.), NMM (3 eq.), NaOH (11 eq.), CH2Cl2 (0.12 
M). b Calculated using relative 1H NMR integral of the starting material and product in the spectrum of the crude material. c 
Published aziridination condition used.53 d Isomerisation to compound 87a observed. e Dienoate stirred with NaOH (11 eq.). 
Although aziridination of compound 87a had been successful, the low isolated yield and observed 
instability of resulting aziridine 89 prompted further investigation to be halted. Attention was instead 
turned to the target synthesis of a small, naturally occurring, NH-aziridine-2-carboxylate. 
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1.3.2.6 Towards ‘pleurocybellaziridine’ 
A timely publication from the group of Kan described the isolation of cytotoxic amino acids from the 
mushroom Pleurocybella porrigens.
89
 The mushroom is eaten widely in Japan, and was believed to 
have caused 17 deaths from acute encephalopathy in 2004. The structural similarity of the amino 
acids led the group to propose a common NH-aziridine-2-carboxylate precursor, appropriately named 
„pleurocybellaziridine‟ (Scheme 53). The group completed the enantioselective synthesis of the 
aziridine in six steps from D-Serine, using a triphenyl-phosphine-mediated ring-closure of the amino 
alcohol for the key aziridine-forming step. The aziridine presented an interesting structural target to 
test our chemistry, and accordingly, gem-dimethyl tert-butyl acrylate 92 was prepared. Synthesis was 
initially attempted using the esterification conditions optimised for tert-butyl cinnamate. 
gem-Dimethyl acrylic acid (90) was treated with oxalyl chloride, and complete conversion of the 
starting material was observed by TLC analysis after 4 h. Quenching the acid chloride with KO
t
Bu (1 
M in THF), and isolation of the crude material led to two products, as observed by TLC and 
1
H NMR 
analysis. Chromatography on neutral alumina (due to instability of crude mixture on silica) provided 
the required product 92 in poor yield (11%) along with the bis-alkene 93 also in a low yield of 9% 
(Scheme 53). Although the required product had been isolated, a higher yielding synthesis was 
sought. Wittig chemistry was attempted, stirring the commercial phosphorane 81 with acetone used 
both stoichiometrically and as the reaction solvent. However, the required product was not observed 
in reactions performed both at room temperature and at reflux. Pleasingly, treatment of gem-dimethyl 
acrylic acid 90 with trichloroacetamide 91 in the presence of BF3.OEt2, following Jackson‟s 
procedure,
90
 allowed isolation of product 92 in 42% yield, following filtration of the crude product 
through a silica pad (Scheme 53). 
 
Scheme 53: Synthetic routes to gem-dimethyl tert-butyl acrylate 
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gem-Dimethyl tert-butyl acrylate 92 was subjected to the two sets of enoate aziridination conditions 
(Table 20, entries 1 and 2), and also the published conditions (entry 3).
53
 Aziridine 94 was not 
observed upon work-up and analysis of the 
1
H NMR spectra. Instead, a good mass recovery of clean 
starting material was observed, indicating that the substrate is unreactive to the conditions. It was 
hypothesised that the gem-dimethyl moiety rendered the olefin too electron-rich for the nucleophilic 
aziridination, and that the increased steric bulk at the β-position would also disfavour aminimine 
addition.  
Table 20: Aziridination of gem-di-methyl tert-butyl acrylate 92 
 
Entry Scale (mmol) Concentration [M] X (eq.) Y (eq.) Z (min.) 
1 0.32 0.32 1.04 4 20 
2 0.16 0.16 3 11 20 
3
53 
0.13 0.06 1.04 2 0 
Owing to the poor reactivity of the β-alkyl tert-butyl enoates tested in the aziridination, it was decided 
not to pursue further investigation into this class of substrate. It should be noted that there is 
possibility for further investigation here, with the aim to expand the scope of the tert-butyl enoate 
aziridination. It is likely that the electronic properties of the β-alkyl substituent will have a large effect 
on the success of the aziridination, as observed for tert-butyl cinnamates. Further investigation should 
include alkyl substituents with varied electronic properties to probe this hypothesis.  
1.3.3 Summary of the enoate aziridination 
It was considered prudent at this point, to bring investigation into the tert-butyl enoate aziridination to 
a close, and move forward with the exploration of ring-opening methodology. Pleasingly, 
optimisation of the aziridination protocol had allowed an improvement in yield on small scale (0.12 
mmol) from 32%, using the published aziridination conditions, to 60%. A larger scale (10.0 mmol) 
reaction provided an optimum 65% isolated yield of aziridine 1a (Scheme 54). En route to the 
improved enoate-specific conditions, a range of tertiary amines, bases, solvents and aminating agents 
were tested, revealing that the combination of reagents used in the published conditions were indeed 
optimum. The main differences between the published and newly optimised conditions included: 
a) An increase in concentration with respect to tert-butyl cinnamate 
b) An increase in the equivalents of reagents 
c) The inclusion of a 20 min. time delay between the addition of base and substrate 
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Scheme 54: Optimised conditions for the aziridination of tert-butyl cinnamate 
The enoate aziridination conditions were found to be substrate specific; lower esters and lactones 
tested were susceptible to hydrolysis under the basic conditions. Furthermore, the aziridination was 
found to be highly dependent on the electronic properties of the tert-butyl cinnamate in question. A 
study of tert-butyl cinnamates bearing aromatics with varying electronic properties showed that 
electron-poor substrates were more reactive and gave better yields in the aziridination, whilst 
electron-rich systems were considerably less prone to degradation under the reaction conditions, but 
gave lower yields of aziridine. Indeed, two sets of aziridination conditions were developed to account 
for this; a moderate set and a super-stoichiometric, more forcing set (Scheme 55).  
 
Scheme 55: Two sets of conditions for the aziridination of tert-butyl cinnamates 
tert-Butyl enoates bearing non-aromatic β-functionality that were tested included two 
α,β,γ,δ-unsaturated substrates 87 and 88 and a gem-dimethyl enoate 92, with the latter attempted to 
access a natural product. Dienoate substrate 87a reacted to give regioselective aziridination at the α,β-
position, although the resulting aziridine was isolated in poor yield. gem-Dimethyl tert-butyl acrylate 
92 was found to be stable and unreactive to the aziridination, likely due to its electron-rich and 
sterically hindered nature. Further investigation into the susceptibility of of β-alkyl tert-butyl enoates 
to the aziridination has the potential to expand the scope of the methodology further. 
 
A final large-scale aziridination was performed to access sufficient material for ring-opening. On 
standing overnight, the purified aziridine 1a (a clear oil) was observed to crystallise, forming white 
plates. The crystals were of high quality, allowing X-Ray data to be obtained, clearly showing the 
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trans-relationship across the aziridine ring (Fig. 6). 
1
H NMR confirmed the high purity of the 
material, which was taken forward for ring-opening experimentation. 
 
Fig. 6: Crystal structure of aziridine 1a 
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1.3.4 The ring-opening of aziridine-2-carboxylates  
The ring-opening chemistry of N-functionalised aziridine-2-carboxylates is well documented, and a 
wide range of nucleophiles have been used with success (Scheme 56). The breadth of the area does 
not permit a full review herein; instead the interested reader is directed towards seminal review 
articles.
3, 11
 
 
Scheme 56: Ring-opening of N-functionalised aziridine-2-carboxylates 
As with all aziridine ring-opening chemistry,
2, 91
 mixtures of product isomers may result, dependent 
on the mechanism and site of nucleophilic attack. Considering direct nucleophilic attack at the 
aziridine ring, four isomers are possible from the ring-opening of one aziridine substrate (Fig. 7). 
Regioisomers can result dependent on whether attack occurs at C2 or C3, and a syn- or anti-
relationship between the nucleophile and the leaving group can arise from alternative mechanisms of 
nucleophilic attack, leading to diastereomers. An anti- relationship is most commonly observed via 
SN2-like ring-opening, although syn-products can arise from reaction with an internal nucleophile, for 
example, nucleophilic functionality on the aziridine nitrogen, or via a mechanism of double inversion. 
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Fig. 7: Isomers arising from the direct ring-opening of an aziridine carboxylate 
Although ring-opening chemistry is well established for N-functionalised substrates, only two 
methodological studies of ring-opening NH-aziridine-2-carboxylates exist. Letgers has demonstrated 
the propensity of methyl-ester substituted aziridines to ring-opening upon treatment with conc. 
hydrochloric acid, benzene thiol, indole and acetic acid. However, inseparable mixtures of regio- and 
diastereomers were obtained.
17
 This poor selectivity was improved upon in methodology from Hruby, 
who showed that benzyl-cinnamate derived NH-aziridine 95 undergoes selective attack at C3 to yield 
anti-products exclusively. Nucleophiles used were indole, acetic acid and p-methoxy benzene thiol 
(Scheme 57). A hydrogenation protocol was also developed by Hruby, resulting in regioselective 
cleavage of the benzylic CN bond and concomitant benzyl ester hydrogenolysis to give phenylalanine 
(96) (Scheme 57).
18
 
 
Scheme 57: Hruby’s ring-opening of benzyl-cinnamate derived NH-aziridine 9518  
Drawing on this precedent, it was hoped that tert-butyl ester substituted NH-aziridine 1a would be 
susceptible to ring-opening chemistry. If successful, the potential to expand the range of nucleophiles 
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from those used previously could be explored. Additionally, both literature reports described involve 
multi-step syntheses of the starting aziridines. Ring-opening of aziridine 1a would provide access to 
ring-opening products in just two steps from readily available tert-butyl cinnamate.  
1.3.4.1 Ring-opening with indole 
Indole was selected as the initial nucleophile for the ring-opening of aziridine 1a, taking a lead from 
Hruby‟s report.18 To start, Hruby‟s conditions were applied; the aziridine and indole were dissolved in 
CH2Cl2 and cooled to 0 °C. BF3.OEt2 was added dropwise, and the reaction allowed to warm to r.t. 
After 2 h., the intense pink reaction mixture was quenched using NaHCO3 (sat. aq.), and 
1
H NMR 
analysis of the crude reaction mixture allowed identification of a ring-opened product, along with 
considerable conversion to other unidentified side-products. Chromatographic purification led to the 
isolation of the identified ring-opened product 97a in a meagre 7% yield (Scheme 58).  
 
Notwithstanding the low yield, careful analysis of NMR spectra allowed the selectivity of the reaction 
to be determined. Despite impurity formation, only a single ring-opened product had been observed in 
the 
1
H NMR spectrum of the crude product, leading to the conclusion that inversion had occurred at 
C3 following SN2-like reactivity. Although in theory, a single diastereomer could be observed with 
retention at C3, for example, following a double-inversion mechanism, no structural features of 
aziridine 1a were identified that might cause this. The regiochemistry of substitution at the indole C3‟ 
rather than nitrogen could be confirmed, as a broad singlet at 8.19 ppm corresponding to the indole 
NH- proton was evident in the 
1
H NMR spectrum of the pure compound. The regiochemistry of 
nucleophilic attack at the aziridine was confirmed using
 
HMBC spectrocospy. The aromatic signals in 
the 
1
H NMR spectrum of 97a were assigned, and a 
2
J correlation between the C3-proton and the 
ipso-carbons of both the indole and the phenyl groups could be observed (Scheme 58). No correlation 
was observed from the C2-proton to any aromatic carbon signals. Further confirmation of the regio-
and stereochemical assignment was obtained through comparison with a literature preparation of 
tryptophan 97a.
92
 The synthetic strategy employed meant that the regiochemistry of the derivative was 
unambiguous. However, both syn- and anti-diastereomers of tryptophan 97a were observed, with data 
provided for each. Comparison of 
1
H NMR shift values revealed a close match for tryptophan 97a 
with the literature values for the anti-diastereomer. 
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Scheme 58: Ring-opening of aziridine 1a with indole 
Limiting impurity formation 
It was desirable to limit impurity formation in the indole ring-opening to obtain an increased yield of 
tryptophan 97a. BF3.OEt2 is strongly activating, and has been used to catalyse many Lewis acid-
mediated processes, so was highlighted as a possible cause of the degradation observed. Initial 
experimentation showed that impurity formation increased significantly at reaction times above 2 h., 
lending support to this hypothesis. In particular, BF3.OEt2 can used to hydrolyse tert-butyl esters, and 
this was recognised as a possible decomposition pathway. Consequently, initial optimisation focussed 
on limiting the quantity of this reagent used.  
 
A control experiment lacking BF3.OEt2 provided a quantitative recovery of starting aziridine, despite 
an extended reaction time of 96 h., indicating that aziridine activation was necessary for ring-opening 
to occur (Table 21, entry 1). The BF3.OEt2 was re-introduced, but used in a catalytic quantity (0.5 
eq.), and pleasingly provided considerably less by-product formation by TLC analysis upon 
quenching the reaction after 2 h. Indeed, analysis of the 
1
H NMR spectrum of the crude material 
showed that impurity formation had been significantly prevented so as to allow calculation of an 
1
H 
NMR conversion (51%), using relative integration of signals corresponding to the starting aziridine 
and the ring-opened product. Chromatographic purification allowed the isolation of the tryptophan 
derivative 97a in an improved yield of 44% (entry 2). Halving the equivalents of indole used caused 
similarly low levels of impurity formation, but a decreased conversion of 36% to ring-opened product 
97a (entry 3). In each of these reactions, by-product formation had been limited to such an extent that 
a second ring-opened product had been observed in the 
1
H NMR spectra of the crude material. The 
similarity of the 
1
H NMR shifts of the C2- and C3-protons with those in the major product led to the 
product being tentatively assigned as the minor syn-diastereomer 97b. The product had not formed in 
sufficient quantity to allow isolation in acceptable purity, so it was decided to maintain the focus of 
the investigation on increasing the yield of the major isomer, and to return at a later point to 
identification of the minor product.  
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Alternative Lewis acids (InCl3 and MgBr2) described in the literature
93
 for the ring-opening of 
N-substituted aziridine-2-carboxylates were also tested, but these provided decreased conversions to 
97a of 21% and 0% respectively (entries 4 and 5). Returning to boron Lewis acids, the less activating 
BF3.THF was next tested, rationalising that degradation of the reagents and/or product would be 
further reduced. A conversion of 86% to tryptophan 97a was observed, although this translated to a 
considerably lower isolated yield (51%) (entry 6). Promisingly, the diastereomeric ratio calculated 
using the 
1
H NMR spectrum of the crude material was improved (11:1), although this was also 
downgraded upon purification to 4:1. However, the longer reaction time of 24 h. had not led to 
increased impurity formation, in contrast to the analogous reaction with BF3.OEt2. In an attempt to 
further moderate the reactivity of the system, BF3.SMe2 was substituted as the Lewis acid. No 
conversion to product was observed after 20 h., with a good mass recovery of aziridine 1a obtained 
following work-up (entry 7). Finally, it was found that an increased quantity of BF3.THF (1.5 eq.) led 
to the optimum isolated yield, 63% (entry 8). A diastereomeric ratio of 10:1 was observed by 
1
H 
NMR analysis of the crude product, although none of the minor diastereomer was isolated on 
purification. 
Table 21: The effect of Lewis acid 
 
Entry Lewis acid Temperature (°C) Time (h.) 
1
H NMR conversion (%)
a 
dr
b 
1 -
c 
23 96 0 -
d 
2 BF3.OEt2 0 - 23 2 51 (44) 9:1 
3
e 
BF3.OEt2 0 - 23 2 36 9:1 
4 InCl3 0 - 23 20 21 -
d 
5 MgBr2 0 - 23 20 0 -
d 
6 BF3.THF 0 - 23 24 86 (51) 11:1 
7 BF3.SMe2 0 - 23 20 0 -
d 
8
f 
BF3.THF 0 - 23 24 87 (63) 10:1
d 
All reactions performed on 0.11 mmol scale at [0.13 M]. a Conversion to 97a, where applicable. Isolated yields in 
parentheses. b Diastereomeric ratio calculated using relative integrals in the 1H NMR spectrum. c Lewis acid omitted. d No 
minor isomer observed. e Indole (1 eq.) used. f BF3.THF (1.5 eq.) used. 
It was noted that the BF3.THF was mildly acidic (pH 3) on testing with pH paper, with the acidity 
presumably arising from the generation of HF on exposure of the reagent to atmospheric moisture. To 
establish whether the ring-opening was in fact acid catalysed, aziridine 1a was treated with indole in 
the presence of BF3.THF (0.5 equiv.) and Proton Sponge® (0.5 equiv.). Clean starting material was 
recovered in quantitative mass, upon work-up after 20 h. (Table 22, entry 1). It seemed likely that the 
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lack of degradation and conversion to product as observed by 
1
H NMR and TLC analysis of the crude 
product was due to coordination of the boron reagent to the additive. To the same end, a range of acid 
catalysts were tested in place of the BF3.THF. An excess (5 eq.) of the mild acid NH4Cl did not 
provide any conversion to product by TLC analysis, at either r.t. or reflux, despite increased reaction 
times (entries 2 and 3). Additionally, stirring indole with aziridine 1a in CH2Cl2 in the presence of 
silica gel (20 eq. w/w) provided a quantitative recovery of clean starting material upon filtration after 
5 h. (entry 4). Camphor-sulfonic acid (CSA) was also chosen, owing to the poor nucleophilicity of the 
counter anion. No ring-opening was observed, although some degradation was seen by 
1
H NMR 
analysis of the crude product (entry 5). Stronger acid catalysts bearing more nucleophilic counter-ions 
(AcOH, HCl) did provide conversion to the required product, although as mixtures with acetate and 
chloride ring-opened products (vide infra).  
Table 22: Alternative catalysts for ring-opening with indole 
 
Entry Catalyst Equivalents of catalyst Time (h.) 
1
a 
BF3.THF
 
0.5 20 
2
b 
NH4Cl
 
5.0 40 
3
c 
NH4Cl
 
5.0 8 
4 Silica gel 20.0
d 
5 
5 CSA 0.2 40 
All reactions performed on 0.11 mmol scale at [0.13 M] using indole (2 eq.). a Proton Sponge (0.5 eq.) added. b Performed at 
23 °C. c Performed at reflux. d 20 eq. w/w.  
As none of the range of acids tested had provided either ring-opened product, further investigation 
into acid catalysis was halted. Having improved the yield of the major product of the ring-opening 
with indole from 7% to 63%, attention was turned to the identification of the minor product in the 
reaction. 
Promoting formation of a minor product 
The minor product had been tentatively assigned as the syn-diastereomer 97b, resulting from 
borderline SN2/SN1 reactivity at C3 of the aziridine. Insufficient material had been obtained to collect 
characterisation data other than a 
1
H NMR spectrum. The shifts of the C2- and C3-protons in the 
minor product were similar to those observed in the major product 97a (Table 23), although it was 
very possible that product 97c, arising from regioisomeric attack of the indole at C2, would present 
similar 
1
H NMR shifts. Literature 
1
H NMR data for compounds with comparable structures to the 
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regioisomer are not available. Thus, the aim was to promote the formation of the minor product, so 
that sufficient material could be isolated for full characterisation.  
Table 23: 
1
H NMR shifts in major and minor ring-opened products  
 
Proton 
1
H NMR shift (ppm)
a 
 Major Minor 
C2 4.17 4.07 
C3 4.63 4.82 
a Shift  in CDCl3 
Initially several azaphilic Lewis acids were selected,
94
 to test whether the regioselectivity of the 
ring-opening would be altered on their use in place of BF3.THF. On stirring the aziridine with indole 
and the azaphilic Lewis acids, either complete degradation to unidentified products or clean recovered 
starting material was observed (Table 24). The lack of ring-opening observed in the presence of these 
catalysts prompted an alternative strategy to promote SN1-like reactivity in the aziridination, and 
hopefully increase the formation of the minor product. 
Table 24: ‘Azaphilic’ Lewis acids94 
 
Entry Lewis acid Equivalents Observations
a 
1 Cu(OTf)2 0.5 -
b 
2 CuCl2 0.5 R.S.M 
3 CuCl2 1.0 -
b 
4 CuCl 1.0 R.S.M 
5 CoCl2 0.5 -
b 
Reactions performed on 0.11 mmol scale in PhMe [0.13 M]. a Observations from analysis of crude reaction mixture by TLC 
and 1H NMR.  b Degradation to unidentified products. 
As no ring-opening had been observed in this brief investigation, a second strategy was considered. 
An elegant experiment was reported by Letgers et al., as part of investigation into the ring-opening 
chemistry of NH-aziridine-3-aryl-2-methyl esters with indole. Enantiopure PMP-derivative 98 was 
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subjected to the reaction conditions, resulting in a mixture of C3 epimers 99a and 99b, whilst 
complete C3 inversion was observed with the corresponding phenyl-aziridine (Scheme 59). Electron 
donation from the para-methoxy group allowed stabilisation of positive charge build up at C3 during 
ring-opening, causing a change in mechanistic preference from SN2-like to SN1-like.
17
 
 
Scheme 59: Diastereomeric ratios in Letgers’ ring-opening with indole17 
Taking a lead from Letgers, a batch of the required PMP-aziridine 1b was prepared using the 
previously described chemistry (vide supra). Application of the literature conditions led to 
degradation of the starting aziridine to multiple unidentified products, as evidenced by 
1
H NMR and 
TLC analysis of the crude reaction mixture.
95
 As the tert-butyl ester analogues had proved sensitive to 
BF3.OEt2, the recently optimised conditions employing BF3.THF were tested, using catalytic 
quantities of the boron reagent to minimise decomposition. Unfortunately, degradation of the aziridine 
to unidentified products was again observed, after a reaction time of 45 min. It was hypothesised that 
the increased electron-density of the PMP-aziridine caused increased reactivity of this substrate, and 
its observed incompatibility to the reaction conditions (Table 25). 
Table 25: Attempting to promote an SN1-like pathway 
 
Entry Lewis acid Equivalents 
1 BF3.OEt2 1.5 
2
a 
BF3.THF 0.5 
All reactions performed on 0.11 mmol scale at [0.13 M]. a PhMe used as solvent 
The chemistry of tryptophan 97a 
As attempts to promote the formation of the minor product had been unsuccessful, it was decided not 
to pursue this avenue of research further, meaning that the minor product would remain 
uncharacterised and tentatively assigned. Instead, further reactivity of tryptophan 97a was envisaged, 
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whereby electrophilic activation of the indole moiety followed by trapping with the free amine could 
lead to fused tricycle 101. Cyclisation of a similar substrate in this manner is known in the literature, 
using tert-butyl hypochlorite as the electrophile.
7
 In a preliminary experiment, NBS was used in a test 
reaction (Scheme 60). No conversion to product was observed by TLC analysis, after stirring 
tryptophan 97a in the presence of NBS and Et3N for 24 h. Subsequent heating to reflux for 4 h. did 
not cause any conversion of starting material. The lack of cyclisation could be attributed to interaction 
of the nucleophilic amine and NBS; the nitrogen nucleophile in the literature substrate was protected 
as an amide, a likely necessity in the presence of the strong electrophile. 
 
Scheme 60: Attempted tricycle formation 
Following the unsuccessful formation of 101 from tryptophan derivative 97a, it was decided to bring 
further experimentation surrounding the ring-opening with indole to a close. The ring-opening 
reaction had been significantly optimised, to provide a 63% yield of the tryptophan derivative 97a, 
from an initial 7% using literature conditions. Full characterisation of a minor product arising from 
the reaction had not been possible. Alternative nucleophiles were next considered, to further probe the 
ring-opening susceptibility of aziridine 1a. 
1.3.4.2 Ring-opening with hydrogen 
Hydrogenation of N-functionalised aziridines to the resulting amines is well documented in the 
literature.
96, 97
 The regioselectivity of bond cleavage is dependent upon functionality at the aziridine 
carbon atoms; significantly weaker or less sterically encumbered CN- bonds can be hydrogenated 
selectively. A single example of hydrogenation of an NH-aziridine-2-carboxylate exists.
18
 The 
substrate in question was a benzyl ester, thus hydrogenation yielded the free amino acid upon 
concomitant ring-opening and de-benzylation. If analogous ring-opening was observed with aziridine 
1a then the product would be isolated as the tert-butyl ester, with the advantage that this product 
would be easier to handle than the free amino acid isolated in the literature procedure. 
 
Aziridine 1a was treated with palladium on carbon under an atmosphere of hydrogen for 2 h., before 
filtration and work-up. Concentration of the organic phase provided pure phenylalanine tert-butyl 
ester 102 in 95% yield (Scheme 61). Hydrogenation of the benzylic CN- bond had occurred 
regioselectively, as evidenced by comparison with literature data for the product.  
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Scheme 61: Hydrogenation of aziridine 1a 
The excellent selectivity and yield of the hydrogenation protocol meant that optimisation of the 
reaction was not required. Chloride was the next nucleophile of choice for the ring-opening of 
aziridine 1a.  
1.3.4.3 Ring-opening with chloride 
Chloride is a common nucleophile for the ring-opening of N-functionalised aziridines, but is less 
established for NH-aziridine-2-carboxylates. Only one example exists, and was neither accomplished 
regio- nor diastereoselectively.
17
 Initially, aziridine 1a was dissolved in CH2Cl2 and treated with an 
excess of HCl (37% aq.). After 20 min. at r.t. a white precipitate was seen forming, which was 
removed by filtration after 1 h. 
1
H NMR analysis of the solid showed pure β-chloro phenylalanine 
103, isolated in 67% yield (Scheme 62). TLC analysis of the mother liquor showed no other products, 
confirmed by concentration of the phase in vacuo. It was presumed that the product had been isolated 
as the hydrochloride salt due to the complete insolubility of the product in CH2Cl2 and CDCl3. No 
attempt was made to break the salt using a basic wash, owing to the likely difficult extraction of the 
free amino acid from an aqueous layer. Interestingly, analogous chemistry using HBr (48% aq.) 
resulted in the formation of a pale yellow precipitate, which showed significant degradation to 
unidentified products on 
1
H NMR analysis. 
 
Scheme 62: Ring-opening using HCl (37% aq.) 
Following the observed cleavage of the tert-butyl ester using HCl (37% aq.), a milder source of HCl 
was proposed, reasoning that the tert-butyl ester might exhibit greater stability. Addition of 
commercial HCl in dioxane (4 M) to aziridine 1a in CH2Cl2 resulted in complete consumption of 
starting material by TLC analysis after 30 min. Removal of volatiles in vacuo and 
1
H NMR analysis 
of the crude reaction mixture revealed complete conversion to a single ring-opened product, with the 
tert-butyl ester intact. However, multiplets arising from unidentified by-products were observed in the 
1
H NMR spectrum, between 3.60 and 3.85 ppm. Further investigation revealed that concentration of a 
portion of the commercial HCl in dioxane provided a residual oil that exhibited the same signals upon 
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1
H NMR analysis. Thus, some polymerisation of dioxane in the presence of HCl was assumed, also 
observed in analyses of different batches of the reagent. Purification of an analytical sample of the 
ring-opened product was achieved via trituration from Et2O in 36% yield, allowing its identification 
as β-chlorophenylalanine tert-butyl ester hydrochloride 104a (Scheme 63). Evidence that the product 
had been isolated as the hydrochloride salt included an Rf of 0.0 in EtOAc/MeOH (5%), and poor 
solubility of the product in common organic solvents (including CDCl3 and Et2O). This was 
confirmed on washing a CH2Cl2 solution of 104a with NaHCO3 (sat. aq.). Separation and 
concentration of the organic phase resulted in pure β-chlorophenylalanine tert-butyl ester 104b 
(Scheme 63), bearing considerably different shifts on 
1
H NMR analysis to the hydrochloride salt, and 
an Rf of 0.8 in EtOAc/MeOH (5%). Gratifyingly, it was found that the aqueous bicarbonate wash was 
sufficient to remove the polymeric dioxane impurity, without necessity for trituration of the crude 
hydrochloride salt 104a from Et2O. As a result, inclusion of a bicarbonate wash in the work-up 
procedure following treatment of the aziridine with HCl in dioxane, provided β-chlorophenylalanine 
tert-butyl ester 104b in 90% yield from aziridine 1a (Scheme 63).  
 
Scheme 63: Access to β-chlorophenylalanine derivatives 
A single product was observed in the crude material of each reaction, following the ring-opening of 
aziridine 1a with both HCl (37%) and HCl (4 M in dioxane). This suggested that an SN2-like 
mechanism was in operation, and led to the assignment of 103, 104a and 104b as the 
anti-diastereomers. Regiochemistry was assigned by comparison to known literature compounds 
(Table 26). The methyl ester analogue of 104a, compound 105a (entry 3) has been prepared as a 10:1 
mixture with its regioisomer 105b, allowing comparison with the 
1
H NMR shifts of 104a (entry 2). 
The C2-proton in tert-butyl ester 104a exhibits a very similar shift (4.55 ppm) to the analogous proton 
in the methyl-ester 105a (4.62 ppm). The C2-proton in regioisomer 105b is deshielded by 
comparison, as demonstrated by the considerable downfield shift at 4.95 ppm. Similarly, a downfield 
shift is observed for the C3-protons in 104a and 105a (5.90 and 5.75 ppm respectively) in comparison 
to the analogous proton in 105b (5.50 ppm). The regiochemistry of amino acid 103 was assigned 
similarly; values of 4.54 and 5.81 ppm were observed for the C2- and C3-protons respectively, 
comparable with analogues 104a and 105a. 
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Table 26: Regiochemical assignment of compounds 103 and 104a 
Entry Compound 
1
H NMR shift (ppm)
a 
  C3-proton C2-proton 
 
1 
 103 
 
5.81 
 
4.54 
 
2 
104a 
 
5.90 
 
4.55 
 
3
17 
105a 
 
5.75 
 
4.62 
 
4
17 
105b 
 
5.50 
 
4.95 
a Values in d6-DMSO. 105a and 105b synthesised as single enantiomers. 
With good yields obtained for the synthesis of the β-chloro compounds 103, 104a and 104b, 
ring-opening with oxygen-based nucleophiles became the new investigative target. Acetic acid is the 
only oxygen-based nucleophile known to ring-open NH-aziridine-2-carboxylates, with two reports 
provided by separate groups.
17, 18
 As such, acetic acid was selected initially to establish precedent for 
the ring-opening of aziridine 1a with oxygen-based nucleophiles.  
1.3.4.4 Ring-opening with oxygen-based nucleophiles 
Acetic acid  
Analogous conditions are used in the two prior literature reports,
17, 18
 and so these were applied to 
aziridine 1a. The substrate was heated to 70 °C in AcOH, before concentration of the reaction mixture 
in vacuo. Addition of NaHCO3 (sat. aq.) and extraction with CH2Cl2 provided the N-acylated 
derivative 106 as a single product by 
1
H NMR analysis, in 88% yield (Table 27, entry 1). Acyl-group 
transfer from O- to N- (which had also been observed in both literature reports) was evidenced by: 
(a) The amide stretch in the IR spectrum (1655 cm-1) 
(b) Two broad signals in the 1H NMR spectrum at 6.42 and 3.90 ppm, corresponding to the NH 
and OH protons respectively. 
Despite the good yield, a brief optimisation study was carried out (Table 27), to try to circumvent the 
use of acetic acid as solvent. Aziridine 1a was dissolved in MeCN and treated with a stoichiometric 
quantity (10 eq.) of AcOH at 70 °C. Only a 10% conversion to 106 was observed by 
1
H NMR analysis 
upon work-up after 20 h. (entry 3). Reasoning that the more nucleophilic NaOAc might provide a 
better conversion, an analogous reaction was performed, using this reagent with 15-crown-5 (entry 4). 
However, no conversion to product was seen by 
1
H NMR analysis after 2 h. at 70 °C; the same was 
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true of reactions performed with NaOAc in EtOH and H2O (entries 5 and 6). It seemed that use of the 
acetic acid as solvent was necessary for good conversions to 106, and so efforts were channelled into 
decreasing the temperature of the reaction. Although conversion to 106 was observed, the rate of 
reaction appeared to decrease considerably with decreasing temperature (entries 7 and 8). Given the 
good initial yield of 88%, further investigation was ceased. 
Table 27: Attempted optimisation of acetate ring-opening 
 
Entry Solvent Temperature (°C) Time (h) 
1
H NMR conversion (%)
a 
1 AcOH 70 1.0
b 
100 (88) 
2 AcOH 70 1.5 100 (79) 
3
c 
MeCN 70 20 10 
4
d 
MeCN 70 2.0 0 
5
d 
EtOH 70 5.0 0 
6
d 
H2O 70 5.0 0 
7 AcOH 16 20.0 50 
8 AcOH 50 5.0 40 
All reactions performed on 0.11 mmol scale at [0.06 M]. Isolated yields in parentheses. a By relative integration of tert-butyl 
singlet in starting material and product. b Followed by an additional 16 h. at r.t.  c AcOH (10 eq.) used. d NaOAc (10 eq.) and 
15-crown-5 (10 eq.) used. 
Once again, as a single product had been observed in by 
1
H NMR analysis of the crude reaction 
mixture, SN2-like reactivity was concluded, and a corresponding anti- relationship between the 
incoming nucleophile and amine leaving group. The regiochemistry was assigned by correlation with 
the benzyl and methyl ester analogues 107 and 108 (Table 28, entries 2 and 3). Additionally, 
comparison with regioisomeric analogue 109 showed a considerable difference in shift for the C2- 
and C3-protons.  
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Table 28: Regiochemical assignment of product 106 
Entry Compound 
1
H NMR shift (ppm)
a 
  C3-proton C2-proton 
 
1 
106 
 
5.26 
 
4.90 
 
2
18 
107 
 
5.21 
 
5.03 
 
3
17 
108 
 
5.25 
 
5.01 
 
4
98 
109 
 
5.57 
 
4.58 
aValues in CDCl3. Products 107, 108 and 109 synthesised as single enantiomers. 
Considering that benzoic acid has a similar pKa to acetic acid, it was suggested that this might be a 
suitable oxygen-based nucleophile for ring-opening. However, a test reaction employing 5 eq. of the 
reagent, and heating to 70 °C in toluene, provided recovered starting material after 20 h. (Scheme 64). 
 
Scheme 64: Attempted ring-opening with benzoic acid 
Alcohols 
The ring-opening of NH-aziridine-2-carboxylates with alcohols is unexplored. If successful, such 
chemistry would provide access to O-functionalised 1,2-amino alcohols, synthetically useful 
intermediates whose O-functionality can either be removed or elaborated dependent upon synthetic 
requirements. Methanol was selected as an initial nucleophile owing to ready availability. 
Methanol 
Encouraged by the success of Brønsted acid catalysis in previous ring-openings, aziridine 1a was 
treated with a solution of methanolic HCl (2 M), synthesised in situ from AcCl, in order to omit 
nucleophilic water. After 1 h., complete consumption of aziridine 1a was noted by TLC analysis of 
the reaction mixture. On removal of volatiles in vacuo and analysis of the resulting oil using 
1
H NMR, 
complete conversion to the chloride ring-opened product 103a was observed. Decreasing the 
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concentration of the methanolic HCl (0.5 M) led to mixtures of chloride- and methoxy-ring-opened 
products according to 
1
H NMR
 
analysis of the crude product, along with unreacted aziridine 1a.  
 
It was clear that suppressing the nucleophilicity of chloride sufficiently so as to provide the methoxy-
ring-opened product selectively would be difficult. Consequently, camphor-sulfonic acid (CSA), 
which bears a poorly nucleophilic counter anion, was selected as an alternative catalyst. Initially, a 2 
M solution of CSA in methanol was prepared and used to treat aziridine 1a. Basic work-up after 
1.5 h., followed by chromatographic purification allowed isolation of the methoxy-ring-opened 
product 111 in 49% yield (Table 29, entry 1). No other products had been observed by analysis of 
1
H 
NMR or the crude reaction mixture, although starting aziridine remained, in a 1:2 ratio with 
compound 111. Reasoning that a longer reaction time might allow complete conversion of aziridine 
1a, a second experiment using a stoichiometric quantity (5 eq.) of CSA was set up, and monitored by 
TLC analysis, until disappearance of starting material was observed (6 h.). Work-up and 
concentration of the organic phase in vacuo provided pure compound 111 in quantitative yield (entry 
2). Further experimentation revealed that 1 equiv. of CSA was sufficient to provide the product 
quantitatively after an identical reaction time (entry 3). An endeavour to use methanol 
stoichiometrically (5 eq.) resulted in a low (30%) conversion to compound 111 after 20 h. (entry 4), 
with the remaining material identified as unreacted aziridine by 
1
H NMR analysis of the crude 
reaction material.  
Benzyl and allyl alcohols 
With methanol used successfully as a nucleophile in the ring-opening chemistry, similar methodology 
was applied using allyl- and benzyl- alcohols. It was found that an increased stoichiometry of CSA 
(2.5 eq.) and a longer reaction time (20 h.) with each alcohol as solvent provided complete conversion 
to the ring-opened products. Chromatographic purification was called for in each case to remove 
minimal quantities of unidentified degradation products, although no regio- or diastereomers were 
present by 
1
H NMR analysis of the crude products. It should be noted that the lower isolated yields 
observed for ring-opening with allyl and benzyl alcohols (57 and 46% respectively, (Table 29 entries 
5 and 6) are un-optimised. Loss of material possibly occurred in the work-up procedures in each case, 
which involved multiple aqueous washes for complete removal of the polar alcoholic solvents. 
Optimisation would likely allow greatly improved yields in these reactions. Furthermore, these two 
products bear useful functionalities. The allyl group in 112 could potentially serve as a functional 
handle in a synthetic strategy. O-Benzylated 113 would allow access to the free amino alcohol on 
deprotection, and further, bears orthogonal protection to the N-acylated derivative 106 discussed 
previously.  
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Table 29: Ring-opening with alcoholic nucleophiles 
 
Entry R= CSA (eq.) Time (h.) Product Isolated yield (%) 
1
a 
Me 2 M solution
 
1.5 111 49 
2 Me 5.0 6.0 111 Quant.
b 
3 Me 1.0 6.0 111 Quant.
b 
4
c 
Me 1.0 20.0 111 (30) 
5 H2C=CHH2 2.5 20.0 112 57 
6 Bn 2.5 20.0 113 46 
All reactions performed on 0.11 mmol scale in ROH at [0.11 M]. 1H NMR conversion in parentheses. a Performed at [0.06]. b 
Purification not required. c Reaction performed in CH2Cl2 using MeOH (5 eq.). 
The complete stereoselectivity of the alcoholic ring-openings allowed assignment of compounds 111, 
112 and 113 as the anti-products, arising from an SN2-like mechanism. Comparison of benzylated 113 
with regioisomeric analogue 114 showed a considerable difference in shifts (ca. 0.30 ppm) for both 
the C2- and C3-protons (Table 30, entries 3 and 4). Similarly, inspection of these signals in regio-
analogous methoxy-compounds 111 and 115 revealed only a small difference in shift values between 
the two compounds. Indeed, careful analysis of the 
1
H NMR spectra of compounds 111, 112 and 113 
provided further confirmation that the assignments of signals corresponding to the C2- and C3-
protons had been made correctly, and the products had arisen from attack at C3. The shifts of the C2-
protons differ only slightly (by 0.06 ppm) across the series, owing to their similar chemical 
environments (entries 1-3). The C3-protons exhibit greater variance in shift values (0.22 ppm), with 
the shift to downfield ppm exaggerated with increasing inductive effect of the O-alkyl group. 
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Table 30: Regioisomeric assignments of compounds 111, 112 and 113 
Entry Compound 
1
H NMR shift (ppm)
a 
  C3-proton C2-proton 
 
1
 
111 
 
4.39 
 
3.67 
 
2
 
112 
 
4.52 
 
3.66 
 
3 
113 
 
4.61 
 
3.72 
 
4
99 
114 
 
4.32 
 
4.06 
 
5
100 
115 
 
4.31 
 
3.64 
aValues in CDCl3. Products 114 and 115 synthesised as single enantiomers. 
1.4 Conclusions 
Stereoselective ring-opening of aziridine 1a had been observed with all the nucleophiles tested 
(Scheme 65). Despite the lack of an N-activating group, complete consumption of aziridine 1a had 
been observed in all cases, following relatively short reaction times (<20 h.). Moreover, the majority 
of reactions had occurred at r.t., further exemplifying the susceptibility of aziridine 1a to nucleophiles. 
Ring-opening with indole showcased an interesting carbon-carbon bond forming methodology. The 
novel openings with alcoholic nucleophiles yielded O-alkyl amino alcohols, presenting the possibility 
of selecting appropriate alkyl functionality for a given synthesis. Compound 113 in particular bears 
orthogonal protection to product 106; such simple access to orthogonally protected compounds is an 
attractive feature of the methodology. Appropriate choice of chloride source was shown to provide β-
chloro phenylalanine derivatives, with or without the tert-butyl ester intact.  
 
The range of examples proves the susceptibility of aziridine 1a to nucleophilic ring-opening (Scheme 
65). Although further scope was not examined in this study, it seems likely that similar products could 
be accessed using alternative nucleophiles under Lewis or Brønsted acid activation of the aziridine.  
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Scheme 65: Ring-opening compounds of aziridine 1a 
To conclude part one of this thesis, it has been possible to access amino acid derivatives in two steps 
from readily available starting materials, from the ring-opening of NH-aziridine-2-carboxylates 
derived from enoates (Scheme 66).
101
 Although the aziridination of some tert-butyl cinnamates 
proceeds in moderate yield, the chemistry is competitive with current multi-step protocols, owing to:  
a) the direct aziridination methodology employed 
b) the lack of necessity for deprotection of the amino-acid derivative. 
The aziridination is currently limited in scope although more work can be carried out here, for 
example, investigating the potential for β-alkyl tert-butyl enoates as substrates. The high susceptibility 
to ring-opening of an NH-aziridine-2-carboxylate has been demonstrated; other nucleophiles and 
aziridine substrates could be tested here to further increase the scope of the chemistry.  
 
Scheme 66: Amino acid derivatives in two steps from readily available starting materials 
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2. Novel Pyrazolo[3,4-d]pyrimidines for Kinase-substrate 
Identification  
89 
 
2.1 Introduction 
2.1.1 A novel method for kinase protein-substrate identification 
Kinases are enzymes that regulate protein-phosphorylation, a post-translational protein modification 
that is fundamental in cell signalling pathways. Kinases bind ATP and a protein-substrate in two 
spatially adjacent surface binding pockets, in order that the ATP can transfer its γ-phosphate to a 
residue of the protein-substrate (Scheme 67). In eukaryotic cells, serine/threonine residues are most 
commonly phosphorylated, accounting for 97-98% of all phosphorylation.
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Scheme 67: Kinase-templated protein phosphorylation 
There are 518 identified human kinases, collectively known as the kinome, each with a specific set of 
protein-substrates. Approaches to identify kinase protein-substrate sets in vitro include library-based 
methods
103, 104
 and methods to exploit the physical association between the kinase and its protein-
substrate, for example using affinity chromatography.
105
 Substrate determination in vivo is more 
challenging, with the majority of methods involving the exclusion of kinase activity from the cell 
system. Genetic modification can be used for „knock-out‟ experiments,106 where the function of wild-
type and modified cells are compared to identify pathways the kinase is involved in. However, this 
approach is inapplicable to kinases that are essential for survival. Small molecule inhibition is 
attractive, although most kinase inhibitors are ATP competitive. The highly conserved shape of the 
ATP binding site across the kinome means that these strategies suffer from poor selectivity. 
Consequently, a selective method to identify kinase protein-substrate sets that is applicable in vivo is 
desired. This would allow further understanding of cell cycle processes, leading, for example, to the 
development of new treatments for cellular disease.  
 
It is possible to address the selectivity issue arising from small-molecule inhibition via a steric 
complementation approach known as „bump-hole inhibition‟. This involves mutating a kinase of 
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interest to have an enlarged ATP binding site, by reducing the size of the „gate-keeper‟ residue. 
Incubation with a sterically bulky ATP mimic results in the selective targeting of this mutant kinase in 
the presence of wild-type kinases (Scheme 68).  
 
Scheme 68: Selectivity via steric complementation: Bump-hole inhibition 
Shokat has used the bump-hole approach to target protein tyrosine kinase v-Src.
107
 An alkyl group 
was installed at N4 of ATP, to act as the „bump‟ (Fig. 8). N4-(Cyclopentyl) and N4-(benzyl) were 
found to exhibit particularly high affinity for mutant v-Src (V323A, I338A) in the presence of its 
wild-type. However, the method was not applicable in vivo owing to the triphosphate rendering the 
ATP derivatives cell-impermeable. Further development of the methodology by Shokat led to the 
identification of the C3-substituted pyrazolo[3,4-d]pyrimidine scaffold, as an alternative to the first-
generation ATP-derivatives (Fig. 8).
108, 109
 Compounds based on the pyrazolo[3,4-d]pyrimidine 
scaffold have been used with success as ATP mimics in other methodologies.
110, 111
 The C3-
substituent is the „bump‟ in Shokat‟s inhibitors, with several C3-aryl pyrazolo[3,4-d]pyrimidines 116 
identified as particularly potent inhibitors of mutant tyrosine-kinases. An advantage of the bump-hole 
strategy is that it has the potential to be applied to a wide range of kinases, as long as the mutant form 
is accessible.  
 
Fig. 8: Shokat’s compounds for kinase ‘bump-hole’ inhibition 
Following Shokat‟s seminal work, work in our laboratories resulted in the design of compounds 2 
(Fig. 9), based on the pyrazolo[3,4-d]pyrimidine scaffold, that would utilise the bump-hole inhibition 
methodology to label the protein-substrate of a kinase of interest. The work specifically targeted 
PKCα, a tyrosine-kinase involved in the regulation of gene expression, cell migration and cell growth 
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and regulation. The protein-substrates of PKCα are known, making it a suitable substrate for initial 
investigation and proof of concept. Mutant PKCα (M417A) was generated, and was shown to retain 
its phosphorylation activity. N1-tert-Butyl analogues 116 (Fig. 8) were then synthesised, to identify 
the optimum C3-aryl group for inhibition of PKCα (M417A). Six C3-aryl pyrazolo[3,4-d]pyrimidines 
were identified with IC50 values in the nanomolar range. These six scaffolds would be further 
elaborated with a cross-linker, necessary for covalent cross-linking to the kinase protein-substrate 
(Fig. 9).
112
 
 
Fig. 9: Target compounds 2 for kinase protein-substrate identification 
It is hoped that following selective binding of the C3-aryl pyrazolo[3,4-d]pyrimidine unit of 2 to the 
ATP-site of the mutant kinase of interest, the cross-linker will be held in the correct orientation to 
bind with the docked protein-substrate. The azide is key to this methodology; application of UV light 
transforms the functionality into a reactive nitrene precursor necessary for cross-linking. Once 
labelled, the alkyne would provide a functional handle for the attachment of a biotin molecule and/or 
a fluorophore, allowing separation and identification of the labelled protein-substrate (Scheme 69). 
 
Scheme 69: A novel kinase protein-substrate identification strategy 
This technique is novel, in that it combines two previously recognised methodologies, bump-hole 
inhibition and photoactivatable cross-linking for kinase protein-substrate identification. Considerable 
research went towards the design of compounds 2 for these purposes; for a full account, the reader is 
directed towards the relevant thesis.
112
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2.1.2 Synthesis of C3-unfunctionalised pyrazolo[3,4-d]pyrimidines 
One of the key synthetic challenges was the development of methodology to incorporate the α-
tert-alkyl amine cross-linker side-chain. A synthetic route to access the C3-hydro analogues 129 
lacking the C3-aryl functionality had previously been developed (Scheme 70), in order to test whether 
cross-linking to substrates of wild-type PKCα could be successfully achieved. Synthesis began with 
benzylation of prenyl alcohol (117) in 92% yield, followed by the installation of the α-tert-amine 
functionality, using a hydrohydrazination procedure to give 120.
113
 Acidic hydrolysis followed by 
condensation with enol ether 121 provided pyrazole 122 in 90%. Treatment of 122 with formamide 
established the pyrazolo[3,4-d]pyrimidine core, and the resulting product 123 was de-benzylated and 
oxidised to give aldehyde 125. Crude 125 underwent reductive amination, to install the terminal 
alkyne in 50% yield over two steps. A final amidation step was used to install the aryl azide 
functionality; the synthesis diverged at this step, with the coupling of two regioisomeric aryl azides, as 
the optimum position of the azide motif for cross linking (meta or para) was not known. Inhibition of 
PKCα was observed with both regioisomers of 129 (100 μM, 30-50%). However, upon incubation and 
photolysis of the compounds with PKCα, no labelling was observed. It was suggested that the lack of 
labelling may be due to the low affinity of the C3-hydro derivatives for the wild-type kinase. Indeed, 
it was shown in the N1-tert-butyl series that C3-aryl „bumped‟ inhibitors and mutant kinase pairs bind 
with higher affinity than C3-unsubstituted inhibitors do with the wild-type kinase.
112
 As a result, the 
synthesis of the C3-aryl substituted compounds was required for continued investigation. 
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Scheme 70: Access to C3-hydro pyrazolo[3,4-d]pyrimidines 129 with cross linker
112
 
2.2 Project aims 
In the N-tert-butyl series 116 (Fig. 8), an efficient synthesis allowing late-stage introduction of the 
C3-aryl had been developed, using halogenation and subsequent arylation. However, halogentation at 
C3 of 123 (Scheme 70) had not proved possible, so the strategy could not be used to access the C3-
aryl target compounds.
112
 Further to this, the synthetic route also required optimisation at the key 
α-tert hydrazine forming step. The hydrohydrazination procedure used was lengthy and capricious, 
and required initial synthesis of cobalt catalyst 119 whose purity is difficult to determine (Scheme 
71). A more robust synthesis was sought in order to carry sufficient material through the remaining 
steps of the linear synthesis.  
 
Scheme 71: Synthesis of cobalt catalyst 119
113
 
Presented with these two synthetic problems, the aims of the project were clear: 
1. To develop a synthetic strategy to C3-aryl pyrazolo[3,4,d]pyrimidines 2  
2. To avoid the hydrohydrazination step en route to the pyrazolo[3,4,d]pyrimidine core of 129. 
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2.3 Results and discussion 
2.3.1 Synthesis of pyrazolo[3,4,d]pyrimidine 123 
As a start point, it was decided to investigate CH activation methodologies for the C3-aryl 
functionalisation of pyrazolo[3,4-d]pyrimidine 123. Recent literature documenting the 
direct-CH-activation of heteroaromatics suggested that direct arylation at C3 of 123 could be possible. 
Although the C3 is regarded to be the least „activated‟ of the pyrazole carbon atoms with respect to 
CH-activation,
114
 examples are known (vide infra). Additionally, pyrazole 123 bears functionality at 
all positions aside from C3, thus arylation is only possible at the desired position.  
 
Accordingly, the developed route (Scheme 70) was followed to bring through material. Initial 
benzylation of prenyl alcohol led to variable yields of compound 118, and the isolated product was 
contaminated with inseparable impurities, arising from the degradation of benzyl bromide on silica. 
As the first intermediate in the route, the purity of 118 was considered important, and following brief 
optimisation, reaction of prenyl bromide and benzyl alcohol in the presence of NaH provided pure 
118 in quantitative yield (Scheme 72).
115
 The hydrohydrazination step led to disappointing yields of 
120 on both 3 and 19 mmol scales. In addition, a large quantity (52%) of di-tert-butyl 
hydrazodiformate 132 was isolated on 19 mmol scale (and observed by TLC on 3 mmol scale), 
proving that reduction of the diazo-compound was occurring at a faster rate than amination. 
Gratifyingly, pyrazole formation was facile, proceeding to 122 in reproducible yield on small and 
moderate scales. Finally, reflux of 122 in formamide led to 123 in good yield, providing high purity 
formamide was used (Scheme 72). 
 
Scheme 72: Synthesis of pyrazolo[3,4-d]pyrimidine 123 using reported chemistry 
Due to the low-yielding hydrohydrazination step, an insufficient quantity of 
pyrazolo[3,4-d]pyrimidine 123 had been accessed for rigorous testing of CH-activation conditions. 
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Given this, it was considered prudent to first re-examine the synthetic strategy, to provide the 
derivative in higher yield. 
2.3.1.1 Strategies to N-tert-alkyl pyrazolo[3,4-d]pyrimidines 
Despite the widespread use of the pyrazolo[3,4-d]pyrimidine motif as an ATP mimic, N-substituted 
α-tert-alkyl pyrazolo[3,4-d]pyrimidines are unknown in the literature, aside from N-tert-butyl 
derivatives. The dearth of other N-tert-alkyl derivatives can be attributed to the difficulty in 
synthesising the structures.  
 
The two most commonly used synthetic methods used to access N-alkyl-pyrazolo[3,4-d]pyrimidines 
are not applicable for varied tert-alkyl derivatives. The first method involves the initial synthesis of an 
N1-unfunctionalised pyrazolo[3,4-d]pyrimidine 133 (Scheme 73). N-Alkyl functionality is then 
established using SN2 chemistry, so access to a wide variety of N-primary and N-secondary 
substituents is possible, but N-tertiary alkylation cannot be accomplished (Scheme 73). Researchers in 
Washington State recently used this method to access a range of N-alkyl pyrazolo[3,4,d]pyrimidines 
as kinase inhibitors for the parasite Toxoplasma gondii. Twenty one mesyl-alcohols were synthesised 
and reacted with N-unfunctionalised pyrazolo[3,4-d]pyrimidines.
116
 Such chemistry was also 
exemplified by GlaxoSmithKline in their synthesis of inhibitors of the PERK enzyme, which has been 
identified as a potential drug target in the treatment of cellular disease. N-Unfunctionalised 
pyrazolo[3,4-d]pyrimidine 134 was treated with 2-iodopropane and CsCO3 in DMF at 80 °C, to yield 
the C3-iodo N-isopropyl compound 135, which was subjected to derivatisation at C3 (Scheme 73).
117
 
 
The second widely used method to access N-alkyl pyrazolo[3,4-d]pyrimidines involves an N-alkyl 
hydrazine 136 in the initial pyrazole-forming step (Scheme 73). Simple, commercially available 
N-alkyl hydrazines are often reaction partners, owing to the desire to avoid expensive reagents at the 
initial step. However, the methodology presents an opportunity to install elaborate N-tert-alkyl 
functionality if required. This is limited in practise, due to the difficult synthesis of N-tert-alkyl 
hydrazines. The functional group has previously been accessed using SN1 chemistry from the parent 
tert-halo or tert-alcohol compounds,
118, 119
 although yields are often low, and the strongly acidic 
conditions allow for limited alkyl functionality. 
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Scheme 73: Synthetic routes to N-alkyl pyrazolo[3,4-d]pyrimidines 
Development of a more compatible synthetic strategy is clearly required, so that elaborate tert-alkyl 
hydrazines can be more readily accessed. Notwithstanding use of the methodology in the project 
discussed herein, this would allow for the synthesis of highly derivatised N-tert-alkyl 
pyrazolo[3,4-d]pyrimidines that could be tested as ATP mimics. Crystal structure data have shown the 
N-alkyl functionality sitting outside the kinase ATP binding site on inhibition of a kinase with an N-
alkyl pyrazolo[3,4-d]pyrimidine, analogous to the phosphate tail of ATP.
116
 Despite its external 
location, the N-alkyl functionality has been shown to play an important role in binding, with specific 
secondary binding interactions identified for some alkyl motifs.
116
 Additionally, a study comparing 
N-tert-butyl and N-isopropyl C3-aryl pyrazolo[3,4-d]pyrimidine analogues showed the former to be a 
considerably more potent inhibitior of calcium-dependent protein kinases.
120
 Simple access to varied 
N-tert-alkyl pyrazolo[3,4-d]pyrimidines would allow testing, to establish whether a correlation 
between tert-alkyl functionality and increased potency exists. 
2.3.1.2 An alternative synthesis of an α-tert-alkyl hydrazine 
Grignard reagent addition to an azo-dicarboxylate 
It was hoped that through investigation of an alternative methodology to access α-tert-alkyl hydrazine 
120, a more general approach to α-tert hydrazines might be developed. Literature precedent exists for 
the addition of tert-butyl magnesium chloride into the diazo-linker of di-tert-butyl azodicarboxylate 
141 (Scheme 74).
121
 A moderate yield (30%) is reported, although after a more amenable reaction 
time (10 h.) than the hydrohydrazination protocol (5 d.). Additionally, a protocol exists documenting 
the conjugate addition of tertiary Grignard reagent 138 to enone 137 in good yield (85%) (Scheme 
74).
122
 It was hoped amalgamation of the two procedures would provide access to hydrazine 120 in 
superior yield following a diminished reaction time in comparison with the current protocol.  
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Scheme 74: Synthesis and reactivity of tertiary Grignard reagents 
To evaluate the feasibility of the proposed route, addition of tert-butyl magnesium chloride into 
di-tert-butyl azodicarboxylate was first carried out. Following the literature procedure, the Grignard 
reagent was synthesised from tert-butyl chloride 140 and magnesium turnings (washed in hexane) in 
THF, with a crystal of iodine required for activation. The solution was transferred via cannula to 
azodicarboxylate 141; work-up after 2 h. and chromatographic purification provided the addition 
product 142 in 39% yield. Dicarbamate 132 was also isolated in 29%, presumably from reduction of 
the diazo- compound by the hindered Grignard reagent (Scheme 75). A control reaction, in which the 
azodicarboxylate was stirred at r.t. in THF under argon, saw no reduction product by TLC analysis 
after 24 h., lending support to the hypothesis.  
 
Scheme 75: Grignard reagent addition to an azo-dicarboxylate 
Encouraged by this result, chloro-alkane 145 was synthesised according to the literature procedure.
122
 
Methyl lithium was added to commercial ketone 143 over 30 min. at -78 °C, before a quench after a 
further 30 min. at this temperature. Purification provided the tert-alcohol 144 in 84% yield, which was 
then treated with HCl (37% aq.) to yield the tert-chloro compound 145 in 60% yield following 
purification. Brief optimisation indicated that 2 equiv. of methyl lithium were necessary for complete 
consumption of ketone 143, and quenching the reaction at -78 °C was required to limit impurity 
formation. Employing these conditions, the crude tert-alcohol 144 could be isolated in sufficient 
purity for immediate use in the chlorination step, providing an improved 56% yield of the tert-chloro 
compound 145 over two steps (Scheme 76).  
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Scheme 76: Synthesis of tert-chloro alkane 145 
Accordingly, formation of Grignard reagent 138 was attempted with a plethora of activation methods 
on various scales of the chloro-alkane, in different ether solvents. No obvious initiation was observed, 
and subsequent addition of the mixture to the diazo-compound resulted in return of chloro-alkane 145 
on work-up, indicating that formation of the Grignard reagent had not occurred. Further to this, the 
remaining magnesium turnings from one reaction were washed and weighed; quantitative mass 
recovery provided further evidence that magnesium insertion into the carbon-chlorine bond had not 
occurred. As such, it was hypothesised that the strength of the carbon-chlorine bond might be 
preventing formation of the Grignard reagent. This led to the proposal of the tert-bromo derivative 
146 (Scheme 77) as an alternative substrate. Interestingly, synthesis of 146 was less facile than the 
chlorinated compound. Analogous treatment of tert-alcohol 147 with HBr (48% aq.) led to complete 
conversion to the tert-bromo alkane, although impurity formation was observed by 
1
H NMR analysis 
of the crude reaction mixture, which worsened upon silica chromatography. Silica catalysed 
degradation of 146 was suspected; indeed a small quantity of the di-benzylated derivative 144a was 
isolated following chromatography, which had not been observed in the 
1
H NMR spectrum of the 
crude material. Accordingly, the crude product was subjected to distillation at reduced pressure. 
However, co-distillation of impurities led to an alternative synthesis being sought. Markovnikov 
addition of HBr to olefin 118 was attempted (Scheme 77), although degradation was observed by 
1
H 
NMR analysis upon work-up. The use of LiBr to control impurity formation in the synthesis of tert-
bromo alkanes from tert-alcohols has been reported.
123
 Pleasingly, addition of the salt to neat alcohol 
147 followed by treatment with 2 equiv. HBr (48% aq.) led to the isolation of bromo-alkane 146 in 
sufficient purity to attempt formation of the Grignard reagent. 
 
Scheme 77: Synthetic routes to tert-bromo alkane 146 
Reflux of 146 in THF in the presence of magnesium turnings led to no obvious initiation of Grignard 
reagent formation, although on addition of the mixture to the diazo-compound 140, reduction to 
dicarbamate 132 was observed. It is known that hindered Grignard reagents can act selectively as 
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hydride transfer agents.
124
 To establish whether such a process could be responsible for the reduction 
observed, a control experiment was set up heating the diazo-compound under analogous conditions, in 
the absence of the Grignard reagent. However, dicarbamate 132 was observed, showing that 
formation occurs under the reaction conditions, in the absence of the „Grignard reagent‟ solution. The 
control experiment provided further evidence that Grignard reagent formation was not occurring. 
Given the difficulty observed in forming the Grignard reagents from either tert-halo compound 145 or 
146, it was considered prudent to adopt an alternative strategy to α-tert-amine 120.  
Amine amination 
Disconnection of the nitrogen-nitrogen bond of a hydrazine was mooted, so that the synthesis would 
begin with the α-tert-amine functionality in place. This amination approach had previously been 
explored by a co-worker, who had established that tert-butyl amine 148 could be aminated using 
electrophilic oxaziridine 149,
125
 and subsequently converted to pyrazole 151 in a one-pot 
transformation (Scheme 78).
112
 Despite the success of the procedure, synthesis of oxaziridine 149 is 
multi-step. However, it is possible to synthesise the N-Boc protected analogue of DppONH2, the 
electrophilic aminating agent discussed in Chapter 1 of this thesis. The N-Boc protected analogue 152 
(DppONHBoc) can be synthesised in a single step from commercial N-Boc-hydroxylamine. Previous 
work within the group has shown that the reagent can effect enone aziridination,
67
 and so it was 
decided to test the potential of this reagent for the electrophilic amination of hindered amines 
(Scheme 78). The reagent (prepared by a co-worker) was first tested using tert-butyl amine as a 
model substrate. 
 
Scheme 78: Disconnection of the nitrogen-nitrogen bond in a hydrazine 
Initially, the conditions discovered for the aziridination of enones with DppONHBoc 152 were 
applied in the amination of tert-butyl amine 148 (Table 31, entry 1). Work-up and analysis of the 
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crude reaction mixture by 
1
H NMR showed un-reacted aminating agent, along with minimal amine. It 
was suggested that the volatility of the amine could account for the lack of reactivity, and so an excess 
of this reagent was used in a second reaction. Again, no conversion to product was observed (entry 2), 
and so a solvent and base switch to MeCN and NaOH, a combination used with considerable success 
in the aziridination, was trialled. When again, no amination was observed (entry 3), it was suggested 
that product volatility might be a problem. A final reaction was performed in an NMR tube in 
d3-MeCN, under analogous conditions. Although formation of the phosphinic acid was observed, no 
amine amination occurred over a time-period of 4 d. (entry 4). 
Table 31: Attempted amination of tert-butyl amine using DppONHBoc 
 
Entry tert-Butyl amine (eq.) DppONHBoc (eq.) Base (eq.) Solvent Time (h.) 
1 1 2 Cs2CO3 (3) CH2Cl2 2 
2 4 1 Cs2CO3 (2) CH2Cl2 20 
3 4 1 NaOH (2) MeCN 40 
4
a
 4 1 NaOH (2) d3-MeCN 96 
All reactions performed on 0.75 mmol scale of limiting reagent. a Performed on 0.02 mmol scale of DppONHBoc. 
Hydrazone alkylation 
The lack of amination observed meant that further investigation was halted, and an alternative route to 
the α-tert-amine was sought. A third retrosynthesis was considered, with the key 
α-tert-amine-forming step arising from alkylation of a hydrazone. The synthesis of hydrazone 154 is 
described in the literature,
126
 and it was suggested that access to derivative 156 might also be possible, 
using similar chemistry (Scheme 79). Methylation of 156 would establish the required α-tert-amine 
functionality, providing compound 155, analogous to 120. As hydrazone 154 is readily available, this 
was selected as a test substrate for methylation. A brief literature search revealed that alkylation of 
activated hydrazones (where the α-nitrogen bears a conjugating electron-withdrawing group) is 
common, although methyl nucleophiles are relatively rare. Notwithstanding, hydrazone 154 was 
synthesised following reflux of tert-butyl carbazate 153 in acetone. Work-up was facile, with filtration 
and evaporation of the reaction mixture providing the pure compound in quantitative yield, 
reproducible on large scale (76 mmol). 
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Scheme 79: Hydrazone alkylation as a synthetic strategy 
Having prepared the substrate, common methylating agents were selected for testing. In each case, 
two equiv. of methylating agent were used, to account for initial deprotonation of the carbamate 
nitrogen. There was also concern for the stability of the carbamate functionality under the reducing 
conditions. 
 
However, treatment with methyl lithium at -78 °C followed by warming to r.t. for 1 h. led to 
quantitative recovery of starting material 154 (Table 32, entry 1). Methyl magnesium chloride and 
bromide were selected as „softer‟ methylating agents, but treatment of hydrazone 154 with each, again 
led to quantitative recovered starting material, despite reflux of the reaction using the former reagent 
(entries 2 and 3). It seemed likely that the initial deprotonation was significantly reducing the 
electron-withdrawing capability of the carbamate functionality, rendering the hydrazone less reactive 
towards nucleophilic attack. Reasoning that a softer nucleophile might be more compatible with the 
hydrazone, dimethylcuprate was prepared in situ and added to the hydrazone in THF at 0 °C. 
Interestingly, the reagent caused complete degradation of the hydrazone to unidentified products by 
1
H NMR analysis of the crude material upon work-up, and a poor mass recovery was observed (entry 
4). An attempt to control the reactivity was made, by performing the reaction at -40 °C, although 
similar degradation and mass loss was observed (entry 5). 
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Table 32: Attempted methylation of hydrazone 153 
 
Entry Methylating agent Temp (°C) Solvent Observations
a 
1 MeLi -78 to 23 THF R.S.M.
b 
2 MeMgCl -78 to 50 THF R.S.M.
b 
3
c 
MeMgBr -78 to 23 THF R.S.M.
b 
4 Me2CuLi 0 to 10 Et2O Degradation 
5
d 
Me2CuLi -40 Et2O Degradation 
All reactions performed on 1.7 mmol scale.  a By 1H NMR analysis of the crude material. b Recovered starting material. c 0.6 
mmol scale. d 0.9 mmol scale. 
Returning to the literature, a procedure was found in which hydrazone 154 was treated with allyl 
magnesium bromide, to access α-tert-amine 157 in 51% yield.127 Analysis of compound 157 led to the 
proposal of a modified route (Scheme 80). The olefin provided an alternative to the benzyl ether 
functionality, which had presented problems in the original synthetic strategy. Benzyl group removal 
had been troublesome, providing alcohol 124 in moderate yield (59%) upon treatment with BBr3 
(Scheme 70). It was suggested that oxidative cleavage of the olefin following pyrazolo[3,4-
d]pyrimidine formation from α-tert-amine 157 could provide access to the late-stage aldehyde 125 
required for reductive amination (Scheme 80).  
 
Scheme 80: A common aldehyde intermediate of the first generation and proposed routes 
Hydrazone 154 was treated with allyl magnesium bromide according to the literature procedure. The 
substrate was dissolved in THF and cooled to 0 °C, prior to dropwise addition of the Grignard 
reagent. A further 1 h. at 0 °C, followed by the same time at r.t. led to complete consumption of 
hydrazone by TLC analysis, although unreacted starting material was observed in a 1:3 ratio with 
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product by 
1
H NMR analysis of the crude mixture. Gratifyingly, work-up and purification allowed 
isolation of the required hydrazine 157, albeit in low yield (26%) (Table 33, entry 1). Given the 
successful alkylation observed using allyl magnesium bromide, it was suggested that initial 
deprotonation of the carbamate nitrogen was not occurring, causing increased electrophilicity of the 
substrate.  To evaluate this, an analogous reaction was performed using 1 equiv. of the Grignard 
reagent, although no conversion to product was seen by 
1
H NMR
 
analysis on work-up, suggesting that 
anion formation was in fact occurring prior to nucleophilic addition (entry 2). Additionally, a pale 
green colour had been seen intensifying in the initial experiment, throughout addition of the first 
equivalent of the Grignard reagent, which turned immediately to yellow once the quantity of the 
reagent exceeded 1 equiv. Hydrazone 154 was next treated with three equiv. of Grignard reagent, to 
promote complete consumption of starting material. Although the quantity of unreacted starting 
material appeared to have decreased, considerable conversion to unidentified side-products was also 
observed in the 
1
H NMR sprectrum of the crude reaction mixture (entry 3). A reaction in diethyl ether 
provided a poorer conversion of starting material and increased side-product formation than the 
analogous reaction in THF (entry 4). Finally, the effect of temperature was tested, in a reaction that 
was kept at 0 °C for 2 h. Predictably, a lower conversion of starting hydrazone 154 was observed, yet 
conversely, side-product formation was increased, by comparison with the reaction warmed to r.t. for 
1 h (entry 5). Remarkably, the scale of the reaction appeared to have a considerable effect on the 
consumption of starting material and purity of the crude product. In a large-scale reaction (33 mmol), 
starting material and product were the only compounds observed by 
1
H NMR of the crude reaction 
mixture, in a 1:5 ratio. Chromatographic purification provided the α-tert-amine 157 in considerably 
improved yield (68%) than observed on 0.6 mmol scale (entry 6). This good yield was found to be 
reproducible, with two identical yields of 70% observed on 50 mmol scale (entry 7). 
Table 33: Allylation of hydrazone 154 
 
Entry Scale (mmol) Grignard reagent (eq.) Temperature (°C) Isolated yield (%) 
1 0.6 2 0 (1 h.) – 23 (1 h.) 26 
2 0.3 1 0 (1 h.) – 23 (1 h.) N.D.a(i) 
3 0.3 3 0 (1 h.) – 23 (1 h.) N.D.a(ii) 
4
b 
0.3 2 0 (1 h.) – 23 (1 h.) N.D. a(ii) 
5 0.3 2 0 (2 h.) N.D.
 a(ii)
 
6 33.0 2 0 (1 h.) – 23 (1 h.) 68 
7
c 
50.0 2 0 (1 h.) – 23 (1 h.) 70 
All reactions performed in THF at [0.1 M]. a Isolated yield not determined: 1H NMR observations of crude reaction mixture: 
(i) Starting hydrazone only; (ii) Starting hydrazone, required product, and unidentified side-products. b Reaction performed in 
Et2O. 
c Performed twice with identical yield observed. 
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Furthermore, the applicability of the chemistry to alternative hydrazone substrates (synthesised in turn 
from readily available ketones) could be envisaged. Potentially, access to a range of α-tert-hydrazines 
would be possible, bearing an olefinic functional handle for later elaboration. However, it was felt 
prudent to first assess the validity of the alkene-bearing substrate in the forward synthesis. 
2.3.1.3 Towards a common aldehyde 
Pyrazole formation was attempted, as in the first generation route. Reflux in ethanolic HCl was found 
to effect hydrolysis of the Boc- moiety, with complete consumption of starting material observed by 
TLC analysis after just 20 min. The time compared favourably with the 1.5 h. required for 
α-tert-amine 120 in the first generation route. The decreased reaction time was attributed to the single 
Boc- moiety in compound 157, whereas hydrolysis of two Boc- groups was required in the original 
α-tert-amine substrate. The reaction mixture was basified, before the addition of enol ether 121 
(synthesised from malononitrile and triethylorthoformate in 68% yield).
128
 TLC analysis showed 
complete consumption of enol ether 121 after a further 1 h. at reflux; an analogous reaction time to 
that observed in the first generation pyrazole synthesis. Work-up and chromatographic purification 
provided pyrazole 158 in 55% yield on 0.5 mmol scale (Table 34, entry 1). A comparable yield of 
59% was observed for a larger scale reaction on 5.0 mmol of substrate (entry 2). Despite the good 
yields obtained, a disadvantage at this step was the large quantity of ethanol solvent required, which 
was subject to distillation and rigorous drying prior to use. Pleasingly, a solvent swap to more readily 
available anhydrous methanol, led to the isolation of pyrazole 158 in an improved yield of 71% on 0.5 
mmol scale (entry 3), with a slight drop in yield to 63% observed on scale-up to 21.0 mmol (entry 4). 
A slight increase in reaction time for the first step to 1 h. was required, likely due to the lower reflux 
temperature of methanol. 
Table 34: Formation of pyrazole 158 
 
Entry Scale (mmol) Solvent Step i. time (min.) Isolated yield (%) 
1 0.5 EtOH 20 55 
2 5.0 EtOH 20 59 
3 0.5 MeOH 60 71 
4 21.0 MeOH 60 63 
Following synthesis of pyrazole 158, the intermediate was heated to reflux in formamide for 
pyrimidine formation, in accordance with the first generation route. It had been noted when repeating 
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the first generation synthesis, that fresh formamide was required for a good yield of the pyrimidine, 
and to avoid troublesome emulsions during work-up. Purification of the crude material following 19 
h. at reflux in formamide led to the isolation of pyrimidine 159 in 76%, along with pyrimidone 161 in 
21% (Table 35, entry 1). Careful chromatographic separation was required due to the similar Rf 
values of the compounds. The by-product was assumed to have arisen from hydrolysis of the nitrile by 
trace water under the forcing reaction conditions, or indeed from hydrolysis of the product itself; the 
analogous benzyl-ether derivative had been observed in the first generation route. In order to 
circumvent pyrimidone formation, and improve the yield with respect to pyrimidine 159, analogous 
reactions were performed using; a) formamide stored over molecular sieves and b) molecular sieves 
as an additive in the reaction. However, neither method appeared to decrease formation of pyrimidone 
161 by TLC or 
1
H NMR analysis and, and so further attempts to remove water from the reaction were 
not pursued. Scale-up of the reaction led to slightly diminished, yet reproducible yields (entries 2 and 
3).  
Table 35: Pyrimidine formation 
 
Entry Scale (mmol) Isolated yield (%) 
  Pyrimidine 159 Pyrimidone 161 
1 0.5 76 21 
2 10.5 63 N.D
a 
3 13.0 66 N.D
a 
All reactions performed at [0.5 M]. a Isolated yield not determined. 
Having accessed pyrazolo[3,4-d]pyrimidine 159 bearing the terminal olefin, oxidative cleavage to 
provide the aldehyde and reconnect with the first generation route would be the test for the strategy. 
Consultation of the literature highlighted an ozonolysis protocol used on a molecule with a similar 
southern fragment to compound 159.
129
 To follow the procedure, pyrazolo[3,4-d]pyrimidine 159 was 
dissolved in dichloromethane and cooled to -78 °C. Ozone gas was bubbled through the solution until 
a blue colour persisted, prior to the addition of dimethyl sulfide and warming to -10 °C. The reaction 
mixture was concentrated and the crude material analysed by 
1
H NMR; considerable degradation to 
unidentified products was observed, along with minimal starting material and no signal in the 
aldehyde region. Additionally, mass recovery was poor. Subsequently, an analogous reaction was 
performed, calculating the output of the ozoniser. This was done using a calibration chart provided 
with the ozoniser, and monitoring gas output using a flow meter, to limit the quantity of ozone 
bubbled through the reaction mixture to 1 equiv. 
1
H NMR analysis of the resulting crude material 
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revealed starting material, along with some degradation. Again, no aldehyde proton was observed. A 
solvent swap to MeOH, commonly used for ozonolysis, along with similar control of ozone quantity, 
led to a similar 
1
H NMR spectrum of the crude material. A final experiment was set up, with careful 
TLC monitoring of reaction progress at regular intervals, until consumption of starting material was 
observed, followed by reductive work-up with PPh3. Chromatographic purification of the crude 
product provided the required aldehyde 125, but in poor purity and low mass (Scheme 81). Given 
this, it was decided not to pursue ozonolytic cleavage methods further. It seemed likely that the 
electron-rich aromatic nature of pyrazolo[3,4-d]pyrimidine 159 was the cause of degradation under 
the reaction conditions, and consequently the poor mass recoveries observed.  
 
Scheme 81: Ozonolysis to aldehyde 125 
Johnson-Lemieux oxidation was next investigated to provide access to aldehyde 125. A one-pot 
protocol was tested, according to a literature procedure.
130
 Catalytic OsO4 and excess NMO were 
added to pyrazolo[3,4-d]pyrimidine in a THF/
t
BuOH solvent mixture. TLC analysis showed complete 
consumption of starting material after 1.5 h., at which point a phosphate buffer (pH 7) was added, 
followed by NaIO4. Work-up after 16 h. necessitated the use of an extremely polar organic solvent 
combination of CHCl3/EtOH (2:1) for complete extraction of the aqueous phase. However, ensuing 
analysis of the crude reaction mixture revealed degradation, and no evidence of the required diol or 
aldehyde (Scheme 82).  
 
Scheme 82: A one-pot dihydroxylation and cleavage approach 
As the dihydroxylation step appeared to have proceeded smoothly by TLC analysis, a two step 
procedure was next investigated. Pyrazolo[3,4-d]pyrimidine 159 was treated with AD-mix-α in 
t
BuOH/H2O, according to Sharpless‟ procedure.
131
 Work-up that included extraction of the aqueous 
phase with CHCl3/EtOH (2:1) led to isolation of the required diol 160 in moderate yield (39%) (Table 
36, entry 1). The exceedingly polar diol had precipitated out of the organic phase in high purity, 
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negating the need for chromatographic purification. However, analysis of the mother liquor following 
filtration revealed that starting material was still present, along with some product diol. As no other 
compounds were observed, it was clear that complete consumption of starting material would allow 
improved recovery of product, following simple removal of work-up solvent. Vigorous stirring of the 
heterogeneous reaction mixture was found to be key; an analogous reaction at high r.p.m, using two 
magnetic stirrer bars led to complete consumption of starting olefin 159 after 20 h., and an improved 
isolated yield (72%) of pure diol 160 on a 0.5 mmol scale (entry 2).  
 
Diol cleavage was attempted using NaIO4 in water. Five equiv. of the periodate reagent were used in 
an initial reaction, following a literature method.
132
 However, removal of the reagent during work-up 
was troublesome, with partial solubility observed in both the aqueous and organic phases. 
Additionally, the periodate caused signal broadening in the 
1
H NMR of the crude reaction mixture, 
making visualisation of other peaks exceedingly difficult. An alternative set of conditions, employing 
one equiv. of NaIO4 in MeOH/H2O, meant that work up was more facile. Chromatographic 
purification led to isolation of the required aldehyde 125 in excellent yield (83%) (Table 36, entry 3). 
Purification of the aldehyde had been problematic in the first generation route, resulting in the crude 
aldehyde being used directly in the reductive amination step. Isolation of aldehyde 125 via the new 
strategy presented a considerable improvement to the synthesis. Both dihydroxylation and cleavage 
steps were found to be amenable to scale-up (3.0 mmol), with a quantitative yield of diol 160 isolated, 
which underwent cleavage to the pure aldehyde 125 in 82% yield (entry 4).  
Table 36: Dihydroxylation and cleavage with NaIO4 
 
Entry Scale (mmol) Isolated yield (%) 
  Step 1 Step 2 
1 0.5 39
a 
n/a
b 
2 0.5 72 n/a
b 
3 0.2 n/a
b 
83 
4 3.0 Quant. 82 
a Moderate stirring, leading to incomplete conversion to aldehyde. b Not applicable.  
2.3.1.4 Rejoining the first generation strategy 
A more robust synthesis to the key intermediate aldehyde 125 had been developed. To access the 
linker-bearing pyrazolo[3,4-d]pyrimidines, the two final steps of the first generation strategy were all 
that remained. The penultimate step, a reductive amination with propargyl amine (126), was required 
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to establish the terminal alkyne necessary for “click chemistry” separation and labelling. Accordingly, 
aldehyde 125 was treated with propargyl amine and acetic acid in methanol. NaCNBH3 reduction 
resulted in isolation of the crude amine after a reaction time of 17 h., and extraction from a neutral 
aqueous phase on work-up. Chromatographic purification led to the isolation of compound 127 in a 
moderate yield of 42% (Table 37, entry 1), although a small amount of an unidentified impurity was 
present by 
1
H NMR analysis. Indeed the same impurity was observed in the isolated product in two 
subsequent reactions. However, further attempts to remove the impurity were not made due to the 
highly polar nature of the amine. It was felt that purification would be substantially easier following 
amide formation. Amine 127 was synthesised in three batches on similar scales, in reproducible yield 
(Table 37). 
Table 37: Reductive amination 
 
Entry Scale (mmol) Isolated yield
a
 (%)
 
1 0.5 42 
2 0.5 44 
3 0.9 48 
a Containing a small amount of unidentified impurity. 
The final amide coupling would install the aryl azide necessary for cross-linking of the molecule to a 
kinase protein-substrate. Prior to amide formation, synthesis of the aryl azide coupling partners 162 
was required. The chemistry described in the first generation route was followed (Scheme 83), 
starting from the commercial anilines (161).
112
 Diazotisation followed by ipso-substitution with azide 
provided 162 in 80-89% yield.  
 
Scheme 83: First generation route; formation of acid chlorides 
In the first generation route, the resulting carboxylic acids are transformed into acid chlorides through 
reaction with oxalyl chloride, and fully characterised (Scheme 83). Following previous success 
generating acid chlorides in situ (vide Chapter 1) it was considered prudent to attempt acid chloride 
formation in situ, thus avoiding any hydrolysis over long-term storage. Amide formation using the 
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para-azide coupling partner 128a was attempted first. Treatment of the carboxylic acid with oxalyl 
chloride showed complete consumption of 128a by TLC analysis after 1 h. The acid chloride solution 
was transferred to a reaction vessel containing amine 127 in dichloromethane and triethylamine. 
Work-up after 20 h. revealed degradation to unidentified products, with no starting material or amide 
observed. It was suggested that the triethylamine could be at fault, due to lack of purification prior to 
use. The reagent was distilled and stored over molecular sieves, before repetition of the reaction. It 
was also decided to remove reaction volatiles in vacuo following acid chloride formation. The acidic 
nature of remaining oxalyl chloride and its associated decomposition products could also have been 
responsible for the lack of amidation observed.  Applying these changes in an analogous reaction led 
to isolation of the final para-azido product 129a in reproducible 50% yield on 0.2 mmol scale, 
following chromatographic purification (Table 38, entries 1 and 2). The amide bearing azide 
functionality in the meta-position, 129b, was accessed in 40% yield on the same scale (entry 3). Both 
compounds exist as rotamers as observed by 
1
H NMR, in a ratio of ca. 2:1. Analytical data for the 
final compounds was in complete agreement with that obtained from the first generation synthesis.  
Table 38: Final step amide formation  
 
Entry Azide position Isolated yield (%) 
1 para, 129a 50 
2 para, 129a 53 
3 meta, 129b 40 
                    All reactions performed on 0.2 mmol scale.  
2.3.2 Summary of the second generation synthesis  
An alternative, more robust synthesis of the C3-hydro target compounds had been developed. The 
troublesome hydrohydrazination step of the first generation route had been bypassed, with a 
hydrazone reduction exploited as the key α-tert-hydrazine forming step. The two steps to provide this 
intermediate had proved reproducible on scales of >30 mmol. The α-tert-hydrazine 157 was accessed 
in 70% yield over two steps, by comparison with a maximum 53% yield to analogue 120 in the first 
generation route (Scheme 84). Subsequent formation of the pyrazolo[3,4-d]pyrimidine moiety had 
proceeded smoothly with the second-generation hydrazine. It was possible to oxidatively cleave the 
110 
 
terminal olefin to access the late stage aldehyde 125 and thus reconnect with the first generation 
synthetic route to access the target compounds.  
 
Scheme 84: Comparison of first and second generation routes 
2.3.3 C3-functionalisation of pyrazole 159 
2.3.3.1 CH-activation 
With a high-yielding and reproducible route to the α-tert-hydrazine developed, it was possible to 
access a sufficient quantity of the intermediate pyrazolo[3,4-d]pyrimidine 159 to begin rigorous 
investigation into C3-arylation. 
 
Initial review of the literature revealed that Mateos et al. used a Design of Experiments strategy to 
identify optimum conditions for pyrazole arylation. Preference for C5-substitution was observed, but 
in cases where this position was blocked such as 163, C3-arylation took place (Scheme 85).
133
 Two 
sets of conditions were found to be applicable; a standard set, and a more forcing set for troublesome 
substrates. Both sets were applied to pyrazole 159 using phenyl bromide as the coupling partner, but 
unfortunately no C3-arylation was observed. Return of starting material was observed in both cases, 
with some degradation seen under the more forcing conditions. 
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Scheme 85: Mateos’ conditions for pyrazole arylation 
The lack of success was attributed to the increased complexity of pyrazole 159 in comparison to the 
literature substrates. In particular, the primary amine of 159 was identified as a potential contributor to 
the lack of conversion; amines are known to poison palladium catalysts and thus limit reactivity.
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Mindful of this, an intramolecular palladium-catalysed C3-arylation protocol was identified for 
further experimentation.
135
 The reaction is used in a literature report as a key cyclisation step in the 
synthesis of a Chk1 kinase inhibitor. Additionally, substrate 166 bears considerable functionality 
which is not reported to affect the procedure (Scheme 86). Considering that the methodology might 
be appropriate for highly functionalised pyrazole 159, a test reaction was carried out. The report 
provides no experimental detail or quantities of reagents, and so these were estimated using 
mechanistic understanding. Analysis of the crude product by 
1
H NMR after 18 h., revealed starting 
material and the tentatively assigned Heck product 168. On chromatographic purification, both 
compounds eluted with the same Rf values and could not be separated. A second reaction was left for 
a longer time period, allowing complete conversion to the Heck product, whose identity was 
confirmed upon isolation in 62% yield (Scheme 86). Interestingly, the isolation of 168 in good yield 
shows that the palladium catalyst is not poisoned by the primary amine to any significant extent. 
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Scheme 86: Intramolecular coupling conditions 
Nakamura et al. disclosed a nitrogen-directed CH-bond activation protocol for aryl-aryl coupling. The 
chemistry is iron-catalysed, taking place in the presence of a zinc-TMEDA complex with 
dichloro-alkane 170 as a re-oxidant (Scheme 87).
136
 It was suggested that the exocyclic pyrimidine 
nitrogen in compound 159 might be suitably located to direct pyrazole arylation at C3 (Scheme 87). A 
facile reaction, treating a THF solution saturated with ZnCl2 provided the required zinc-TMEDA 
complex, but unfortunately, dichloro-alkane 170 did not prove accessible. The reagent is expensive to 
purchase, and so Markovnikov addition of HCl (37% aq.) to iso-crotyl chloride was attempted. 
However, the reaction led to a mixture of products that could not be separated upon purification. 
Pleasingly, a second generation protocol from the same group uses oxygen gas as the re-oxidant, 
negating the necessity for the costly chloro-alkane (Scheme 87).
137
 Pyrazolo[3,4-d]pyrimidine 159 
was treated under the literature conditions, but unfortunately quantitative recovery of starting material 
was observed. Indeed, the directing-groups in the published scope are limited to tertiary amines, and it 
was plausible that the primary pyrimidine nitrogen was incompatible with the chemistry.  
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Scheme 87: Nitrogen-directed CH-arylation 
2.3.3.2 Nucleophilic addition 
As CH-pyrazole activation of compound 159 had thus far proved unattainable, it was decided to 
investigate some alternative strategies to C3-functionalisation. As discussed previously, the addition 
of allyl magnesium bromide to a hydrazone had been successfully exploited to provide access to the 
key α-tert-amine intermediate 157 in the second generation synthesis of the C3-hydro target 
compounds. It was mooted that similar chemistry might be possible at the hydrazone-like C3-position 
of 159, with subsequent oxidation necessary to regenerate the aromatic structure. Unfortunately, two 
experiments set up with super-stoichiometric quantities of the Grignard reagent, led to recovered 
starting material on work-up, despite elevated reaction temperatures (Scheme 88).  
 
Scheme 88: Attempted C3-allylation 
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2.3.3.3 Metallation 
Heteroaromatic deprotonation followed by electrophilic trapping is a common functionalisation 
method. Literature examples of pyrazole metallation occur preferentially at the C5-position,
133, 138
 but 
as this position is substituted in compound 159, it was considered prudent to attempt deprotonation at 
C3. It was clear that initial deprotonation would occur at the pyrimidine amine, but it was hoped that 
treatment with an excess of strong base would effect a second deprotonation at C3. Subsequent 
electrophilic trapping would then occur initially at the more basic anion. 
n
Butyl lithium has been 
reported to lithiate at the C5-position of pyrazoles, with a range of electrophiles used to trap the 
resulting anion.
138
 Of these, Et3SiCl was selected, owing to its compatibility with other functional 
groups in the substrate. Treatment of pyrazole 159 with 2 equiv. of 
n
BuLi at -78 °C, followed by a 
quench with the chloro-silane at this temperature after 1 h., provided complete conversion by 
1
H 
NMR analysis of the crude product to N-silylated 173 (Scheme 89). Reasoning that the steric bulk of 
the silane might be preventing trapping of the C3-anion, the reaction was repeated, quenching with 
D2O. However, no C3-deuteration was observed on analysis of the crude product by 
1
H NMR.  
 
Knochel et al. have prepared a range of specialised mixed-metal organometallics that have been 
reported to directly metallate pyrazoles in high regioselectivity, as evidenced by subsequent 
electrophilic quench. Once such reagent, iPrMgCl.LiCl 175, is commercially available, and so was 
applied to pyrazole 159 according to the literature method (using an extra equiv. to account for initial 
deprotonation of the free amine).
139
 The chloro-silane electrophile 174 was also used by Knochel, and 
so the reagent was again used to quench, at -30 °C after 2 h. Complete conversion to N-silylated 
amine 173 was observed by 
1
H NMR analysis of the crude material, and the product was subsequently 
isolated (54%) (Scheme 89). The moderate yield was attributed to the difficulty in purifying 173; 
despite a considerable difference in Rf values, the product co-eluted with the starting chloro-silane 
174 during chromatographic purification.  
 
Scheme 89: Formation of N-silylated amine 
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This class of specialised organometallic reagents also includes TMPMgCl.LiCl 177, synthesised from 
the commercial 
i
PrMgCl.LiCl 175 and 2,2,4,4-tetramethylpiperidine 179 (TMPH) (Scheme 90). 
Knochel et al. have demonstrated the successful use of 177 for C3-pyrazole metallation, following 
with electrophilic trapping (Scheme 90).
139, 140
 Organometallic 177 was prepared on the same scale as 
the literature procedure; TMPH 179 was added dropwise to freshly titrated commercial 
i
PrMgCl.LiCl 
175 and stirred until gas evolution ceased (24 h.). A concentration of 1.11 M in THF (lit. 1.20 M in 
THF) was calculated following titration with salicalhydrazone.
141
 To test for the formation of the 
organometallic, Knochel reports the ortho-iodination of isoquinoline (180) in 92% yield, following 
treatment with 177 and quench with iodine after 2 h. By analogy, 
i
PrMgCl.LiCl 175 which required 
12 h. for comparable metallation, provided 81% of the iodinated product 181, following an iodine 
quench (Scheme 90).
139
 Accordingly, 180 was treated with the synthesised TMPMgCl.LiCl 177, and 
iodine quench after 2 h. led to a 41% isolated yield of the ortho-iodo product 181 (Scheme 90). A 
simultaneous reaction using commercial 
i
PrMgCl.LiCl 175 for metallation, followed by iodine quench 
after 2 h., led to no required product formation by TLC analysis. The reaction was carried out under 
an argon balloon, likely accounting for the considerably lower isolated yield of 181 (41%) following 
TMPMgCl.LiCl and iodine treatment than the literature value (92%), obtained using Schlenk 
technique. Despite this, the reagent quality was deemed satisfactory, given the considerable difference 
in reactivity observed on comparing TMPMgCl.LiCl 177 and commercial 
i
PrMgCl.LiCl 175. 
 
Scheme 90: Chemistry of Knochel’s organometallics 
The TMP-organometallic 177 was applied to pyrazole 159, using a range of conditions, adapted from 
the literature. D2O was selected for electrophilic quench, as deuterium incorporation would be easily 
observed by 
1
H NMR analysis of the crude product. However, no C3-deuteration was observed, 
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although a decrease in the integral of the pyrimidine amine protons was noted, indicating 
deprotonation. 
From these results, and preceding experiments, it was suggested that competing amine deprotonation 
could be preventing C3-functioanlisation. It seemed possible that formation of the di-anion was too 
unfavourable under the conditions. As such, a protective-group strategy was envisaged. Ester-directed 
metallation has been observed by Knochel (Scheme 91).
142, 143
 It was suggested that N-Boc-protection 
could serve not only to limit initial deprotonation at the exocyclic pyrimidine nitrogen, but also might 
direct metallation at C3 of pyrazole 159 (Scheme 91). 
 
Scheme 91: Ester-directed metallation of aromatics 
Initial attempts to Boc-protect the exocyclic pyrimidine nitrogen revealed the reduced reactivity of the 
group in comparison to the aniline motif. Boc-protection did not occur under standard conditions,
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and so it was suggested that full deprotonation of the pyrimidine could first be accomplished using 
strong base (as observed previously) followed by quenching with Boc-anhydride. However, treatment 
under these conditions returned an inseparable mixture of the mono- and bis-Boc protected 
pyrimidines. In due course, a set of conditions employing DMAP as a nucleophilic catalyst was found 
to be the most suitable.
145
 Rapid formation of the mono-Boc pyrimidine 186 was observed by TLC 
analysis, with concurrent gradual formation of the bis-Boc pyrimidine 182. Due to difficult 
separation, it was decided to effect full formation of 182, which occurred in 5 h. (Scheme 92). An 
added advantage of this strategy was the lack of acidic protons in the final bis-Boc compound, 
meaning that subsequent treatment with organometallics could not lead to unwanted deprotonation. 
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Scheme 92: bis-Boc protection of pyrimidine 159 
Consequently, bis-Boc pyrimidine 182 was treated with TMPMgCl.LiCl 177 at r.t. for 2 h., before 
electrophilic quench with D2O. Upon work-up and chromatographic purification, the mono-Boc 
pyrimidine 186 was isolated in 47% yield, along with a second product  identified as nitrile 183, in 
21% (Table 39, entry 1). No starting material was observed. Nitrile 183 had presumably formed from 
deprotonation at C3 followed by collapse of the pyrazole. Evidence of note for the structural 
assignment included a) the nitrile stretch at 2222 cm
-1
 in the infra-red spectrum; b) the considerable 
upfield shift of the protons in the α-tert-amine unit, by analogy with those in the mono-Boc compound 
186. In addition, a clear trend was observed on comparing the shift of C* (78 ppm) with the analogous 
carbon in similar heteroaromatics (Fig. 10). 
 
Fig. 10: 
13
C shifts for cyano-pyrimidines and related structures 
Formation of nitrile 183 suggested that metallation at the pyrazole C3- had occurred. It was hoped that 
the proposed magnesiate intermediate would exhibit greater stability at lower temperature, and so an 
analogous reaction was performed at 0 °C. However, after work-up, analysis of the crude product by 
1
H NMR showed mainly starting material (72%), along with mono-Boc pyrimidine 186 (18%) and 
nitrile 183 (9%) (Table 39, entry 2), indicating that the lower temperature had served to decrease the 
reaction rate rather than stabilise the intermediate magnesiate. A reaction at -20 °C further confirmed 
this, with no nitrile observed upon work-up. A short reaction time was suggested, to trap the 
seemingly transient metallo-pyrazole. However, 20 min. at 0 °C again provided mixtures of the Boc-
protected pyrimidines 182 and 186 and nitrile 183 (entry 3). Intriguingly, treatment of the mono-Boc 
compound 186 with the organometallic led to recovered starting material after 2 h., indicating that 
nitrile 183 was derived from bis-Boc pyrimidine 182, with Boc-group removal occurring 
subsequently.  
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In an effort to promote the longevity of the metallated pyrazole intermediate, a mixed zinc-magnesiate 
reagent 184 was prepared. 184 is reported to be particularly suitable for sensitive aromatics, such as 
oxadiazoles and thiazoles, which are prone to degradation, often via ring-opening, on treatment with 
strong base.
146
 TMPMgCl.LiCl 177 was added to anhydrous zinc chloride (dried at 140 °C, under high 
vacuum, 8 h.) at r.t. and stirred for 15 h., to generate (TMP)2Zn.2MgCl2.2LiCl 184 (Scheme 93). A 
concentration of 0.61 M in THF was calculated, following titration with salicalhydrazone, comparable 
to the literature value of 0.50 M. Unfortunately, neither a quantitative nor qualitative test of reagent 
quality is reported in the literature.  
 
Scheme 93: Chemistry of Knochel’s zinc-magnesiate 184 
The zinc-magnesiate was used immediately once prepared, and added to the bis-Boc pyrimidine 182 
at r.t., following a literature procedure. Quench with D2O after 2 h., revealed a 50% conversion by 
1
H 
NMR to the mono-Boc pyrimidine 186, although neither nitrile 183 nor C3-deuteration were observed 
(Table 39, entry 4). Formation of the latter two compounds was not promoted by a decrease in 
reaction time to 20 min. (entry 5).  
 
The zinc-magnesiate 184 did not appear to be strong enough to effect C3-metallation. Accordingly, a 
third of Knochel‟s organometallics, reported to be particularly effective for ester-directed 
metallation,
147
 was prepared, using Schlenk technique. Lithium-TMP was first synthesised from 
treatment of TMPH with 
n
BuLi at -40 °C, before the addition of TMPMgCl.LiCl. The volatiles were 
removed in vacuo, and the resulting solid re-dissolved in THF, to provide TMP2Mg.2LiCl 185 as a 
0.56 M solution in THF (lit. 0.70 M) (Scheme 94).  
 
Scheme 94: Chemistry of (TMP)2Mg.2LiCl, 185 
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On treatment of the bis-Boc pyrimidine 182 with organometallic 185 at r.t., starting material, the 
mono-Boc pyrimidine 186 and nitrile 183 were again isolated (Table 39, entry 6). Reactions 
performed at lower temperatures with fewer equivalents of the organometallic resulted in no 
conversion of the bis-Boc pyrimidine 182 (entry 7). 
Table 39: Selected pyrazole metallations with Knochel organometallics 
 
Entry Organometallic (eq.) Temperature (°C) Time (h.) Product ratio
a 
    182 186 183 
1 177 (2.5) 23 2.0 0 (47) (21) 
2 177 (2.5) 0 2.0 72 18 9 
3 177 (2.5) 0 0.3 80 10 10 
4 184 (0.6) 23 2.0 50 50 0 
5 184 (0.6) 23 0.3 66 33 0 
6 185 (2.5) 23 2.0 (16) (16) (21) 
7
b 
185 (1.1) 0 2.0 100 0 0 
All reactions performed on 0.12 mmol scale, at [0.12 M], quenching with D2O at the reaction temperature. Isolated yields in 
parentheses. a Calculated from relative intensities of signals in 1H NMR of the crude product. b Quench with Et3SiCl.  
It seemed that the intermediate derived from C3-metallation using the Knochel reagents was too 
transient for electrophilic trapping prior to pyrazole collapse. Given the lack of success at 
C3-functionalisation of 159 despite the variety of methods attempted, it was considered prudent to 
adopt an alternative strategy to install the C3-aromatic.  
2.3.3.4 An alternative enol ether 
Review of the intermediate immediately prior to the pyrazolo[3,4-d]pyrimidine in the synthetic 
strategy offered a potential alternative for C3-functionalisation. The intermediate in question, pyrazole 
159 is synthesised from condensation of the α-tert-amine 157 (pre-treated with acid for Boc-group 
hydrolysis) with enol ether 121 (Scheme 95). The enol ether bears a proton at the position that is to 
become the C3 of pyrazole 159; would it be possible to condense an aryl-bearing enol ether with the 
α-tert-amine to establish C3-functionality at this step? Although this route would require installation 
of the C3-aromatic derivative relatively early in the synthesis, an advantage would be the lack of 
requirement for an extra synthetic step for C3-functionalisation.  
120 
 
 
Scheme 95: An aryl-enol ether for C3-aromatic installation 
A literature search revealed that enol ethers bearing varied aromatic functionality are easily accessed 
from the corresponding benzoic acids.
148, 149
 Formation of the acid chloride followed by condensation 
with malononitrile establishes the parent enol, and methylation provides the enol ether in reportedly 
good yields (Scheme 96). Additionally, phenyl-enol ether 188 can be prepared in a single step from 
the commercial phenyl-ortho ester 187 (Scheme 96).
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As it was unclear as to whether an aryl-enol ether would be reactive enough for condensation in the 
pyrazole-forming step, the readily accessible phenyl-enol ether was synthesised for testing. As in the 
synthesis of unsubstituted enol ether 121, ortho ester 187 was treated with malononitrile in acetic 
anhydride, although an increased reaction temperature of 140 °C was required for phenyl-enol ether 
formation (cf. 80 °C for the hydro-enol ether 121). Chromatographic purification provided the 
required compound 188 in 49% yield (Scheme 96). 
 
Scheme 96: Enol ether syntheses 
Phenyl-enol ether 188 was applied in the pyrazole-forming step. Reflux of α-tert-amine 157 in acidic 
methanol led to the consumption of starting material by TLC analysis after 1 h., as observed 
previously. The reaction mixture was basified with triethylamine prior to the addition of phenyl-enol 
ether 188. Further reflux of the reaction mixture led to complete consumption of enol ether 188 by 
TLC analysis after the slightly extended time of 2 h. 30 min. (cf. 1 h. for hydro-enol ether 121). Work-
up and chromatographic purification gratifyingly provided the C3-phenyl pyrazole 189 in 65% yield 
on 0.5 mmol scale (Table 40, entry 1). Moderate scale-up of the chemistry to 9.3 mmol led to a slight 
reduction in isolated yield (52%) (entry 2). Formation of the C3-phenyl compound 189 was somewhat 
lower yielding on moderate scale than the analogous C3-hydro pyrazole 158 (entry 2 vs. 3). It was 
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rationalised that the extended conjugation in phenyl-enol ether 188 decreased the relative reactivity of 
the substrate in comparison to the hydro-analogue 121. Although complete consumption of the 
phenyl-enol ether was observed by TLC analysis prior to work-up, it is possible that the substrate is 
unstable to prolonged reflux under the basic conditions, leading to the decreased yield observed. 
Table 40: Pyrazole formation 
 
Entry C3-functionality Scale (mmol) Step ii. time (h.) Isolated yield (%) 
1 Ph 0.5 2.5 65 
2 Ph 9.3 2.5 52 
3 H 21.0 1.0 63 
Pyrimidine formation was subsequently tested on a 0.4 mmol scale. Complete conversion to a single 
product was observed by TLC analysis after reflux in formamide (20 h.). Purification by 
chromatography provided pyrimidine 190 in a moderate yield of 39% (cf. 66% isolated yield for 
C3-hydro pyrimidine 159) (Table 41, entry 1 vs. 3). Interestingly, no by-product pyrimidone was 
detected by TLC or 
1
H NMR analysis of the crude reaction mixture, despite the analogous by-product 
having been isolated from the pyrimidine-forming step for the C3-hydro compounds. Although the 
reaction was low-yielding, it was felt that continuing with the synthetic strategy to test the 
applicability of the C3-phenyl bearing intermediate to the developed route was of greater importance 
than optimisation of pyrimidine formation at this stage. As such, the reaction was scaled to 4.4 mmol, 
providing compound 190 in an identical yield (39%), proving reproducibility (entry 2).  
Table 41: Pyrimidine formation 
 
Entry C3-functionality Scale (mmol) Isolated yield (%) 
1 Ph 0.4 39 
2 Ph 4.4 39 
3 H 13.0 66 
Ensuing treatment of compound 190 with AD-mix-α in tBuOH/H2O successfully provided diol 191 in 
93% on 0.34 mmol scale (Table 42, entry 1). The C3-phenyl diol 191 was found to be considerably 
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less polar than the C3-hydro derivative 160, with EtOAc sufficient for extraction during work-up. A 
reaction on 3.1 mmol scale provided diol 191 in a slightly lower yield (79%, entry 2). Diol cleavage 
with periodate was high yielding, with reproducible isolated yields of aldehyde 192 on both small and 
moderate scales (entries 4 and 5). Yields at this step were comparable with those obtained for the C3-
hydro aldehyde 125 (entry 3).  
Table 42: Oxidative cleavage of alkene 
 
Entry C3-functionality Scale (mmol) Isolated yield (%) 
   Step 1 Step 2 
1 Ph 0.34 93 n/a
a 
2 Ph 3.10 79 n/a
a 
3 H 3.10 Quant. 82 
4 Ph 0.15 n/a
a 
84 
5 Ph 1.26 n/a
a 
78 
               a Not applicable 
The penultimate synthetic step, reductive amination, proved to be challenging for C3-phenyl aldehyde 
192. Treatment with propargyl amine (126) in the presence of NaCNBH3 under the previously 
described conditions, provided a mixture of products by TLC analysis after 17 h. Chromatographic 
purification of the crude reaction mixture yielded the required amine 193 as a 2:1 mixture with an 
impurity, tentatively assigned as primary alcohol 194 resulting from reduction of aldehyde 192 
(Scheme 97). Despite considerable effort, a solvent system could not be found to separate the two 
compounds. Consequently, it was decided to proceed with the final amidation step using the crude 
material, in the hope that purification of the final compounds would be more facile. Scale-up of the 
reaction to 0.69 mmol afforded the crude amine in a poorer 1:1 mixture with the impurity. The 
increased scale of this reaction allowed the isolation of a second impurity, identified as nitrile 195, in 
10% yield (Scheme 97). Clearly the compound had arisen from addition of cyanide from the reducing 
agent into the imine, and could potentially be avoided through the use of an alternative reductant. 
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Scheme 97: Reductive amination of C3-phenyl aldehyde 192 
The optimised amidation conditions for the final step were applied to the crude amine 193. 
Thankfully, coupling with each of the acid chlorides 128a and b, bearing the para- and meta-azido 
aryl functionalities, was successful. Chromatographic purification led to the isolation of the pure 
target compounds 2a and b in similar yields which were calculated over two steps from aldehyde 192 
(Table 43, entries 1 and 2). The yields were also comparable to the C3-hydro target compounds 129a 
and b, when calculated over the final two steps (entries 3 and 4). 
Table 43: Final-step amidation  
 
Entry C3-functionality Scale (mmol) Azide position Isolated yield (%)
a 
1 Ph 0.25 para 34, 2a 
2 Ph 0.49 meta 30, 2b 
3 H 0.20 para 43, 129a 
4 H 0.20 meta 33, 129b 
a Yield calculated over 2 steps. 
2.4 Conclusions 
The synthesis of the C3-hydro target compounds had been improved, avoiding the capricious 
hydrohydrazination step. The α-tert-hydrazine motif had proved difficult to establish; Grignard 
reagent addition to an azodicarboxylate had not proved possible, due to difficulty in preparing the 
required tertiary organometallic. Similarly, amination of tert-butylamine with DppONHBoc had 
returned unreacted starting material. Synthesis of hydrazone 154 derived from tert-butyl carbazate 
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(153) and acetone, followed by reduction with allyl magnesium bromide had finally provided robust 
access to an analogous α-tert-hydrazine 157 to that used in the first generation route (Scheme 99). 
Allyl magnesium bromide was the only reagent of several attempted, observed to alkylate the 
hydrazone. It was possible to rejoin the first generation route at a late stage aldehyde 125; the second 
generation route provided access to the intermediate in high purity, which had not proved possible 
with the first generation strategy. The penultimate step of the first generation route provided alkyne 
127 in comparable yield. Treatment of 127 with acid chlorides 128a and b synthesised in situ to 
install the aryl-azide functionality, provided the C3-hydro target compounds 129 in moderate yield 
(Scheme 99). 
 
C3-functionalisation of the intermediate C3-hydro pyrazolo[3,4-d]pyrimidine 159 (Fig. 11) was 
attempted, using literature CH activation protocols and specialised organometallic reagents. Return of 
starting material in the majority of cases led to the free amine of the pyrimidine being protected as its 
di-Boc derivative 182 (Fig. 11). Evidence of C3-metallation of this analogue was provided on the 
isolation of nitrile 183 (Fig. 11) following treatment with an organometallic, assumed to have arisen 
from pyrazole collapse following C3-anion formation. Stabilisation of the anion for electrophillic 
trapping prior to pyrazole collapse did not prove possible, despite using lower reaction temperatures 
and alternative organometallic reagents. 
 
Fig. 11: Pyrimidine derivatives 
An alternative strategy was opted for, whereby the required C3-aromaic functionality was 
incorporated in the enol ether used at the pyrazole-forming step (Scheme 98). Although this route 
required early installation of the C3-aromatic, which was less desirable due to the derivatisation 
required at this position, no extra step(s) for C3-functionalisation were required. Additionally 
literature syntheses exist to access a variety of aryl-enol ethers using simple chemistry from benzoic 
acid derivatives (Scheme 98). 
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Scheme 98: Aryl enol ether synthesis and reactivity 
Use of the the phenyl enol ether in the second generation route led to the isolation of two target 
pyrazolo[3,4-d]pyrimidines 2a and b (Scheme 99). 
 
Scheme 99: Second generation route to C3-hydro and C3-phenyl target compounds 
Further work on this project includes the incubation of the target compounds with PKCα (M417A) to 
establish proof of concept cross-linking. If successful, then the remaining C3-arylated target 
compounds 2 should be synthesised and subject to testing. 
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In terms of methodological development, the susceptibility of alternative hydrazones (synthesised 
from readily available ketones) to treatment with allyl magnesium bromide could be investigated. If 
the chemistry has considerable scope, then this methodology provides a useable synthetic method to 
access α-tert-hydrazines and thus, α-tert-pyrazolo[3,4-d]pyrimidines. As a result, varied 
α-tert-pyrazolo[3,4-d]pyrimidines could be tested as ATP mimics, which has not previously been 
possible due to the lack of available synthetic methods to access the structural motif. 
  
127 
 
 
 
 
 
3. Experimental  
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3.1 General procedures 
All reactions were carried out under an Argon atmosphere in oven (160 °C) or flame-dried glassware 
unless otherwise stated. 
 
Solvents: EtOH was distilled from MgOEt and stored over 4Å molecular sieves; Et2O, THF, CH2Cl2, 
and PhMe were purified by Innovative Technology Inc. PureSolv™ Solvent Purification System. H2O 
was distilled for use in reactions. Acetone was used as commercially supplied. Where solvent 
mixtures were used, the ratios refer to component volumes. 
 
Reagents: Formamide was purchased and used within 2 months. For the final step amidation to 
access the C3-aryl pyrazolo[3,4-d]pyrimidines, Et3N was distilled and stored over 3Å molecular 
sieves. CH2Cl2 solutions of mCPBA were washed with a phosphate buffer (pH = 7.4) and dried 
(MgSO4). KH was washed with hexane (x 3) and dried under high vacuum for 5 min. γ-Butyrolactone 
was distilled. NaOH was ground to a fine powder immediately prior to use in all aziridination 
protocols. Anhydrous NMM was purchased for aziridinations and used as supplied. Anhydrous 
i
PrOH 
was purchased and used as supplied.  Indole was recrystalised from hexane. Commercial 
organometallic solutions were titrated against salicalhydrazine
141
 prior to use. All other reagents were 
used as commercially supplied. 
 
Chromatography: Flash chromatography was carried out using silica gel (Merck Kieselgel 60 F254 
230-400 mesh) or neutral aluminium oxide (Merck, 63-200 μm). TLC was performed using glass-
backed plates pre-coated with silica gel 60 F254 or Merck aluminium backed silica gel 60 F254 plates, 
and visualised by UV radiation (254 nm) or KMnO4 in water as stated. 
 
IR spectroscopy: Spectra were recorded on a Perkin Elmer Spectrum FT-IR Spectrometer; 
absorbancies (νmax) are recorded in wavenumbers (cm
-1
). 
 
NMR spectroscopy: All chemical shifts are quoted in parts per million (ppm) downfield of 
tetramethylsilane (0.00 ppm). All coupling constants are reported in Hertz (Hz). 
1
H
 
NMR spectroscopy: Spectra were recorded at 400 and 500 MHz on Bruker AV400, AV500 or 
DRX-400 spectrometers, in CDCl3, d6-DMSO, CD3OD, with reported values referenced to the 
residual protic solvent peak; CDCl3 (δH = 7.26), d6-DMSO (δH = 2.50), CD3OD (δH = 3.30). Data are 
reported as follows: chemical shift (δ) (to the nearest 0.01 ppm), (number of protons, multiplicity, 
coupling constant J (Hz, reported to the nearest 0.1 Hz), assignment. The term „multiplet‟ is only used 
for symmetrically centred peaks.  
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13
C NMR spectroscopy: Spectra were recorded at 101 and 126 MHz on Bruker AV400, AV500 or 
DRX-400 spectrometers, in CDCl3, d6-DMSO, CD3OD, with reported values referenced to the 
appropriate solvent peak; CDCl3 (δC = 77.0), d6-DMSO (δC = 39.5), CD3OD (δC = 49.1). Chemical 
shifts are reported to the nearest 0.1 ppm. 
31
P NMR spectroscopy: Spectra were recorded at 162 MHz on a Bruker AV400 spectrometer, in 
CDCl3, or d6-DMSO. Chemical shifts are reported to the nearest 0.1 ppm.  
 
Mass spectrometry: Low resolution mass spectra (m/z) were recorded on VG Platform II or VG 
AutoSpec spectrometers, with only molecular ions (e.g. MH
+
), and major fragmentation peaks 
reported. High resolution mass spectra were recorded on a VG AutoSpec spectrometer. 
 
Melting points: Melting points were determined on a Reichert microscope melting point apparatus.  
 
Nomenclature: Compounds are names according to IUPAC nomenclature. Skeleton carbon/nitrogen 
atoms in compounds containing the pyrazolo[3,4-d]pyrimidine ring system are numbered according to 
IUPAC conventions: 
 
3.2 Experimental details 
3.2.1 Aziridination and ring-opening 
O-Diphenylphosphinyl hydroxylamine, 39
53
  
 
Adapted from the procedure of Armstrong et al.
53
 Aqueous NaOH (3.89 g, 97.5 mmol in 14.0 mL 
H2O) was added to a stirred solution of hydroxylamine hydrochloride (7.93 g, 114.5 mmol) in H2O 
(17 mL) in air. Dioxane (60 mL) was added and the solution cooled to -3 °C using an ice-salt bath. 
Diphenylphosphinic chloride (10.00 g) in dioxane (50 mL) was added in one portion with vigorous 
stirring. Rapid precipitation ensued and the flask contents were swirled manually when magnetic 
stirring failed. After 5 min., H2O was added (60 mL). The slurry was filtered and washed with H2O 
(60 mL). The white, tacky solid produced was dried in a dessicator for 3 h. The solid was then slurried 
with NaOH (1 g in 100 mL H2O). After 30 min., the slurry was filtered and the white tacky product 
dried in a dessicatior for 18 h. The pure product was isolated as white crumbly solid (4.40 g, 45%). 
Mp > 130 ° C [lit. >130 ° C
53
]; H (CDCl3, 400 MHz) 7.82-7.87 (4H, ArH), 7.57-7.54 (2H, ArH), 
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7.50-7.47 (4H, ArH), 5.90 (2H, br s, NH2); P (CDCl3, 162 MHz) δ 37.6. All data are in agreement 
with reported values.
53
 
 
Alternative synthesis 
According to the procedure of Lahulé et al.
72
 Hydroxylamine hydrochloride (6.46 g, 93 mmol) was 
dissolved in H2O (20 mL) and cooled to -10 °C (acetone/dry ice, bath temperature) with overhead 
stirring. A solution of NaOH (3.58 g, 89 mmol) in H2O was prepared and cooled to 0 °C. The NaOH 
solution was added to the hydroxylamine solution at -10 °C. Et2O (180 mL) was added, and the 
solution cooled to -15 °C (bath temperature). Diphenylphosphinic chloride (10.00 g, 42.3 mmol) was 
added at this temperature, in one portion via syringe. Copius precipitation of white solid was 
observed, and the reaction mixture was stirred vigorously at -15 °C for 10 min. The acetone/dry ice 
bath was removed and the reaction vessel quickly submerged in an ice bath at 0 °C. The reaction was 
stirred at 0 °C (bath temperature) for a further 15 min. The reaction mixture was filtered, washing 
with cold (4 °C) distilled water (60 mL) then Et2O (70 mL). The resulting white solid was dried in air 
for 4 h., before drying under high vacuum for 14 h. A solution of NaOH (1.20 g, 30 mmol) in distilled 
water (120 mL) was prepared and cooled to 0 °C. The crude product was slurried in the NaOH 
solution and stirred at 0 °C for 30 min. The solution was filtered, and washed with cold (8 °C) 
distilled water (40 mL). The resulting white solid was dried in air for 1.5 h., before freeze drying for 
20 h. The pure product was provided as a white powdery solid (10.30 g, quant.). 
 
3,3’-Di-tert-butyl oxaziridine, 4876 
 
Adapted from the procedures of Kostyanovskii et al.
151
 and Ellman et al.
76
 2,2,4,4,tetramethyl 
pentanone imine (2.0 g, 14.0 mmol) was added to CH2Cl2 (10 mL), and cooled to 0 °C. mCPBA (2.7 
g, 16.0 mmol) in CH2Cl2 (50 mL) was added via dropping funnel over 1.5 h. behind a blast shield, 
maintaining the temperature between -2 °C and +3 °C. After the addition, the reaction was stirred at 0 
°C for 1 h. NaHCO3 (sat. aq., 60 mL) was added, and the aqueous phase extracted with CH2Cl2 (3 x 
40 mL). The organic phases were combined and dried over MgSO4 and concentrated in vacuo, with 
the rotary evaporator behind a blast shield. Kugelrohr distillation (2 mm Hg, 21 °C) provided the 
oxaziridine (1.3 g, 60%) as a pale yellow runny oil (93% purity by 
1
H NMR, with 7% di-tert-butyl 
ketone). Rf 0.50 (KMnO4 dip, EtOAc/petroleum ether, 1:10); νmax/cm
-1 
2962 (br), 1684, 1484, 1368, 
1192; H (CDCl3, 400 MHz) 1.15 (18H, s, C(CH3)); C (CDCl3, 101 MHz) 85.2, 37.5, 28.0; m/z 
HRMS (NH3 CI
+
), found: MH
+
, 158.1551. C9H19NOH requires 158.1546, Δ 3.8 ppm. All data are in 
agreement with reported values.
76
 NB: Although no problems were observed during the preparation 
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and handling of oxaziridine 48, the potentially explosive nature of the reagents and product should be 
realised. Manipulations should be performed behind a blast shield where possible. 
 
Benzaldehyde O-(1R, 2S, 5R)-(-)-menthol oxime, 51
76
 
 
Adapted from the procedure of Ellman et al.
76
 A solution of menthol (120 mg, 0.77 mmol) and 
18-crown-6 (20 mg, 0.07 mmol) in anhydrous DMPU (1 mL) was transferred via cannula over 15 min 
to a suspension of washed KH (40 mg, 0.92 mmol) in DMPU (1 mL) at r.t. After 1 h., the alkoxide 
solution was added dropwise over 10 min. to a solution of 3,3‟-di-tert-butyl oxaziridine 48 (377 mg, 
1.54 mmol, ca. 90% pure) in DMPU (1 mL) at -40 °C. The solution was warmed to r.t. over 2 h. 
Benzaldehyde (0.1 mL, 0.92 mmol) was added followed by AcOH (1 drop). On the addition of the 
benzaldehyde, the solution turned from yellow to brown. After 0.5 h, the reaction was diluted with 
Et2O (30 mL) and washed with NaCl (sat. aq., 8 x 30 mL). The organic phase was dried over MgSO4 
and concentrated in vacuo to provide the crude product as yellow oil (305 mg). Purification by 
column chromatography eluting with EtOAc/petroleum ether (1:100) provided the pure product as 
clear oil (74 mg, 37%). Rf 0.40 (UV 254 nm, EtOAc/petroleum ether, 100:1); νmax/cm
-1
 2960 (CH), 
2930 (CH), 2878 (CH), 1454 (CH); H (CDCl3, 400 MHz) 8.08 (1H, s, NCH), 7.61 (2H, m, ArH), 
7.40 (3H, m, ArH), 4.08 (1H, dt, J 10.0 and 4.4, HCON), 2.29 (1H, m), 2.22 (1H, dquin, J 6.8 and 
2.8), 1.75 (2H, m), 1.57-1.43 (2H), 1.17-1.09 (2H), 0.97 (6H, m, J 7.2), 0.88 (4H, d, J 6.8); C 
(CDCl3, 101 MHz) 147.5, 132.9, 129.4, 128.6, 126.8, 83.0, 47.0, 41.5, 34.6, 31.6, 26.1, 23.8, 22.3, 
20.8, 16.6; m/z HRMS (NH3 CI
+
), found: MH
+
, 260.2010. C17H25NOH requires 260.2014, Δ 1.5 ppm. 
All data are in agreement with reported values.
76
 
 
Bis(4-nitrophenyl)disulfide, 55
152
 
 
Adapted from the procedure of Schmitz et al.
75
 3,3‟-Di-tert-butyl oxaziridine 48 (33 mg, 21 mmol) 
was dissolved in CH2Cl2 (1 mL), and nitrobenzene thiol (30 mg, 19 mmol) added. The mixture was 
stirred for 45 min. at r.t., at which time a yellow precipitate was seen forming. The sample was 
concentrated in vacuo, providing the crude product as a yellow powder (11 mg). Purification by 
column chromatography eluting with EtOAc/petroleum ether (1:5) provided the pure disulfide as a 
yellow powder (8 mg, 13%). Mp 185-188 °C [lit. 177-178 °C
153
]; Rf 0.40 (UV 254 nm, 
EtOAc/petroleum ether, 1:5); νmax/cm
-1 
3100 (CH), 2925 (CH), 1597, 1545, 1476; H (CDCl3, 400 
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MHz) 8.24 (4H, dt, J 8.8 and 2.4 ArH), 7.66 (4H, dt, J 8.8 and 2, ArH); C (CDCl3, 101 MHz) 147.0, 
144.1, 126.4, 124.5; m/z HRMS (NH3 CI
+
), found: MNH4
+
, 326.0271. C12H12N3O4S2 requires 
326.0269, Δ 0.5 ppm. All data are in agreement with reported values.152 
 
(3E)-3-Benzylidenedihydrofuran-2(3H)-one, 63
154
 
 
Adapted from the procedures of Lewis et al.
154
 Anhydrous hexane (5 mL) was added to freshly cut Na 
(0.5 g, 22 mmol) and cooled to 0 °C.  MeOH (7 mL, 176 mmol) was added dropwise over 20 min. 
After addition was complete, the ice-bath was removed and the reaction was stirred until no Na (s) 
remained. The solvent was removed under reduced pressure, and the resulting NaOMe (white solid) 
was suspended in Et2O (12 mL). γ-Butyrolactone (1.48 mL, 18 mmol) in Et2O (4 mL) was added in 
one portion, followed by freshly distilled benzaldehyde (2.12 mL, 20 mmol) in Et2O (4 mL), also in 
one portion. On addition of the benzaldehyde, precipitation was noted, and the reaction turned from 
clear to bright cloudy yellow. An exotherm was also noted. After 1 h, H2O (10 mL) was added, 
followed by HCl (aq., 1M, 15 mL). The aqueous phase was extracted with Et2O (3 x 10 mL), the 
organics washed with Na2SO3 (sat. aq., 10 mL), dried over MgSO4 and the solvent removed in vacuo, 
to provide the crude product as pale yellow solid (1.26 g). Column chromatography eluting with 
EtOAc/petroleum ether (3:1) provided the pure product as white flaky crystals (0.87 g, 24%). Mp 
117-20 °C [lit. 117 °C154]; Rf 0.4 (KMnO4 dip, petroleum ether/EtOAc, 3:1); νmax/cm
-1
 1738 (s) (C=O); 
H (CDCl3, 400 MHz) 7.59 (1H, t, J 3.0, PhCH), 7.55-7.41 (5H, PhH), 4.48 (2H, t, J 7.6, CO2CH2), 
3.26 (2H, dt, J 7.6 and 3.0, CHCCH2); C (CDCl3, 101 MHz) 172.5, 136.7, 134.7, 130.0, 129.9, 
128.9, 123.5, 65.4, 27.5.
154
 m/z HRMS (NH3 CI
+
), found: MH
+
, 175.0755. C11H11O2 requires 
175.0759, Δ 2.3 ppm. All data are in agreement with reported values.154 
 
(2E)-2-Benzylidene-5-hydroxypentanoic acid, 65
80
 
 
Adapted from the procedure of Lewis et al.
154
  Anhydrous hexane (5 mL) was added to freshly cut Na 
(0.67 g, 29 mmol) and cooled to 0 °C. MeOH (7 mL, 176 mmol) was added dropwise over 15 min. 
After the addition was complete, the ice-bath was removed and the reaction was stirred until no Na (s) 
remained. The solvent was removed in vacuo, and the resulting NaOMe (white solid) was suspended 
in Et2O (12 mL). δ-Valerolactone (1.74 mL, 18 mmol) in Et2O (4 mL) was added in one portion. The 
mixture was then cooled to 0°C, and benzaldehyde (2.12 mL, 20 mmol) in Et2O (4 mL), added in one 
portion. On the addition of benzaldehyde, a yellow precipitate was observed forming. After 1 h., H2O 
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(10 mL) was added, followed by HCl (aq., 1M, 15 mL). The aqueous phase was extracted with Et2O 
(3 x 20 mL), the organics washed with Na2SO3 (sat. aq., 10 mL), dried over MgSO4 and the solvent 
removed in vacuo, to provide the crude product as pale yellow solid (1.26 g) in a 1:2.3 ratio with the 
cyclised lactone, visible by 
1
H NMR. Recrystalisation (Et2O) provided the hydroxy acid as white 
flaky crystals (166 mg, 6%). Mp 97-102 °C [lit. 99-100 °C
80
]; Rf  0.0 (UV 254 nm, petroleum 
ether/EtOAc, 3:1); νmax/cm
-1
 3288 (br) (OH), 2529 (br) (OH), 1674 (s) (C=O); H (CD3OD, 400 MHz) 
7.73 (1H, s, PhCH), 7.49-7.35 (5H, PhH), 3.64 (2H, t, J 6.8, CH2OH), 2.66 (2H, m, PhCHCCH2), 
1.86 (2H, m, HOCH2CH2); m/z HRMS (NH3 CI
+
), found: MH
+
, 207.1028, C12H15O3 requires 
207.1021, Δ 3.3 ppm. All data are in agreement with reported values.80 
 
(3E)-3-Benzylidenetetrahydro-2H-pyran-2-one, 64
80
 
 
Adapted from the procedure of Six et al.
80
 2-benzilydene-propanoic acid-5-ol 65 (236 mg, 1.14 mmol) 
was dissolved in and toluene (20 mL), MgSO4 (200 mg, 1.67 mmol) added, and the reaction heated to 
120 °C. After 20 h., the heat source was removed and the reaction allowed to cool. The MgSO4 was 
filtered off, and the solvent removed in vacuo to provide the pure product as a clear oil in quantitative 
yield. Rf 0.50 (UV 254 nm, EtOAc/petroleum ether, 1:3); νmax/cm
-1
 2937 (CH), 2860 (CH), 1707 (s) 
(C=O), 1616; H (CDCl3, 400 MHz) 7.93 (1H, t, J 2.4, PhCH), 7.46-7.33 (5H, PhH), 4.41 (2H, m, 
OCH2), 2.90 (2H, m, CHCCH2), 2.00 (2H, m, OCH2CH2); C (CDCl3, 101 MHz) 167.0, 141.6, 
135.0, 130.2, 129.1, 128.6, 125.8, 68.7, 25.9, 23.0; m/z HRMS (ESI
+
), found: MH
+
, 189.0920. 
C12H13O2 requires 189.0916, Δ 2.1 ppm. All data are in agreement with reported values.
80
 
 
5-[(E)-2-Phenylethenyl]-1,3-oxazole, 70
81
 
 
According to the procedure of  Šagud.81 MeOH (4.5 mL) was added to TosMIC (148 mg, 0.76 mmol) 
and K2CO3 (105 mg, 0.76 mmol), followed by cinnamaldehyde (95 μL, 0.76 mmol). The mixture was 
heated to reflux, and after 15 min. heating, all solid had dissolved to give a clear yellow solution. 
After 4 h., the heat was removed and the reaction allowed to cool to r.t. The volatiles were removed in 
vacuo and H2O (10 mL) added. The aqueous phase was extracted with Et2O (3 x 10 mL), and dried 
over MgSO4. The organic phase was concentrated in vacuo to give a yellow oil (968 mg). Purification 
by column chromatography eluting with EtOAc/petroleum ether (1:5) provided the pure product as a 
beige powder (44 mg, 34%). Rf 0.20 (UV, 254 nm, EtOAc/petroleum ether 1:5); δH (CDCl3, 
400 MHz) 7.84 (1H, s, oxazole N=CH), 7.50-7.45 (2H, m, PhH), 7.39-7.34 (2H, t, J 7.3, PhH), 7.32-
7.26 (1H, tt, J 7.3 and 2.3, PhH), 7.12 (1H, d, J 16.3, alkene CH), 7.07 (1H, s, oxazole OC=CH), 6.93 
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(1H, d, J 16.3, alkene CH); δC (CDCl3, 101 MHz) 150.5, 150.4, 136.2, 130.3, 128.8, 128.4, 126.6, 
124.1, 112.9. All data are in agreement with reported values.
81
 
 
(1E,4E)-1-(Dimethylamino)-5-phenylpenta-1,4-dien-3-one, 73
82
 
 
Adapted from the procedure of Tobinaga et al.
83
 Benzylideneacetone (500 mg, 3.4 mmol) was 
dissolved in anhydrous DMF (3 mL) and bis(dimethylamino)methoxymethane (523 μL, 3.4 mmol) 
added in one portion. Concentrated H2SO4 (one drop) was added, and the reaction turned from clear to 
cloudy. After stirring at r.t. for 1 h. 30 min., EtOAc (10 mL) was added, and the organic phase washed 
with brine (6 x 10 mL). The organic phase was dried over MgSO4 and concentrated in vacuo to 
provide the crude product as a yellow oil. Purification by column chromatography eluting with EtOAc 
provided the pure product as a yellow solid (187 mg, 27%). Mp 75-77 °C [lit. 87-89
83
]; Rf 0.20 (UV, 
254 nm, EtOAc); νmax/cm
-1 
3026 (CH), 2928 (CH), 1657 (C=O), 1610; δH (CDCl3, 400 MHz) 7.83 
(1H, d, J 12.7, NMe2CH), 7.60 (1H, d, J 16.1, PhCH), 7.56-7.53 (2H, PhH), 7.38-7.30 (3H, PhH), 
6.81 (1H, d, J 16.1, PhCHCH), 5.30 (1H, d, J 12.7, NMe2CHCH), 3.14 (3H, br s, NCH3), 2.91 (3H, br 
s, NCH3); δC (CDCl3, 101 MHz) 186.3, 153.4, 138.5, 135.8, 129.2, 128.7, 128.3, 127.9, 96.4, 45.0, 
37.2; m/z HRMS (EI
-
), Found: M-H, 200.1073. C13H14NO requires 200.1069, Δ 1.7 ppm. 
 
5-[(E)-2-Phenylethenyl]-1,2-oxazole, 74
82
 
 
Adapted from the procedure of Takeuchi et al.
82
 Hydroxylamnine hydrochloride (166 mg, 2.6 mmol) 
and K2CO3 (165 mg, 1.3 mmol) were added to a flame dried flask followed by 1-dimethylamino-5-
phenyl-1,4-pentadien-3-one 73 (187 mg, 0.9 mmol) as a solution in anhydrous EtOH (3 mL). The 
mixture was heated to reflux for 3 h., when TLC analysis showed complete consumption of starting 
enaminone. The heat was removed and the reaction allowed to cool before the volatiles were removed 
in vacuo. The residue was dissolved in CHCl3 (10 mL) and washed with H2O (10 mL). The aqueous 
phase was extracted with further portions of CHCl3 (2 x 10 mL). The organics were combined and 
washed with HCl (aq., 1M, 15 mL). The organic phase was dried over MgSO4 and concentrated in 
vacuo to provide the crude product as a yellow oil (147 mg). Purification by column chromatography 
eluting with EtOAc/petroleum ether (1:10) provided the pure product as a white oil (22 mg, 14%). Rf 
0.30 (UV, 254 nm, EtOAc/petroleum ether 1:10); νmax/cm
-1 
3060 (CH), 1653, 1585; δH (CDCl3, 
400 MHz) 8.23 (1H, d, J 1.6, isoxazole-C(H)N), 7.54-7.51 (2H, PhH), 7.41-7.32 (3H, PhH), 7.41 
(1H, d, J 16.4, alkene-CH), 7.02 (1H, d, J 16.4, alkene-CH), 6.27 (1H, d, J 1.6, isoxazole-
135 
 
C(H)C(H)N); δC (CDCl3, 101 MHz) 167.9, 150.6, 135.5, 135.0, 129.2, 128.9, 127.1, 112.9, 100.7; 
m/z HRMS (NH3 CI
+
), found: MH
+
, 172.0754. C11H10NO requires 172.0762, Δ 4.6 ppm. 
 
(4E)-3-Oxo-5-phenylpent-4-enenitrile, 76 
 
Adapted from the procedure of Armstrong et al.
53
 DppONH2 (31 mg, 0.13 mmol) was suspended in 
anhydrous MeCN (2 mL). NMM (15 μL, 0.13 mmol) was added dropwise over 1 min., and the 
resulting suspension stirred for 30 min. NaOH (10 mg, 0.26 mmol) was added, followed by trans-5-
styrylisoxazole (22 mg, 0.13 mmol) in MeCN (0.5 mL). The reaction was stirred at r.t. for 16 h. 
NH4Cl (sat. aq., 7 mL) was added, and the aqueous phase extracted with CH2Cl2 (3 x 7 mL). The 
organic phase was dried over MgSO4 and and concentrated in vacuo to provide the crude product as a 
yellow solid (27 mg). Purification by column chromatography eluting with EtOAc/petroleum ether 
(1:3) provided the pure product as a white solid (20 mg, 91%). Mp 99-101 °C [lit. 97-8 °C
155
]; Rf 0.20 
(UV, 254 nm, EtOAc/petroleum ether 1:3); νmax/cm
-1 
3064 (CH), 2958 (CH), 2261 (C≡N), 1678 
(C=O); δH (CDCl3, 400 MHz) 7.70 (1H, d, J 15.9, PhCH), 7.60-7.57 (2H, PhH), 7.49-7.41 (3H, 
PhH), 6.89 (1H, d, J 15.9, PhCHCH), 3.72 (2H, s, C(O)CH2); δC (CDCl3, 101 MHz) 186.4, 146.6, 
133.4, 131.7, 129.2, 128.9, 122.4, 114.0, 30.9; m/z HRMS (NH3 CI
+
), found: MNH4
+
, 189.1026. 
C11H13N2O requires 189.1028, Δ 1.1 ppm. 
 
tert-Butyl (2Z,4E)-hexa-2,4-dienoate, 88b 
 
(tert-Butoxycarbonylmethylene)triphenylphosphorane 81 (1.41 g, 3.75 mmol) was dissolved in 
anhydrous EtOH (25 mL). trans-Crotonaldehyde (0.31 mL, 3.75 mmol) was added in one portion and 
the reaction mixture stirred at r.t. After 2 h. 30 min., the volatiles were removed in vacuo. Purification 
by column chromatography eluting with EtOAc/petroleum ether (1:50) provided the pure product as a 
clear oil (0.05 g, 8%). Rf 0.70 (UV, 254 nm, EtOAc/petroleum ether 1:10); νmax/cm
-1 
2979 (CH), 1712 
(C=O), 1644; δH (CDCl3, 400 MHz) 7.39 (1H, m, alkene-H), 6.48 (1H, m, J 12.3, alkene-H), 6.07 
(1H, m, alkene-H), 5.47 (1H, d, J 12.3, C(O)CH), 1.86 (3H, d, J 6.4, CH3), 1.48 (9H, s, C(CH3)3); δC 
(CDCl3, 101 MHz) 166.1, 144.1, 139.5, 128.3, 117.3, 80.0, 28.2, 18.6. m/z HRMS (NH3 CI+), found: 
MH
+
, 169.1233. C10H17O2 requires 169.1229, Δ 2.8 ppm. 
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tert-Butyl (2E,4E)-hexa-2,4-dienoate, 88a
156
 
 
The title compound was synthesised according to the procedure for 88b. (0.29 g, 46%). Rf 0.50 (UV, 
254 nm, EtOAc/petroleum ether 1:10); δH (CDCl3, 400 MHz) 7.17 (1H, m, alkene-H), 6.19-6.03 (2H, 
alkene-H), 5.70 (1H, d, J 15.1, C(O)CH), 1.83  (3H, d, J 6.3, CH3), 1.47 (9H, s, C(CH3)3); δC 
(CDCl3, 101 MHz) 166.7, 143.9, 138.5, 129.8, 121.0, 80.0, 28.2, 18.6. All data are in agreement with 
reported values.
156
 
 
tert-Butyl (2Z,4E)-5-phenylpenta-2,4-dienoate, 87b 
 
(tert-Butoxycarbonylmethylene)triphenylphosphorane 81 (1.41 g, 3.75 mmol) was dissolved in 
anhydrous EtOH (25 mL). trans-Cinnamaldehyde (0.47 mL, 3.75 mmol) was added in one portion 
and the reaction mixture heated to reflux. After 16 h., the reaction was allowed to cool, and the 
volatiles removed in vacuo. Purification by column chromatography eluting with EtOAc/petroleum 
ether (1:50) provided the pure product as a clear oil (0.36 g, 41%). Rf 0.45 (UV, 254 nm, 
EtOAc/petroleum ether 1:20); νmax/cm
-1 
2984 (CH), 1704 (C=O), 1624; δH (CDCl3, 400 MHz) 8.16 
(1H, ddd, J 15.7, 11.2 and 1.0, alkene-H), 7.53-7.51 (2H, ArH), 7.36-7.27 (3H, ArH), 6.80 (1H, d, J 
15.7, alkene-H), 6.70 (1H, m, alkene-H), 5.66 (1H, d, J 11.2, C(O)CH), 1.54 (9H, s, C(CH3)3); δC 
(CDCl3, 101 MHz) 166.1, 143.6, 140.6, 136.5, 128.8, 128.7, 127.4, 125.0, 119.6, 80.3, 28.3; m/z 
HRMS (NH3 CI+), found: MNH4
+
, 248.1646. C15H22NO2 requires 248.1651, Δ 2.0 ppm. 
 
tert-Butyl (2E,4E)-5-phenylpenta-2,4-dienoate, 87a
157
 
 
The title compound was synthesised according to the procedure for 87b. Clear oil (0.48 g, 55%). Rf 
0.35 (UV, 254 nm, EtOAc/petroleum ether 1:20); δH (CDCl3, 400 MHz) 7.47-7.45 (2H, ArH), 7.38-
7.28 (4H, ArH and alkene-H), 6.87-6.85 (2H, ArH), 5.94 (1H, d, J 15.0, C(O)CH), 1.52 (9H, s, 
C(CH3)3); δC (CDCl3, 101 MHz) 166.4, 143.5, 139.7, 136.2, 128.9, 128.8, 127.1, 126.4, 123.4, 80.3, 
28.2. All data are in agreement with reported values.
157
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tert-Butyl 3-methylbut-2-enoate, 92
158
 
 
Adapted from the procedure of Jackson et al.
90
 di-Methyl acrylic acid (0.50 g, 0.5 mmol) was 
dissolved in CH2Cl2 (0.50 mL) with sonication. tert-Butyl 2,2,2-trichloroacetimidate (1.33 mL, 1.0 
mmol) was dissolved in cyclohexane (2.0 mL) and added in one portion to the CH2Cl2 solution, 
followed by BF3.OEt2 (10 μl, 0.1 mmol). On addition of the BF3.OEt2 white solid formed 
immediately, and an exotherm was noted. After 16 h., solid NaHCO3 was added, followed by cold 
hexane (4 mL). The reaction mixture was filtered through a short plug of silica, washing with cold 
hexane, and the solvent was removed in vacuo. The pure product was isolated as a clear oil (0.33 g, 
42%). Rf 0.50 (UV 254 nm, EtOAc/petroleum ether, 1:100); νmax/cm
-1 
2981 (CH), 2929 (CH), 1713 
(C=O), 1662, 1135;   δH (CDCl3, 400 MHz) 5.58 (1H, quin, J  1.0, C(O)CH), 2.10 (3H, d, J 1.5, 
CHC(CH3)2), 1.83 (3H, d, J 1.2, CHC(CH3)2), 1.44 (9H, s, CO2C(CH3)3); δC (CDCl3, 101 MHz) 
166.3, 154.6, 117.8, 79.4, 28.2, 27.2, 19.9; m/z (NH3 CI+) 157 (MH
+
 100). All data were in 
agreement with reported values.
158
 
 
tert-Butyl 5-methyl-3-oxo-2-(propan-2-ylidene)hex-4-enoate, 93 
 
di-Methyl acrylic acid (0.50 g, 5.00 mmol) was added to anhydrous CH2Cl2 (5 mL), and cooled to 0 
°C. Oxalyl chloride (0.44 mL, 5.24 mmol) was added over 3 min., followed by a drop of DMF. On 
addition, the reaction colour changed from clear to translucent yellow. After 5 min. stirring at 0 °C, 
the reaction was allowed to warm to room temperature. After 4 h., the CH2Cl2 was removed in vacuo 
and the resulting yellow oily solid dissolved in anhydrous THF (5 mL). The solution was cooled to 0 
°C, and KOtBu (6.00 mL, 1 M in THF) was added over 5 min. The reaction mixture turned from 
yellow to dark orange. After 16 h., H2O (25 mL) was added, and the aqueous phase was extracted 
with Et2O (3 x 25 mL). The organic phase was washed with HCl (aq., 1 M, 25 mL), and dried over 
MgSO4. The solvent was removed in vacuo, to provide the crude product as a brown oil (0.30 g). 
Purification by column chromatography (alumina) eluting with EtOAc/petroleum ether (1:40) 
provided the pure product as a clear oil (0.05 g, 9%). Rf 0.45 (UV 254 nm, EtOAc/petroleum ether, 
1:40); νmax/cm
-1 
2986 (CH), 2927 (CH), 1719 (C=O), 1617, 1156; δH (CDCl3, 500 MHz) 6.08 (1H, 
sept, J 1.3, C(O)CH), 2.13 (3H, d, J 1.3, CH3C=CH), 2.05 (3H, s, CH3C=C), 1.89 (3H, d, J 1.3, 
CH3C=CH), 1.87 (3H, s, CH3C=C), 1.44 (9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 193.2, 165.4, 
155.0, 150.6, 134.6, 125.1, 81.2, 28.0, 27.7, 23.1, 22.6, 20.7; m/z HRMS (NH3 CI+), found: MH
+
, 
239.1649. C14H23O3 requires 239.1647, Δ 0.8 ppm. 
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General procedure A: 
 
Oxalyl chloride (1.05 eq.) was added dropwise to the required cinnamic acid (1 eq.) in CH2Cl2 
(10 mL/g), followed by a drop of DMF. Once all the starting acid had been consumed (TLC analysis 
of an aliquot after a MeOH quench), the solvent was removed in vacuo. THF (10 mL/g) was added 
and the mixture cooled to 0 °C. KO
t
Bu (1M solution in THF, 1.2 eq.) was added. After 10 min. at 0 
°C, the ice bath was removed and the reaction stirred at r.t. Once TLC analysis showed consumption 
of starting acid chloride, the reaction was diluted with diethyl ether (30 mL/g) and washed with water 
(30 mL/g). The aqueous phase was extracted with diethyl ether (3 x 30 mL/g), and the combined 
organic phases dried over MgSO4, and concentrated in vacuo. 
 
tert-Butyl (2E)-3-phenylprop-2-enoate, 42a
159
 
 
Following general procedure A; time for step i.: 2 h.; time for step ii.: 16 h. Cinnamic acid (3.62 g, 24 
mmol) provided the title compound as a yellow oil (4.49 g, 90%), with no need for purification. Rf 
0.35 (UV 254 nm, EtOAc/petroleum ether, 1:20); δH (CDCl3, 400 MHz) 7.60 (1H, d, J 16.0, PhCH), 
7.56-7.52 (2H, ArH), 7.43-7.38 (3H, ArH), 6.42 (1H, d, J 16.0, 
t
BuOC(O)CH), 1.55 (9H, s, C(CH3)3). 
All data are in agreement with literature values.
159
 
 
tert-Butyl (2E)-3-(4-methoxyphenyl)prop-2-enoate, 42b
46
 
 
Following general procedure A; time for step i.: 30 min.; time for step ii.: 16 h. 4-Methoxycinnamic 
acid (0.50 g, 2.8 mmol) provided the title compound as a white powdery solid (0.43 g, 65%), after 
chromatographic purification (EtOAc/petroleum ether, 1:20). Mp 43-44 °C [lit. 41-44 °C
46
]; Rf 0.30 
(UV 254 nm, EtOAc/petroleum ether, 1:20); δH (CDCl3, 400 MHz) 7.55 (1H, d, J 16.0, ArCH), 7.47 
(2H, dt, J 8.8 and 2.0, OCH3CCHCH), 6.91 (2H, dt, J 8.8 and 2.0, OCH3CCH), 6.25 (1H, d, J 16.0, 
t
BuOC(O)CH), 3.86 (3H, s, OCH3), 1.55 (9H, s, C(CH3)3). All data are in agreement with literature 
values.
46
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tert-Butyl (2E)-3-(4-nitrophenyl)prop-2-enoate, 42c
46
 
 
Following general procedure A; time for step i.: 50 min.; time for step ii.: 4 h. 4-Nitrocinnamic acid 
(0.50 g, 2.3 mmol) provided the title compound as a brown solid (0.41 g, 63%), with no need for 
purification. Mp 152-55 °C [lit. 155-57 °C
46
]; Rf 0.25 (UV 254 nm, EtOAc/petroleum ether, 1:10); δH 
(CDCl3, 400 MHz) 8.26 (2H, d, J 8.4, NO2CCH), 7.67 (2H, d, J 8.4, NO2CCHCH), 7.62 (1H, d, J 
16.0, ArCH), 6.50 (1H, d, J 16.0, 
t
BuOC(O)CH), 1.56 (9H, s, C(CH3)3). All data are in agreement 
with literature values.
46
 
 
tert-Butyl (2E)-3-(4-methylphenyl)prop-2-enoate, 42d
46
 
 
Following general procedure A; time for step i.: 50 min.; time for step ii.: 4 h. 4-Methylcinnamic acid 
(0.50 g, 3.1 mmol) provided the title compound as a brown oil (0.53 g, 79%), with no need for 
purification. Rf 0.35 (UV 254 nm, EtOAc/petroleum ether, 1:10);  δH (CDCl3, 400 MHz) 7.57 (1H, d, 
J 16.0, ArCH), 7.42 (2H, d, J 8.0, CH3CCHCH), 7.19 (2H, d, J 8.0, CH3CCH), 6.33 (1H, d, J 16.0, 
t
BuOC(O)CH), 2.39 (3H, s, ArCH3), 1.56 (9H, s, C(CH3)3). All data are in agreement with literature 
values.
46
 
 
tert-Butyl (2E)-3-(4-chlorophenyl)prop-2-enoate, 42e
46
 
 
Following general procedure A; time for step i.: 1 h.; time for step ii.: 16 h. 4-Chlorocinnamic acid 
(0.50 g, 2.7 mmol) provided the title compound as a white solid (0.55 g, 84%), after chromatographic 
purification ( EtOAc/petroleum ether, 1:20). Mp 70-72 °C [lit. 69-71 °C
46
]; Rf 0.35 (UV 254 nm, 
EtOAc/petroleum ether, 1:20); δH (CDCl3, 400 MHz) 7.54 (1H, d, J 15.6, ArCH), 7.46 (2H, dt, J 8.8 
and 2.0, ClCCH), 7.36 (2H, dt, J 8.8 and 2.0, ClCCHCH), 6.35 (1H, d, J 15.6, 
t
BuOC(O)CH), 1.56 
(9H, s, C(CH3)3). All data are in agreement with literature values.
46
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tert-Butyl (2E)-3-(3-methoxyphenyl)prop-2-enoate, 42f
160
 
 
Following general procedure A; time for step i.: 1 h 30 min.; time for step ii.: 4 h. 3-Methoxycinnamic 
acid (1.00 g, 5.7 mmol) provided the title compound as a yellow oil (1.32 g, quant.), with no need  for 
purification. Rf 0.40 (UV 254 nm, EtOAc/petroleum ether, 1:20); δH (CDCl3, 400 MHz) 7.57 (1H, d, 
J 16.1, ArCH), 7.30 (1H, t, J 8.1, ArH), 7.11 (1H, d, J 7.4, ArH), 7.03 (1H, br t, J 2.4, ArH), 6.93 
(1H, dd, J 8.1 and 2.4, ArH), 6.37 (1H, d, J 16.1, C(O)CH), 3.82 (3H, s, OCH3), 1.54 (9H, s, 
C(CH3)3). All data are in agreement with literature values.
160
 
 
tert-Butyl (2E)-3-(2-nitrophenyl)prop-2-enoate, 42g
161
 
 
 
Following general procedure A; time for step i.: 2 h., then further portion of oxalyl chloride (1.05 eq.) 
added, then 50 min.; time for step ii.: 16 h. 2-Nitrocinnamic acid (1.00 g, 5.2 mmol) provided the title 
compound as a yellow oil (0.17 g, 13%), after chromatographic purification (EtOAc/petroleum ether, 
1:5). Rf 0.40 (UV 254 nm, EtOAc/petroleum ether, 1:5); νmax/cm
-1 
2990 (CH), 1736 (C=O), 1524, 
1332 (NO2), 1145; δH (CDCl3, 400 MHz) 8.01 (1H, d J 15.6, ArCH), 8.01 (1H, d J 7.6, ArH), 7.64 
(2H, ArH), 7.55 (1H, m, ArH), 6.32 (1H, d, J 15.6, ArCHCH), 1.53 (9H, s, C(CH3)3); δC (CDCl3, 
101 MHz) 165.0, 148.3, 138.7, 133.4, 130.7, 130.1, 129.1, 125.2, 124.8, 81.1, 28.1. All data are in 
agreement with literature values.
161
 
 
tert-Butyl (2E)-3-(furan-2-yl)prop-2-enoate, 79a
162
 
 
Following general procedure A; time for step i.: 30 min.; time for step ii.: 16 h. Furylacrylic acid (1.00 
g, 7.2 mmol) provided the title compound as a brown oil (1.24 g, 88%), with no need for purification. 
Rf 0.80 (UV 254 nm EtOAc/petroleum ether, 1:5); νmax/cm
-1 
2982 (CH), 1707 (C=O), 1639; H 
(CDCl3, 400 MHz) 7.45 (1H, m, furyl-OCH), 7.35 (1H, d, J 16.0, ArCH), 6.57 (1H, d, J  3.6, furyl-
OCCH), 6.49 (1H, m, furyl-OCHCH), 6.30 (1H, d, J 16.0, COCH), 1.57 (9H, s, C(CH3)3); C 
(CDCl3, 101 MHz) 166.4, 151.2, 144.4, 130.1, 118.0, 114.0, 112.1, 80.4, 28.2. m/z HRMS (NH3 CI+), 
found: MNH3
+
, 212.1288. C11H18NO3 requires 212.1287, Δ 0.6 ppm. All data are in agreement with 
literature values.
162
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tert-Butyl (2E)-3-(furan-2-yl)prop-2-enoate, 79c 
 
tert-Butoxycarbonyl-methylene)triphenyl-phosphorane 81 (0.50 g, 1.3 mmol) was dissolved in THF 
(10 mL). 2-chlorofuraldehyde (0.15 g, 1.1 mmol) in THF (5 mL) was added over 5 min. After 2 h., 
the solvent was removed in vacuo. Column chromatography, eluting with EtOAc/petroleum ether 
(1:20) provided the pure product as a white crystalline solid (0.17 g, 71%). Mp 44-47 °C; Rf 0.25 (UV 
254 nm, EtOAc/petroleum ether, 1:20); νmax/cm
-1
 3154 (CH), 2975 (CH), 1704 (C=O), 1645, 1156; 
δH (CDCl3, 400 MHz) 7.20 (1H, d, J 15.7, CCH), 6.50 (1H, d, J 3.4, ArH), 6.21 (1H, d, J 
15.7, C(O)CH), 6.20 (1H, d, J 3.4, ArH), 1.48 (9H, s, C(CH3)3; δC (CDCl3, 101 MHz) 166.0, 150.7, 
138.9, 128.9, 118.3, 115.8, 109.0, 80.5, 28.1; m/z HRMS (NH3 CI+), found: MNH4
+
, 246.0905. 
C11H17NO3Cl requires 246.0897, Δ 3.3 ppm.  
 
tert-Butyl (2E)-3-(5-nitrofuran-2-yl)prop-2-enoate, 79b 
 
tert-Butoxycarbonyl-methylene)triphenyl-phosphorane 81 (0.50 g, 1.3 mmol) was dissolved in THF 
(10 mL) 2-nitrofuraldehyde (0.14 mL) in THF (5 mL) was added over 5 min. After 2.5 h., the solvent 
was removed in vacuo. Column chromatography, eluting with EtOAc/petroleum ether (1:5) provided 
the pure product as flaky bright yellow crystals (0.23 g, 88%). Mp 96-99 °C; Rf 0.20 (UV 254 nm, 
EtOAc/petroleum ether, 1:5); νmax/cm
-1
 2992 (CH), 1704 (C=O), 1530 (NO2), 1355 (NO2); H 
(CDCl3, 400 MHz) 7.33 (1H, d, J  3.8, ArH), 7.33 (1H, d, J 16.1, ArCH), 6.73 (1H, d, J  3.8, ArH), 
6.60 (1H, d, J 16.1, C(O)CH), 1.52 (9H, s, C(CH3)3; C (CDCl3, 125 MHz) 164.8, 152.8, 152.2, 
127.7, 125.0, 114.7, 113.0, 81.6, 28.1; m/z HRMS (ESI+), found: MH
+
, 239.0796. C11H13NO5 requires 
239.0794, Δ 0.8 ppm. 
 
tert-Butyl (2E)-3-(4-iodophenyl)prop-2-enoate, 42h
163
 
 
tert-Butoxycarbonyl-methylene)triphenyl-phosphorane) 81 (49 mg, 0.13 mmol) was dissolved in THF 
(2 mL). 4-iodobenzaldehyde (25 mg, 0.11 mmol) in THF (1 mL) was added over 5 min. After 16 h., 
the solvent was removed in vacuo to provide the crude product as yellow oil. Column 
chromatography, eluting with EtOAc/petroleum ether (1:10) provided the pure product as a pale 
yellow solid (28 mg, 79%). M.p 65-67 °C [lit. 65-66°C
163
]; Rf 0.80 (UV 254 nm, EtOAc/petroleum 
142 
 
ether, 1:10); δH (CDCl3, 400 MHz) 7.71 (2H, d, J 9.0, ArCH), 7.51 (1H, d, J 16.2, ArCH), 7.24 (2H, 
d, J 9.0, ArH), 6.38 (1H, d, J 16.2, C(O)CH), 1.52 (9H, s, C(CH3)3); m/z HRMS (NH3 CI+), found: 
MNH3
+
, 348.0466. C13H19NO2I requires 348.0461, Δ 1.4 ppm. All data are in agreement with 
literature values.
163
  
 
tert-Butyl (2E)-3-(2-chlorophenyl)prop-2-enoate, 42i
164
 
 
PdCl2(PPh3)2 (0.118 g, 0.17 mmol) was added to a Wheaton vial. The vial was flushed with Ar (g), 
before the addition of Et3N (12 mL), 1-chloro,2-iodobenzene (0.200 g, 0.84 mmol) and tert-butyl 
acrylate (0.212 mL, 1.68 mmol) sequentially. The vial was sealed and heated to 115 °C. After 18 h., 
the heat source was removed, and NH4Cl (sat. aq., 15 mL) was added. The aqueous phase was 
extracted with CH2Cl2 (3 x 15 mL) and the organic phase was dried over Na2SO4. The solvent was 
removed in vacuo to provide the crude product as a pale yellow solid (0.447 g). Column 
chromatography, eluting with EtOAc/Petroleum ether (1:30) provided the pure product as yellow oil 
(0.186 g, 93%). Rf 0.25 (UV 254 nm, petroleum ether/EtOAc, 30:1); νmax/cm
-1 
2979 (CH), 1714 
(C=O), 1155; δH (CDCl3, 400 MHz) 8.02 (1H, d, J 16.2, ArCH), 7.61-7.59 (1H, m, ArH), 7.41-7.38 
(1H, ArH), 7.30-7.23 (2H, ArH), 6.38 (1H, d, J 15.9), 1.54 (9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 
165.8, 139.4, 134.8, 132.9, 130.7, 130.1, 127.6, 127.0, 122.8, 80.8, 28.2; m/z HRMS (NH3 CI+), 
found: MNH4
+
, 256.1100. C13H19NO2Cl requires 256.1104, Δ 1.6 ppm. All data are in agreement with 
literature values.
164
 
 
Phenyl (2E)-3-phenylprop-2-enoate, 59
165
 
 
Phenoxycarbonyl-methylene)triphenyl-phosphorane 81 (0.50 g, 1.26 mmol) and benzaldehyde (0.11 
mL, 1.05 mmol) were added to anhydrous THF (15 mL) in a flame dried flask. The reaction mixture 
was heated to 70 °C for 6.5 h. After this time, the solvent was removed in vacuo. Column 
chromatography, eluting with EtOAc/petroleum ether (1:10) provided the product as a white 
crystalline solid (0.17 g, 71%). Mp 64-67 °C [lit. 73 °C
166
]; Rf 0.50 (UV 254 nm, EtOAc/petroleum 
ether, 1:10); νmax/cm
-1
 3063 (CH), 1725 (C=O); H (CDCl3, 400 MHz) 7.90 (1H, d, 15.6, PhCH), 
7.61-7.59 (2H, m, ArH), 7.45-7.35 (5H, ArH), 7.28 (1H, m, ArH), 7.20 (2H, m, ArH), 6.67 (1H, d, 
15.6, COCH); C (CDCl3, 101 MHz) 165.4, 150.8, 146.6, 134.2, 130.7, 129.5, 129.0, 128.3, 125.8, 
121.7, 117.3. m/z HRMS (NH3 CI+), found: MH
+
, 225.0920. C15H13O2 requires 225.0916, Δ 2.0 ppm. 
All data are in agreement with literature values.
165
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4-Methyl-4-{[(2E)-3-phenylprop-2-enoyl]amino}morpholin-4-ium, 60 
 
Adapted from the procedure of Armstrong et al.
53
 N-methyl morpholine (12.7 μL, 0.12 mmol) was 
added to a stirred solution of O-diphenylphosphinyl hydroxylamine (27 mg, 0.12 mmol) in CH2Cl2 
(0.5 mL). The reaction was stirred at r.t. for 30 min. NaOH (17.8 mg, 0.45 mmol) was added in one 
portion, and the reaction stirred for a further 20 min. Phenyl cinnamate (25 mg, 0.11 mmol) was then 
added in one portion. The reaction was stirred at r.t. for 20 h. NH4Cl (3 mL, sat. aq.) was added, and 
the aqueous phase extracted with CH2Cl2 (3 x 3 mL). The organic phase was dried over MgSO4, and 
concentrated in vacuo to provide the crude product as a white solid (37 mg). Column chromatography 
eluting with MeOH/EtOAc (1:4) provided the pure compound as a white solid (14 mg, 51%). Mp 
182-85 °C; Rf 0.20 (UV 254 nm, MeOH/EtOAc, 1:4); νmax/cm
-1 
2873 (NH), 1647 (C=O), 1573, 1118; 
H (CDCl3, 500 MHz) 7.51 (2H, ArH), 7.45 (1H, d, J 16.0, ArCH), 7.33 (2H, ArH), 7.27 (1H, ArH), 
6.60 (1H, d, J 16.0, COCH), 4.39 (2H, br d, J 11.0, 2 x morpholine-eq.-OCH), 4.29 (2H, dt, J 13.0 
and 1.9, 2 x morpholine-ax.-OCH), 3.80 (2H, br d, J 12.5, 2 x morpholine-eq.-NCH), 3.55 (3H, s, 
CH3), 3.20 (2H, dt, J 11.7 and 3.6, 2 x morpholine-ax.-NCH); C (CDCl3, 101 MHz) 170.5, 136.4, 
135.9, 128.6, 128.3, 127.4, 126.2, 62.5, 61.7, 53.5; m/z HRMS (NH3 CI+), found: MH
+
, 247.1455. 
C14H19N2O2 requires 247.1447, Δ 0.8 ppm. 
 
(2E)-N-(morpholin-4-yl)-3-phenylprop-2-enamide, 61 
 
Following general procedure A; time for step i.: 1 h. 20 min.; time for step ii.: 4 h. Work-up: The 
reaction was quenched with NaOH (aq., 1 M, 25 mL) and extracted with EtOAc (3 x 25 mL). The 
organic phase was dried over MgSO4, and concentrated in vacuo to provide the crude product as a 
white solid. 0.50 g of cinnamic acid provided the title compound as a white needles (0.36 g, 46%), 
following recrystalisation from EtOAc. Rf 0.20 (UV 254 nm, EtOAc); νmax/cm
-1 
3188 (NH), 3056 
(CH), 2869 (CH), 1658 (C=O), 1632; H (d6-DMSO, 400 MHz, mixture of rotamers) 9.22 (0.69 x 1H, 
s, NH), 8.76 (0.31 x 1H, s, NH), 7.66-7.33 (6H ArH and 0.31 x 1H, alkene-H), 6.55 (0.69 X 1H, d, J 
16.2, COCH), 3.65 (4H, m, 2 x morpholine OCH2), 2.81 (2H, m, morpholine 2 x ax.-NCH), 2.75 (2H, 
br s, morpholine 2 x eq.-NCH); C (d6-DMSO, 101 MHz, mixture of rotamers) 167.2, 162.8, 141.6, 
139.4, 135.5, 135.4, 130.1, 130.0, 129.4, 129.3, 128.4, 128.0, 121.4, 118.3, 66.4, 66.3, 56.6, 55.2; m/z 
HRMS (ES+), found: MH
+
, 233.1294. C13H17N2O2 requires 233.1290, Δ 1.7 ppm. 
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(2E)-N-Methyl-N-(morpholin-4-yl)-3-phenylprop-2-enamide, 62 
 
Amide 61 (50 mg, 0.22 mmol) was suspended in anhydrous THF (2 mL) and cooled to 0 °C. KOtBu 
(1M in THF, 0.33 mL) was added dropwise. The reaction mixture turned from colourless to bright 
yellow on addition of the reagent. After 30 min. at 0 °C, dimethyl sulfate (21 μL, 0.22 mmol) was 
added. The ice-bath was removed, and a gradual colour change from bright yellow to grey was noted. 
After 10 min. warming to r.t., the reaction was quenched with NaOH (aq., 1 M, 4 mL). After a 2 min. 
stir, the aqueous phase was extracted with EtOAc (3 x 5 mL).  The organic phase was dried over 
MgSO4, and concentrated in vacuo to provide the crude product. Column chromatography eluting 
with EtOAc/petroleum ether (1:1) provided the pure compound as a clear oil (4 mg, 8%). Rf 0.20 (UV 
254 nm, EtOAc/petroleum ether, 1:1); νmax/cm
-1 
2971 (CH), 2852 (CH), 1653 (C=O), 1623; H 
(CDCl3, 400 MHz) 7.71 (1H, d, J 15.8, ArCH), 7.57-7.54 (2H, ArH) 7.56 (1H, J 15.8, C(O)CH), 
7.41-7.33 (3H, ArH), 3.97-3.93 (2H, m, 2 x morpholine-eq.-OCH), 3.80 (2H, dt, J 11.0 and 2.4, 2 x 
morpholine-ax.-OCH), 3.06 (3H, s, CH3), 3.07-3.00 (2H, dt, J 11.0 and 3.3, 2 x morphline-ax.-NCH), 
2.70 (2H, br d, J 11.0, 2 x morphline-eq.-NCH); C (CDCl3, 101 MHz) 168.3, 142.2, 135.7, 129.5, 
128.8, 127.9, 117.4, 66.8, 51.7, 24.1; m/z HRMS (NH3 CI+), found: MH
+
, 247.1455. C14H19N2O2 
requires 247.1447, Δ 0.8 ppm. 
 
General procedure B 
DppONH2 (3 eq.) was suspended in anhydrous CH2Cl2 (0.12 M), and NMM (3 eq.) added dropwise 
over 1 min. The reaction was stirred for 30 min. NaOH (11 eq.) (ground to a fine powder immediately 
prior to use) was added, and the reaction stirred for a further 20 min. The required cinnamate ester (1 
eq.) was then added. After 40 h. stirring at r.t., NH4Cl (sat. aq. 60 mL/g) was added, and the aqueous 
phase extracted with CH2Cl2 (3 x 60 mL/g). The organic phase was dried over Na2SO4, and the 
solvent removed in vacuo. 
 
General procedure C 
DppONH2 (1.04 eq.) was added to anhydrous CH2Cl2 (0.24 M) and NMM (1.04 eq.) added dropwise 
over 1 min. The reaction was stirred for 30 min. NaOH (4 eq.) (ground to a fine powder immediately 
prior to use) was added, and the reaction stirred for a further 20 min. The required cinnamate ester (1 
eq.) was then added. After 40 h. stirring at r.t., NH4Cl (sat. aq. 60 mL/g) was added, and the aqueous 
phase extracted with CH2Cl2 (3 x 60 mL/g). The organic phase was dried over Na2SO4, and the 
solvent removed in vacuo. 
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(±)tert-Butyl trans-aziridine-3-prop-2-enoate, 1a
53
 
 
Following general procedure B, tert-butyl cinnamate (0.58 g, 2.9 mmol) provided the title compound 
as a white crystalline solid (0.40 g, 65%), after chromatographic purification (EtOAc/petroleum ether 
1:10). Mp 63-66 °C; Rf 0.20 (EtOAc/petroleum ether, 1:10); δH (CDCl3, 400 MHz) 7.34-7.27 (5H, 
PhH), 3.17 (1H, br s, CHNH), 2.50 (1H, br s, CHNH), 1.82 (1H, br s, NH), 1.50 (9H, s, C(CH3)3); δC 
(CDCl3, 101 MHz) 170.8, 138.2, 128.4, 127.7, 126.2, 82.4, 40.4, 39.9, 28.1. All data are in agreement 
with literature values.
53
 A crystal structure was obtained for aziridine 1a; see Appendix 1. 
 
(±)tert-Butyl trans-aziridine-3-(4-methoxyphenyl)prop-2-enoate, 1b 
 
Following general procedure B, 4-methoxy-tert-butyl cinnamate (50 mg, 0.21 mmol) provided the 
title compound as a pale yellow powder (21 mg, 39%) after chromatographic purification 
(EtOAc/petroleum ether, 1:10). Mp 79-81 °C; Rf 0.40 (KMnO4 dip, EtOAc/petroleum ether, 1:10); 
νmax/cm
-1 
3291 (NH), 2986 (CH), 2947 (CH), 1715 (C=O); δH (CDCl3, 400 MHz) 7.21 (2H, dt, J 8.7 
and 2.6, ArH), 6.87 (2H, dt, J 8.7 and 2.6, ArH), 3.82 (3H, s, OCH3), 3.14 (1H, dd, J 7.6 and 
2.4,CHNH), 2.47 (1H, dd, J 7.6 and 2.4, CHNH), 1.78 (1H, br t, J 7.6, CHNH),1.53 (9H, s, C(CH3)3); 
δC (CDCl3, 101 MHz) 170.9, 159.3, 130.2, 127.3, 113.9, 82.2, 55.3, 40.3, 39.6, 28.1; m/z HRMS 
(ES+), found: MNa
+
, 272.1269. C14H19NO3Na requires 272.1263, Δ 2.2 ppm. 
 
(±)tert-Butyl trans-aziridine-3-(4-methylphenyl)prop-2-enoate, 1d 
 
Following general procedure B, 4-methyl-tert-butyl cinnamate (50 mg, 0.23 mmol) provided the title 
compound as a white powder (19 mg, 36%) after chromatographic purification (EtOAc/petroleum 
ether (1:50 to 1:10). Mp 62-65 °C; Rf 0.25 (KMnO4 dip, EtOAc/petroleum ether 1:10); νmax/cm
-1
 3275 
(NH), 2981 (CH), 2933 (CH), 1714 (C=O); δH (CDCl3, 400 MHz) 7.21-7.14 (4H, m, ArH), 3.14 (1H, 
dd, 8.8 and 2.7, CHNH), 2.48 (1H, dd, J 8.8 and 2.7, CHNH), 2.36 (3H, s, CH3), 1.80 (1H, br t, J 8.8, 
CHNH), 1.52 (9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 170.9, 137.4, 135.2, 129.1, 126.0, 82.3, 40.4, 
39.8, 28.1, 21.1; m/z HRMS (NH3 CI+), Found: MH
+
, 234.1505. C14H20NO2 requires 234.1494, Δ 4.7 
ppm. 
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(±)tert-Butyl trans-aziridine-3-(2-chlorophenyl)prop-2-enoate, 1i 
 
Following general procedure B, 2-chloro-tert-butyl cinnamate (50 mg, 0.21 mmol) provided the title 
compound as a clear oil (25 mg, 47%) after chromatographic purification (EtOAc/petroleum ether, 
1:30 to 1:20). Rf 0.20 (UV 254 nm, EtOAc/petroleum ether, 1:20); νmax/cm
-1 
3293 (NH), 2982 (CH), 
1729 (C=O), 1229, 1161; δH (CDCl3, 400 MHz) 7.35-7.33 (2H, m, ArH), 7.24-7.17 (2H, m, ArH), 
3.45 (1H, br s, ArCH), 2.39 (1H, br s, C(O)CH), 1.74 (1H, br s, NH), 1.51 (9H, s, C(CH3)3); δC 
(CDCl3, 101 MHz) 170.7, 135.8, 134.2, 129.0, 128.6, 127.2, 126.9, 82.4, 39.4, 37.8, 28.1; m/z HRMS 
(NH3 CI+), found: MH
+
, 254.0947. C13H17NO2Cl requires 254.0948, Δ 0.4 ppm.  
 
(±)tert-Butyl trans-aziridine-3-(3-methoxyphenyl)prop-2-enoate, 1f 
 
Following general procedure B, 3-methoxy-tert-butyl cinnamate (50 mg, 0.21 mmol) provided the 
title compound as a clear oil (17 mg, 32%) after chromatographic purification (EtOAc/petroleum 
ether, 1:20 to 1:10). Rf 0.20 (UV 254 nm, EtOAc/petroleum ether, 1:10); νmax/cm
-1 
2987 (CH), 1719 
(C=O), 1234, 1156; δH (CDCl3, 400 MHz) 7.25-7.20 (1H, m, ArCH), 6.89 (1H, d, J 7.3, ArH), 6.83-
6.80 (2H, ArH), 3.80 (3H, s, OCH3), 3.15 (1H, d, J 2.3 ArCH), 2.50 (1H, d, J 2.3, C(O)CH), 1.74 
(1H, br s, NH), 1.50 (9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 170.7, 159.8, 139.9, 129.4, 118.7, 
113.6, 111.1, 82.3, 55.3, 40.4, 39.9, 28.1; m/z HRMS (NH3 CI+), found: MH
+
, 250.1441. C14H20NO3 
requires 250.1441, Δ 0.0 ppm.  
 
(±)tert-butyl trans-aziridine-3-(4-iodophenyl)prop-2-enoate, 1h 
 
Following general procedure C, 4-iodo-tert-butyl cinnamate (50 mg, 15 mmol) provided the title 
compound as a white solid (17 mg, 33%) after chromatographic purification (EtOAc/petroleum ether, 
1:30 to 1:20). M.p 83-85 °C; Rf 0.40 (UV 254 nm, EtOAc/petroleum ether, 1:20); νmax/cm
-1 
3273 
(NH), 2979 (CH), 1717 (C=O), 1360, 1151; δH (CDCl3, 400 MHz) 7.64 (2H, d, J 8.5, ArH), 7.03 
(2H, d, J 8.5, ArH), 3.11 (1H, d, J 2.0, ArCH), 2.44 (1H, d, J 2.0, C(O)CH), 1.76 (1H, br s, NH), 1.49 
(9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 170.5, 138.0, 137.4, 128.1, 93.0, 82.6, 40.5, 39.4, 28.1; m/z 
HRMS (NH3 CI+), found: MH
+
, 346.0295. C13H17NO2I requires 346.0304, Δ 2.6 ppm. 
 
147 
 
(±)tert-Butyl trans-aziridine-3-(4-chlorophenyl)prop-2-enoate, 1e 
 
Following general procedure C, 4-chloro-tert-butyl cinnamate (57 mg, 24 mmol) provided the title 
compound as a white oil (32 mg, 53%) after chromatographic purification (EtOAc/petroleum ether, 
1:15). Rf 0.35 (KMnO4 dip, EtOAc/petroleum ether, 1:15); νmax/cm
-1
 3289 (NH), 2984 (CH), 2933 
(CH), 1723 (C=O); δH (CDCl3, 400 MHz) 7.33-7.29 (2H, m, ArH), 7.26-7.23 (2H, m, ArH), 3.16 
(1H, br d, J 4.8, CHNH), 2.48 (1H, br s, CHNH), 1.86 (1H, br s, CHNH), 1.53 (9H, s, C(CH3)3); δC 
(CDCl3, 101 MHz) 170.5, 136.8, 133.4, 128.5, 127.5, 82.5, 40.5, 39.2, 28.1; m/z HRMS (NH3 CI+), 
found: MH
+
, 254.0952. C13H17NO2Cl requires 254.0948, Δ 1.6 ppm. 
 
(±)tert-Butyl trans-aziridine-3-(4-nitrophenyl)prop-2-enoate, 1c 
 
Following general procedure C, 4-nitro-tert-butyl cinnamate (63 mg, 0.25 mmol) provided the title 
compound as a yellow powder (51 mg, 76%) after chromatographic purification (EtOAc/petroleum 
ether (1:5). Mp 90-92 °C; Rf 0.25 (KMnO4 dip, EtOAc/petroleum ether, 1:5); νmax/cm
-1
 3281 (NH), 
2984 (CH), 2972 (CH), 1709 (C=O); δH (CDCl3, 400 MHz) 8.22-8.19 (2H, m, ArH), 7.50-7.46 (2H, 
m, ArH), 3.27 (1H, br s, CHNH), 2.52 (1H, br s, CHNH), 1.97 (1H, br s, CHNH), 1.54 (9H, s, 
C(CH3)3); δC (CDCl3, 101 MHz) 169.9, 147.5, 145.8, 127.1, 123.7, 83.0, 41.0, 39.0, 28.0; m/z HRMS 
(NH3 CI+), found: MH
+
,
 
265.1196. C13H17N2O4 requires 265.1188, Δ 3.0 ppm. 
 
(±)tert-Butyl trans-aziridine-3-(2-nitrophenyl)prop-2-enoate, 1g 
 
Following general procedure C, 2-nitro-tert-butyl cinnamate (50 mg, 0.20 mmol) provided the title 
compound as a white oil (21 mg, 40%) after chromatographic purification (EtOAc/petroleum ether, 
1:10). Rf 0.40 (UV 254 nm, EtOAc/petroleum ether, 1:10); νmax/cm
-1 
3298 (NH), 2991 (CH), 1722 
(C=O), 1525 (NO2), 1346 (NO2); δH (CDCl3, 400 MHz) 8.09 (1H, dd, J 8.4 and 1.0, ArH), 7.74 (1H, 
d, J 7.5, ArH), 7.62 (1H, t, J 7.5, ArH), 7.45 (1H, t, J 8.4, ArH), 3.69 (1H, d, J 5.8, ArCH), 2.41 (1H, 
d, J 5.8, C(O)CH), 1.86 (1H, m, NH), 1.53 (9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 170.4, 148.7, 
134.0, 133.8, 128.9, 128.3, 124.7, 82.7, 39.5, 38.1, 28.0; m/z HRMS (NH3 CI+), found: MH
+
, 
265.1190. C13H17N2O4 requires 265.1188, Δ 0.8 ppm.  
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(±)tert-Butyl trans-aziridine-3-(5-chlorofuryl)prop-2-enoate, 77c 
 
Following general procedure C, quenching the reaction after 20 h., 5-chloro-tert-butyl furfural (50 
mg, 22 mmol) provided the title compound as a yellow oil (19 mg, 35%) after chromatographic 
purification (EtOAc/petroleum ether, 1:10). Rf 0.25 (UV 254 nm, EtOAc/petroleum ether, 1:10); 
νmax/cm
-1 
2987 (CH), 1722 (C=O), 1531, 1233, 1158; δH (CDCl3, 400 MHz) 6.27 (1H, d, J 3.1, ArH), 
6.09 (1H, d, J 3.1, ArH), 3.15 (1H, dd, J 9.1 and 2.3, CHN), 2.76 (1H, dd, J 9.1 and 2.3, CHN), 1.75 
(1H, br t, J 9.1, NH), 1.50 (9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 170.1, 150.9, 135.7, 109.6, 107.1, 
82.8, 37.6, 33.7, 28.0; m/z HRMS (ESI+), found: MH3O
+
, 262.0832. C11H17NO4Cl requires 262.0846, 
Δ 5.3 ppm.  
 
(±)tert-Butyl 3-[trans-2-phenylethenyl]aziridine-2-carboxylate, 89 
 
Following general procedure B, dienoate 87a (25 mg, 0.11 mmol) provided the title compound as a 
gritty oil (2 mg, 8%), after chromatographic purification (EtOAc/petroleum ether, 1:10) Rf 0.20 (UV, 
254 nm, EtOAc/petroleum ether, 1:10); νmax/cm
-1 
3290 (NH), 2984 (CH), 1726 (C=O); δH (CDCl3, 
400 MHz) 7.37-7.21 (5H, ArH), 6.74 (1H, d, J 16.2, ArCH), 5.89 (1H, dd, J 16.2 and 7.9, ArCHCH), 
2.84 (1H, dd, J 7.9 and  2.2, ArCHCHCH), 2.48 (1H, d, J 2.5, C(O)CH), 1.64 (1H, br s, NH), 1.50 
(9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 170.9, 136.3, 132.9, 128.6, 127.8, 127.7, 126.2, 82.3, 39.8, 
38.2, 28.1; m/z HRMS (ES+), found: MH
+
, 246.1495. C15H20NO2 requires 246.1494, Δ 0.4 ppm.  
 
(±)Phenyl(trans-3-phenylaziridin-2-yl)methanone, 47
53
 
 
Adapted from the procedure of Ikeda et al.
63
 Anhydrous 
i
PrOH (1.5 mL), dimethylhydrazine (0.19 
mL, 2.5 mmol) and propylene oxide (0.17 mL, 2.5 mmol) were combined and stirred in a tightly 
sealed vessel for 24 h. at r.t. Chalcone (0.43 g, 2.1 mmol) was dissolved in PhMe (2 mL) and iPrOH 
(6 mL), and added to the reaction mixture. After heating to 50 °C for 1 h., the mixture had turned 
from orange to bright red. After 20 h., the reaction mixture was concentrated in vacuo, to give a red 
oily solid. Recrystalisation from MeOH provided the pure product as an orange solid (0.15 g, 31%). 
Mp 103-106 °C [lit. 98-100 °C
66
]; Rf 0.30 (UV 254 nm, EtOAc/petroleum ether, 2:3); νmax/cm
-1
 3225 
(NH), 1666 (C=O), 1455, 1265; H (CDCl3, 400 MHz) 8.05-8.01 (2H, ArH), 7.67-7.62 (1H, m, ArH), 
7.55-7.50 (2H, m, ArH), 7.44-7.32 (5H, ArH), 3.56 (1H, d, J 2.4, CHNH), 3.24 (1H, d, J 2.4, 
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CHNH), 2.85 (1H, br s, NH). C (CDCl3, 101 MHz) 195.8, 138.4, 136.0, 133.9, 128.9, 128.6, 128.4, 
127.9, 126.2, 44.1, 43.6; m/z HRMS (NH3 CI+), found: MH
+
, 224.1076. C15H14NO requires 224.1075, 
Δ 0.3 ppm. All data are in agreement with literature values.63  
 
(±)tert-Butyl-2-amino-3-phenyl-3-(indol-3-yl)propanoate, 97a
92
 
 
Aziridine 1a (25 mg, 0.11 mmol) and indole (27 mg, 0.23 mmol) were dissolved in CH2Cl2 (1 mL), 
and cooled to 0 °C. BF3.THF (19 l, 0.17 mmol) was added over 30 s. The mixture was stirred at 0 °C  
for 5 mins., before warming to r.t., and after 24 h., the reaction was quenched with NaHCO3 (5 mL). 
The aqueous phase was extracted with CH2Cl2 (3 x 5 mL), dried over Na2SO4, and concentrated in 
vacuo to provide the crude product as yellow oil (59 mg).  Column chromatography eluting with 
EtOAc/petroleum ether (2:3) provided the pure product as a white solid (24 mg, 63%). Mp 
167-169 °C [lit. 175-176 °C]; Rf 0.10 (UV 254 nm, EtOAc/petroleum ether 2:3); νmax/cm
-1
 3419 (NH), 
2962 (CH), 2928 (CH), 1722 (C=O); δH (CDCl3, 500 MHz) 8.22 (1H, br s, ArNH), 7.49 (1H, d, J 8.0, 
ArH), 7.40 (2H, d, J 7.5, ArH), 7.33-7.25 (4H, ArH), 7.23 (1H, tt, J 7.5 and 1.5, ArH), 7.17 (1H, m, 
ArH), 7.06 (1H, m, ArH), 4.65 (1H, d, J 6.5, ArCH), 4.20 (1H, br s, NH2CH), 1.72 (2H, br s, NH2), 
1.26 (9H, s, C(CH)3); δC (CDCl3, 101 MHz) 173.7, 140.6, 136.1, 129.0, 128.4, 127.0, 126.8, 122.3, 
122.0, 119.4, 119.4, 116.6, 111.0, 81.2, 59.5, 47.3, 27.8; m/z HRMS (NH3 CI+), found: MH
+
, 
337.1916. C21H25N2O2 requires 337.1916, Δ 0.0 ppm. All data are in agreement with literature 
values.
92
 
 
(±)Phenylalanine-tert-butyl ester, 102
167
 
 
Aziridine 1a (25 mg, 0.11 mmol) and Pd/C (5 mg, 20% w/w) were added to MeOH (1 mL). The flask 
was evacuated and re-filled with H2 (g), and the reaction stirred under a H2 atmosphere (balloon). 
After 3 h., the Pd/C was removed by filtration, and the filtrate washed with CH2Cl2 (10 mL). The 
solvent was removed in vacuo to provide the pure product as clear oil (24 mg, 95%). Rf 0.45 (UV 254 
nm, MeOH/EtOAc, 1:5); νmax/cm
-1
 3388 (NH), 2984 (CH), 1730 (C=O); δH (CDCl3, 400 MHz) 7.31-
7.20 (5H, ArH), 3.63 (1H, br t, J 6.2, NH2CH), 3.06 (1H, dd, J 13.8 and 6.2, ArCHH), 2.87 (1H, dd, J 
13.8 and 8.0, ArCHH), 1.52 (2H, br s, NH2), 1.42 (9H, s, C(CH3)3; δC (CDCl3, 101 MHz) 174.3, 
137.6, 129.4, 128.4, 126.7, 81.2, 56.3, 41.3, 28.0; m/z (ESI+) 222 (M+), 150 (- OtBu). All data are in 
agreement with literature values.
167
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(±)tert-Butyl-2-amino-3-phenyl-3-(methoxy)propanoate, 111 
 
CSA (27 mg, 0.11 mmol) was added to anhydrous MeOH (1 mL) at 0 °C. After 2 min., the ice bath 
was removed and aziridine 1a (25 mg, 0.11 mmol) added immediately. After 6 h., the reaction was 
quenched with NaHCO3 (sat. aq., 5 mL). The aqueous phase was extracted with CH2Cl2 (3 x 5 mL), 
and the combined organic phases dried over Na2SO4. The solvent was removed in vacuo to provide 
the pure product as a clear oil (29 mg, quant.). Rf 0.45 (UV 254 nm, MeOH/EtOAc, 1:50); νmax/cm
-1 
3399 (NH), 2982 (CH), 1735 (C=O), 1370, 1159;  δH (CDCl3, 400 MHz) 7.41-7.28 (5H, ArH), 4.39 
(1H, d, J 5.9, ArCH), 3.67 (1H, d, J 5.9, C(O)CH), 3.27 (3H, s, OCH3), 1.58 (2H, br s NH2), 1.42 
(9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 172.1, 137.4, 128.3, 128.3, 127.6, 85.4, 81.4, 60.5, 57.2, 
28.0; m/z HRMS (NH3 CI+), Found: MH
+
, 252.1602. C14H22NO3 requires 252.1600, Δ 0.8 ppm. 
 
(±)tert-Butyl-2-amino-3-phenyl-3-(hydroxyallyl)propanoate, 112 
 
CSA (66 mg, 0.29 mmol) was added to allyl alcohol (1 mL) at 0 °C. After 2 min., the ice bath was 
removed and aziridine 1a (25 mg, 0.11 mmol) added immediately. After 16 h, the reaction was 
quenched with NaHCO3 (sat. aq., 5 mL). The aqueous phase was extracted with CH2Cl2 (3 x 5 mL), 
and the combined organic phases dried over Na2SO4. The solvent was removed in vacuo to provide 
the crude product as a yellow oil (30 mg). Column chromatography, eluting with EtOAc/petroleum 
ether (1:10) then (1:2) provided the pure product as a clear oil (18 mg, 57%). Rf 0.25 (KMnO4 dip, 
EtOAc/petroleum ether, 1:2); νmax/cm
-1
 2984 (CH), 2867 (CH), 1737 (C=O), 1368, 1156; δH (CDCl3, 
400 MHz) 7.37-7.29 (5H, m, ArH), 5.91-5.81 (1H, m, H2C=CH), 5.25 (1H, dq, Jtrans 17.5 and 1.5, 
HHC=CH), 5.16 (1H, dquart, Jcis 10.4 and 1.5 HHC=CH), 4.52 (1H, d, J 7.2, ArCH), 3.98 (1H, ddt, J 
12.8, 5.7 and 1.5, OCHH), 3.82 (1H, ddt, J 12.8, 5.7 and 1.4, OCHH), 3.66 (1H, d, J 6.5, NCH), 1.47 
(2H, br s, NH2), 1.43 (9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 172.3, 137.8, 134.5, 128.3, 128.3, 
127.7, 116.9, 83.1, 81.4, 69.9, 60.7, 28.0; m/z HRMS (NH3 CI+), found: MH
+
, 278.1766. C16H24NO3 
requires 278.1756, Δ 4.0 ppm. 
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(±)tert-Butyl-2-amino-3-phenyl-3-(hydroxybenzyl)propanoate, 113 
 
CSA (66 mg, 0.29 mmol) was added to benzyl alcohol (1 mL) at 0 °C. After 2 min. stirring, the ice 
bath was removed and aziridine 1a (25 mg, 0.11 mmol) added immediately. After 16 h stirring under 
Ar (g), the reaction was quenched with NaHCO3 (sat. aq., 5 mL). The aqueous phase was extracted 
with hexane (3 x 5 mL). The organic phases were combined and washed with H2O (3 x 8 mL) and 
dried over Na2SO4. The solvent was removed in vacuo. Column chromatography, eluting with 
EtOAc/petroleum ether (1:5) then (1:3) provided the pure product as a clear oil (17 mg, 46%). Rf 0.20 
(UV 254 nm, EtOAc/petroleum ether, 1:3); νmax/cm
-1
 2982 (CH), 1730 (C=O), 1372, 1153; δH 
(CDCl3, 400 MHz) 7.39-7.27 (10H, ArH), 4.61 (1H, d, J 6.5 BnOCH), 4.51 (1H, d, J 11.8, PhCHH), 
4.35 (1H, d, J 11.8, PhCHH), 3.72 (1H, d, J 6.5, NCH), 1.67 (2H, br s, NH2), 1.41 (9H, s, C(CH3)3); 
δC (CDCl3, 101 MHz) 172.0, 137.9, 137.6, 128.4, 128.4, 128.3, 127.8, 127.7, 127.6, 83.2, 81.4, 70.8, 
60.7, 28.0; m/z HRMS (NH3 CI+), found: MH
+
, 328.1903. C20H26NO3 requires 328.1913, Δ 3.0 ppm. 
 
(±)tert-Butyl-2-acetylamino-3-phenyl-3-(hydroxyl)propanoate, 106 
 
tert-Butyl aziridine 1a (25 mg, 0.11 mmol) was suspended in acetic acid (2 mL) and heated to 70 °C. 
After 2 h., the heat source was removed and the reaction cooled. The acetic acid was removed in 
vacuo, and the resulting white crystals dissolved in CH2Cl2 (4 mL). The organic phase was washed 
with NaHCO3 and the aqueous phase extracted with CH2Cl2 (3 x 4 mL). The organic phase was dried 
over MgSO4 and concentrated in vacuo to provide the pure product (27 mg, 79%). Mp 173-174 °C; Rf 
0.20 (KMnO4 dip, EtOAc/petroleum ether, 1:1); νmax/cm
-1 
3357 (br) (Het-H), 3266 (Het-H), 2931 
(CH), 2861 (CH), 1734 (s) (C=O), 1652 (s) (C=O); δH (CDCl3, 400 MHz) 7.34-7.24 (5H, m, ArH), 
6.42 (1H, d, J 6.7, NH), 5.26 (1H, d, J 3.0, ArCH), 4.90 (1H, dd, J 6.7 and 3.0, COCH), 4.30 (1H, br 
s, OH), 2.02 (3H, s, COCH3), 1.41 (9H, s, OC(CH3)3); δC (CDCl3, 101 MHz) 171.7, 168.4, 139.5, 
128.1, 127.8, 126.0, 83.4, 75.3, 59.8, 27.9, 23.0; m/z (NH3 CI+), found: MH
+
, 280.1551. C15H22NO4 
requires 280.1549, Δ 0.7 ppm. 
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(±)3-Chloro-3-phenylalanine hydrochloride, 103 
 
tert-Butyl aziridine 1a (25 mg, 0.11 mmol) was dissolved in CH2Cl2 (1 mL) and HCl (37% aq., 10 
drops) added. After 20 mins, a white precipitate was observed.  After 2 h., the precipitate was filtered 
off and washed with CH2Cl2 (4 mL). The precipitate was dried in vacuo for 15 min., providing the 
pure compound as a white flaky solid (12 mg, 45%). M.p 164-166 °C; Rf 0.0 (UV 254 nm, petroleum 
ether/EtOAc, 3:1); νmax/cm
-1 
2978 (br) (Het-H), 2904 (CH), 1739 (C=O), 1208; δH (d6-DMSO, 
400 MHz) 8.98 (2.5H, br s, OH/NH2), 7.60-7.55 (2H, ArH), 7.49-7.40 (3H, ArH), 5.86 (1H, d, J 4.1, 
ArCH), 4.59 (1H, d, 4.28), 3.86 (0.5H, br s, OH/NH2); δC (CD3OD, 101 MHz) 166.5, 134.4, 129.3, 
128.6, 127.5, 59.3, 59.2; m/z HRMS (ESI+), found: MH
+
, 200.0473. C9H11NO2
35
Cl requires 200.0478, 
Δ 2.5 ppm.  
 
(±)3-Chloro-3-phenylalanine hydrochloride-tert-butyl ester, 104a 
 
tert-Butyl aziridine 1a (25 mg, 0.11 mmol) dissolved in CH2Cl2 (1 mL) and HCl (2 mL, 4M in 
dioxane) was added. After 30 min., the reaction solvent was removed in vacuo to yield the crude 
product as an off white solid. Et2O (10 mL) was added, and the insoluble white solid collected by 
filtration. Removal of solvent from the solid in vacuo yielded the pure product as a white solid (12 
mg, 36%). Mp 155-158 °C; Rf 0.0 (UV 254 nm, MeOH/EtOAc, 20:1); νmax/cm
-1 
2967 (CH), 1729 
(C=O), 1264, 1154; δH (CD3OD, 400 MHz) 7.59 (2H, ArH), 7.52 (3H, ArH), 5.68 (1H, d, J 4.4, 
ArCH), 4.65 (1H, d, J 4.4, NH2CH), 1.43 (9H, s, C(CH3)3); δC (CD3OD, 101 MHz) 164.4, 134.8, 
129.1, 128.5, 127.4, 84.8, 59.7, 59.2, 26.6; m/z HRMS (ESI+), found: MH
+
, 256.1096. C13H19NO2
35
Cl 
requires 256.1104, Δ 3.1 ppm.  
 
(±)3-Chloro-3-phenylalanine tert-butyl ester, 104b 
 
tert-Butyl aziridine 1a (24 mg, 0.11 mmol) was dissolved in CH2Cl2 (1 mL), and HCl (2 mL, 4M in 
dioxane) was added. After 1h., the reaction solvent was removed in vacuo to yield the product as the 
hydrochloride salt. The salt was dissolved in CH2Cl2 (4 mL) and washed with NaHCO3 (4 mL, sat. 
aq.). The organic phase was dried over Na2SO4 and the solvent removed in vacuo, to provide the title 
compound as a clear oil (25 mg, 90%). Rf 0.8 (UV 254 nm, MeOH/EtOAc, 1:20);  νmax/cm
-1 
3394 
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(NH), 2979 (CH), 1731 (C=O), 1371, 1153; δH (CDCl3, 400 MHz) 7.43-7.32 (5H, ArH), 5.06 (1H, d, 
J 7.2, ArCH), 3.87 (1H, d, J 7.2, C(O)CH), 1.52 (2H, br s, NH), 1.47 (9H, s, C(CH3)3); δC (CDCl3, 
101 MHz) 170.9, 137.3, 128.9, 128.6, 128.2, 82.3, 64.0, 62.2, 28.0; m/z HRMS (NH3 CI+), found: 
MH
+
, 256.1105. C13H19NO2
35Cl requires 256.1104, Δ 0.4 ppm.  
3.2.2 Pyrazolo[3,4-d]pyrimidine synthesis 
(3-Methylbut-2enyloxymethyl)-benzene, 118
115
 
 
Adapted from the procedure of Kawasaki,
115
 NaH (0.17 g, 4.4 mmol, 60% in mineral oil) was 
suspended in anhydrous THF and cooled to 0 °C. BnOH (0.39 mL, 3.4 mmol) was added dropwise 
over 1 min. to the mixture, and stirred at 0° C for 3 min. The ice bath was removed, and the reaction 
allowed to warm to r.t. for 15 min. The reaction was then cooled to 0 °C, and prenyl bromide (0.39 
mL, 3.4 mmol) added dropwise over 1 min. The reaction was stirred at 0 °C for 3 min., after which 
the ice-bath was removed and the reaction allowed to warm to r.t. After 20 h., H2O (10 mL) was 
added, and the aqueous phase extracted with hexane (3 x 10 mL). The organic phase was dried over 
MgSO4 and the solvent removed in vacuo to provide the crude product (0.63 g). Purification by 
column chromatography eluting with EtOAc/petroleum ether (1:40) provided the pure product as 
clear oil (0.33 g, 52%). Rf 0.25 (KMnO4, EtOAc/petroleum ether, 1:40); δH (CDCl3, 400 MHz) 7.37-
7.27 (5H, ArH), 5.45-5.41 (2H, m, alkene-H), 4.52 (2H, s, PhCH2), 4.03 (2H, br d, J 6.9, 
(CH3)2CCHCH2) 1.78 (3H, s, CH3), 1.68 (3H, s, CH3); δC (CDCl3, 101 MHz) 138.6, 137.2, 128.4, 
127.8, 127.5, 121.1, 72.1, 66.6, 25.8, 18.1; m/z HRMS (NH3, CI+), found: MNH3
+
, 194.1537. 
C12H20NO requires 194.1545, Δ 4.1 ppm.  All data are in agreement with reported values.
115
 
 
[N-Salicylidene-2-aminoisobutyrato]-[2-aminoisobutyrato]-cobalt (III), 119
113
 
 
Adapted from the procedure of Carreira,
113
 salicaldehyde (2.13 mL, 20.1 mmol) and 2-
aminoisobutyric acid (2.07 g, 20.1 mmol) were suspended in H2O under Ar for 5 min., before the 
addition of Co(OAc)2.4H2O (5 g, 20.1 mmol). The reaction was heated to reflux for 2 h., after which 
the brown-red solid that had formed was filtered off and washed with H2O (20 mL). The solid was 
dried in vacuo for 12 h, to yield a dry brown-red solid (2.87 g). A portion (1g) of the solid was 
suspended in EtOH:H2O (30 mL:12 mL) in air and 2-aminoisobutyric acid (0.32 g) added. After 6 h. 
stirring at r.t., the solvent was removed in vacuo, and the resulting red-solid concentrated from 
CH2Cl2 (2 x 20 mL) and EtOH (20 mL), before drying in vacuo (80 °C, 6 h.). Purification by column 
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chromatography eluting with CH2Cl2/MeOH (10:1 then 1:1) provided the product as dark red crystals 
as a mixture of two isomers (1.15 g, quantitative yield, 83% pure by NMR, with reference to Bn2O as 
an internal standard.) Rf 0.3 and 0.2 (UV 254 nm, CH2Cl2/MeOH, 10:1); 8.62 (0.32Hminor, s, N=CH), 
8.31 (0.68Hmajor, s, N=CH), 7.56 (0.32Hminor, d, J 7.9, ArH), 7.52 (0.68Hmajor, dd J 7.9 and 1.6, ArH), 
7.29-7.21 (1H, m, ArH), 7.11 (1H, d, J 8.8, ArH), 6.71-6.63 (1H, m, ArH), 1.84 (1Hminor, s, CH3), 1.82 
(1Hminor, s, CH3), 1.79 (2Hmajor, s, CH3), 1.71 (1Hminor, s, CH3), 1.68 (2Hmajor, s, CH3), 1.62 (1Hminor, s, 
CH3), 1.33 (2Hmajor, s, CH3), 1.27 (2Hmajor, s, CH3); m/z HRMS (ESI+), found: MH
+
, 367.0693. 
C15H20CoN2O5 requires 367.0705, Δ 3.3 ppm. All data are in agreement with reported values.
113
 
 
4-(Benzyloxy)-2-methylbutan-2-ol, 144
122
 
 
Adapted from the procedure of Asaoka.
122
 4-Benzyloxy-2-butanone (1g, 5.6 mmol) was added to 
anhydrous THF (22 mL) and cooled to -78 °C. MeLi (7 mL, 11.2 mmol, 1.6 M solution in Et2O) was 
added dropwise over 22 min., maintaining the temperature below -75 °C. The reaction was stirred for 
a further 50 min. at -78 °C, and then quenched at this temperature with NH4Cl (sat. aq., 20 mL). Et2O 
(20 mL) was added, followed by H2O (20 mL). The organic phase was separated, and the aqueous 
phase extracted with Et2O (3 x 20 mL). The organic phases were combined and dried over MgSO4, 
and the solvent removed in vacuo. The crude product was isolated as a clear oil (1.13 g). Purification 
by column chromatography eluting with Et2O/petroleum ether (1:4 then 1:1) provided the pure 
product as clear oil (0.92 g, 84%). Rf 0.20 (UV 254 nm, Et2O/petroleum ether, 1:4); νmax/cm
-1 
3432 
(OH), 2978 (CH), 2943 (CH), 2870, 1457; δH (CDCl3, 400 MHz) 7.37-7.26 (5H, ArH), 4.52 (2H, s, 
PhCH2), 3.73 (2H, t, J 6.0, OCH2), 3.26 (1H, s, OH), 1.82 (2H, t, J 6.0, OCH2CH2), 1.23 (6H, s, 2 x 
CH3); δC (CDCl3, 101 MHz) 137.8, 128.5, 127.8, 127.7, 73.4, 70.5, 67.7, 41.6, 29.4; m/z HRMS 
(NH3, CI+) found: MH
+
, 195.1388. C12H19O2 requires 195.1385, Δ 1.5 ppm. All data are in agreement 
with reported values.
122
 
 
Benzyl 3-chloro-3-methylbutyl ether, 145
122
 
 
Adapted from the method of Asaoka.
122
 4-Benzyloxy-2-butanone (5g, 28 mmol) was dissolved in 
anhydrous THF (100 mL) and cooled to -78 °C. MeLi (36 mL, 56 mmol, 1.55 M solution in Et2O) 
was added dropwise over 25 min., maintaining the temperature below -76 °C. The reaction was stirred 
for a further 1 h. at -78 °C, before the cooling bath was removed, and the reaction quenched 
immediately with NH4Cl (sat. aq., 100 mL). H2O (100 mL) was added, and the aqueous phase 
extracted with Et2O (3 x 100 mL). The organic phase was dried over MgSO4, and the solvent removed 
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in vacuo. Crude alcohol 144 was isolated as a clear oil (6.72 g), and suspended in HCl (37% aq., 20 
mL) under Ar with rapid stirring. After 1 h. 35 min., H2O (50 mL) and Et2O (50 mL) were added. 
NaHCO3 (s) was added until the solution reached a pH of 7. Further portions of H2O (50 mL) and 
Et2O (50 mL) were added, and the organic phase separated. The aqueous phase was extracted with 
Et2O (2 x 100 mL), dried over MgSO4 and concentrated in vacuuo to provide the crude product as a 
yellow oil (7.93 g). Purification by column chromatography eluting with EtOAc/petroleum ether 
(1:100) provided the pure product as clear oil (3.43 g, 56%). Rf 0.20 (UV 254 nm, EtOAc/petroleum 
ether, 1:100); νmax/cm
-1 1458, 1370, 1104; δH (CDCl3, 400 MHz) 7.38-7.27 (5H, ArH), 4.52 (2H, s, 
PhCH2), 3.74 (2H, t, J 6.7, CH2CH2OBn), 2.14 (2H, t, J 6.7, CH2CH2OBn), 1.62 (6H, s, 2 x CH3); δC 
(CDCl3, 101 MHz) 138.3, 128.4, 127.7, 127.6, 73.1, 69.6, 67.4, 45.2, 33.0; m/z HRMS (NH3, CI+) 
found: MNH4
+
, 230.1301. C12H21NO
35
Cl requires 230.1312, Δ 4.8 ppm. All data are in agreement 
with reported values.
122
 
 
Benzyl 3-bromo-3-methylbutyl ether, 146 
 
 
Adapted from the procedure of Masada,
123
 LiBr (2.37 g, 27 mmol) was added to alcohol 144 (3.54 g, 
18 mmol) and cooled to 0 °C. On cooling, the alcohol froze, and the mixture became a gum which and 
stirring ceased. HBr (4.20 mL, 36 mmol) was added to the mixture, and the cooling bath removed 
after the addition. On warming to room temperature, the reaction became liquid and changed from 
beige to pink in colour. After 2 h., the organic phase was separated, and ethylene glycol (8 mL) added, 
forming an emulsion. The emulsion was extracted with Et2O (3 x 25 mL), and the combined organics 
washed with H2O (2 x 20 mL). The organic phase was dried over MgSO4 and the solvent removed in 
vacuo to provide the crude product as a yellow oil (3.79 g, 85%) in sufficient purity. Rf 0.25 (UV 254 
nm, EtOAc/petroleum ether, 1:50); νmax/cm
-1
 2971 (CH), 2868 (CH), 1457, 1371; δH (CDCl3, 
400 MHz) 7.43-7.30 (5H, ArH), 4.56 (2H, PhCH2), 3.79 (2H, t, J 6.7, CH2CH2OBn), 2.23 (2H, t, 
J 6.7 CH2CH2OBn), 1.84 (6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 138.3, 128.4, 127.6, 127.6, 73.1, 
68.5, 66.0, 46.6, 34.9; m/z HRMS (NH3 CI+) found: MNH4
+
, 274.0808. C12H21NO
79
Br requires 
274.0807, Δ 0.4 ppm. 
 
1,1'-[(3-Methylbutane-1,3-diyl)bis(oxymethanediyl)]dibenzene, 144a 
  
HBr (49% aq., 15 mL) was added to alcohol 144 (5.53 g, 28 mmol, 88% pure containing 4-
benzyloxy-2-butanone) and stirred in air. On addition of the HBr the mixture turned from clear to 
pink. After 3 h., NaHCO3 (s) was added until the reaction reached pH 7. H2O (15 mL) and Et2O (15 
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mL) were added to the mixture. The aqueous phase was extracted with Et2O (3 x 15 mL), and the 
organics combined and dried over MgSO4. The solvent was removed in vacuo. Purification by column 
chromatography eluting with EtOAc/petroleum ether (1:50) provided the pure product as clear oil 
(0.06 g, 1%). Rf 0.20 (UV 254 nm, EtOAc/petroleum ether, 1:50); νmax/cm
-1
 2978 (CH), 2869 (CH), 
1457, 1362; δH (CDCl3, 400 MHz) 7.42-7.27 (10 H, ArH), 4.56 (2H, s, PhCH2), 4.47 (2H, s, PhCH2), 
3.72 (2H, t, J 7.2, CH2CH2OBn), 2.04 (2H, t, J 7.2 CH2CH2OBn), 1.34 (6H, s, 2 x CH3); δC (CDCl3, 
101 MHz) 139.7, 138.6, 128.4, 128.3, 127.7, 127.6, 127.4, 127.2, 74.4, 73.1, 66.8, 63.7, 40.0, 26.2; 
m/z HRMS (NH3 CI+) found: MH
+
, 285.1857. C19H25O2 requires 285.1855, Δ 0.7 ppm. 
 
N-(3-Benzyloxy-1,1-dimethylpropyl)-N’-(tert-butoxycarbonyl)hydrazinecarboxylic acid tert-
butyl ester, 120
112
 
 
Adapted from the procedure of McCague,
112
 catalyst 119 (0.35 g, 1 mmol) was added to anhydrous 
EtOH (90 mL) at room temperature. Alkene 118 (3.33 g, 19 mmol), PhSiH3 (3.06 g, 28 mmol) and di-
tert-butylazodicarboxylate (9.79 g, 43 mol) were added sequentially. After 5 min., an exotherm was 
noted, and the reaction was cooled to 0°C. After 10 min. at 0°C the ice bath was removed, and the 
reaction stirred at r.t. for 7 d. The reaction was quenched with brine (200 mL, sat. aq.), and H2O (50 
mL) was added. The aqueous phase was extracted with EtOAc (3 x 200 mL), and the organic phase 
dried over MgSO4. The solvent was removed in vacuo to provide the crude product as a brown oily 
solid. Purification by column chromatography eluting with EtOAc/petroleum ether (1:50, 1:10, 1:5) 
provided the pure product as clear viscous oil (2.60 g, 33%). Rf 0.25 (UV 254 nm, EtOAc/petroleum 
ether, 1:5); δH (CDCl3, 400 MHz, mixture of rotamers) 7.37-7.27 (5H, ArH), 6.25 (0.68 x 1H, br s, 
NH), 5.92 (0.32 x 1H, br s, NH), 4.47 (2H, s, PhCH2), 3.64-3.47 (2H, m, PhCH2OCH2), 2.43-2.34 
(1H, m, (CH3)2CCHH), 1.83-1.73 (1H, m, (CH3)2CCHH), 1.53 (3H, s, CH3), 1.45 (9H, s, C(CH3)3), 
1.39 (9H, s, C(CH3)3), 1.28 (3H, s, CH3); m/z HRMS (ESI+) found: MH
+
, 409.2709. C22H37N2O5 
requires 409.2716, Δ 1.7 ppm. All data are in agreement with reported values.112 
 
Di-tert-butyl hydrazine-1,2-dicarboxylate, 132
168
 
 
Following the procedure used to prepare hydrazine 120, di-tert-butylazodicarboxylate (9.79 g, 43 
mmol) provided the title compound as white powdery crystals (5.11 g, 52%), after purification by 
column chromatography, eluting with EtOAc/petroleum ether (1:5, 1:3). Mp 124-126 °C [lit. 124-126 
°C
168
]; Rf 0.15 (KMnO4, EtOAc/petroleum ether, 1:5); νmax/cm
-1 
3321 (NH), 2987 (CH), 1739 (C=O); 
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δH (CDCl3, 400 MHz) 6.36 (2H, br s, C(O)NH), 1.45 (18H, s, 2 x C(CH3)3); δC (CDCl3, 101 MHz) 
155.8, 81.4, 28.2; m/z (NH3, CI+) 250 (M+NH4
+
). All data are in agreement with reported values.
169
 
 
Di-tert-butyl 1-tert-butylhydrazine-1,2-dicarboxylate, 142
121
 
 
Adapted from the procedure of Crowley et al.,
121
 Mg turnings (0.24 g, 10.0 mmol) were washed with 
hexane (3 x 3 mL) and dried under high vacuum (5min., r.t.). A portion of tert-butyl chloride (0.6 mL 
from 1.10 mL, 10.0 mmol) was added to the Mg turnings, with a crystal of I2, and the reaction heated 
gently (ca. 40 °C) for 3 min. The remaining tert-butyl chloride (0.5 mL) was dissolved in dry THF (10 
mL) in a separate flask, and a portion (3 mL) of this solution added to the reaction flask. Initiation was 
observed, and reflux was maintained through heating and slow addition of the tert-butyl chloride/THF 
solution. After the addition was complete, the reaction was heated at reflux for 25 min., after which 
the heat source was removed. The Grignard reagent was allowed to cool to ca. 50 °C, before 
transferring via cannula over 5 min. to a cooled (0 °C) solution of tert-butylazodiformate (1.00 g, 4.3 
mmol) in THF (10 mL). The reaction was warmed to r.t. and stirred for 1 h. 45 min. The reaction was 
diluted with Et2O (20 mL), and H2O (45 mL) added (NaCl (s) required to separate the phases). The 
aqueous phase was extracted with Et2O (3 x 20 mL) and the organics dried over MgSO4. The solution 
was concentrated in vacuo to provide the crude product as brown oil (1.05 g). Purification by column 
chromatography eluting with EtOAc/petroleum ether (1:20, 1:10, 1:5) provided the pure product as 
white solid (0.49 g, 39%). Mp 139-140 °C [lit. 136-137 °C
121
]; Rf 0.20 (KMnO4, EtOAc/petroleum 
ether, 1:20); νmax/cm
-1 
3310 (NH), 2985 (CH), 1739 (C=O), 1687 (C=O), 1370; δH (CDCl3, 400 MHz, 
mixture of rotamers) 6.18 (0.66 x 1H, br s, NH), 5.89 (0.33 x 1H, br s, NH), 1.51-1.48 (18H, 
C(CH3)3,), 1.43-1.39 (9H, N(CH3)3,); δC (CDCl3, 101 MHz, broadened peaks, mixture of rotamers) 
156.4, 156.1, 154.7, 154.1, 81.1, 80.6, 80.5, 59.3, 28.5, 28.3, 28.2; m/z HRMS (NH3, CI+) found: 
MH
+
, 289.2127. C14H29N2O4 requires 289.2127, Δ 0.0 ppm. 
 
tert-Butyl 2-(propan-2-ylidene)hydrazinecarboxylate, 154
126
 
 
According to the procedure of Meyer,
126
 tert-butylcarbazate (10 g, 76 mmol) and MgSO4 (2 g, 20% 
w/w) were added to acetone (80 mL). AcOH (10 drops) was added, and the reaction heated to reflux 
for 1 h. The heat was removed and the reaction allowed to cool to room temperature. The reaction 
mixture was filtered, and the mother liquor concentrated in vacuo to provide the pure product as white 
crystals. Mp 83-86 °C [lit. 87-90 °C
127
]; Rf 0.15 (UV 254 nm, Et2O/petroleum ether, 1:1); νmax/cm
-1
 
158 
 
3251 (NH), 2981 (CH), 1708 (C=O), 1527; δH (CDCl3, 400 MHz) 7.38 (1H, br s, NH), 2.02 (3H, s, 
N=CCH3), 1.80 (3H, s, N=CCH3), 1.49 (9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 152.8, 149.7, 80.7, 
28.3, 25.4, 16.0; m/z HRMS (NH3 CI+) found: MNH4
+
, 173.1292. C8H17N2O2 requires 173.1290, 
Δ 1.2 ppm. All data are in agreement with literature values.126 
 
tert-Butyl 2-(2-methylpent-4-en-2-yl)hydrazinecarboxylate, 157
127
 
 
According to the procedure of Wolfe.
127
 Hydrazone 154 (8.61 g, 50 mmol) was dissolved in 
anhydrous THF (500 mL). The mixture was cooled to 0 °C and allyl magnesium bromide (100 mL, 
100 mmol, 1M solution in Et2O) added over 12 min. A gradual colour change from clear to pale green 
was noted during the addition of the first eq. of Grignard reagent, with a sharp end point to yellow on 
exceeding 1 eq. The temperature was maintained between 1-0 °C for a further hour after the addition, 
after which time, the ice-bath was removed, and the reaction stirred at room temperature for a further 
1 h. The reaction was cooled to 0 °C and quenched with NaOH (1M aq., 200 mL). The aqueous phase 
was extracted with Et2O (3 x 200 mL), dried over MgSO4 and the solvent removed in vacuo, to 
provide the crude product as a clear oil. Purification by column chromatography eluting with 
EtOAc/petroleum ether (1:7) provided the pure product as clear oil (7.51 g, 70%). Rf 0.15 (KMnO4, 
EtOAc/petroleum ether, 1:7); νmax/cm
-1 
3306 (NH), 2983 (CH), 1712 (C=O);  δH (CDCl3, 400 MHz) 
5.90 (1H, br s, amide-NH), 5.89-5.79 (1H, m, H2C=CH), 5.08 (1H, m, HHC=CH), 5.06-5.03 (1H, m, 
HHC=CH), 3.82 (1H, br s, amine-NH), 2.13 (2H, dt, J 7.3 and 1.2, H2C=CHCH2), 1.44 (9H, s, 
C(CH3)3), 1.02 (6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 157.2, 134.6, 117.8, 80.2, 56.8, 44.4, 28.3, 
24.8; m/z HRMS (NH3 CI+), found: MH
+
, 215.1759. C11H23N2O2 requires 215.1760, Δ 0.5 ppm. All 
data are in agreement with literature values.
127
 
 
(Ethoxymethylidene)propanedinitrile, 121
128
 
 
Adapted from the procedure of Quinn.
128
 Malononitrile (8.0 g, 121 mmol), Ac2O (40 mL) and triethyl 
orthoformate (30  mL, 182 mmol) were combined and heated to reflux for 5 h. The heat source was 
removed, and the reaction allowed to cool to r. t., before concentration of the reaction mixture in 
vacuo. The resulting solid was recrystalised from Et2O, and dried in vacuo for 3 h., providing the pure 
product as pale brown crystals (10.1 g, 68%). Mp 66-68 °C [lit. 66-67 °C
128
]; Rf 0.40 (UV 254 nm, 
EtOAc/petroleum ether, 1:2); δH (CDCl3, 400 MHz) 7.59 (1H, s, alkene-H), 4.43 (2H, quart, J 7.5, 
OCH2CH3), 1.49 (3H, t, J 7.5, OCH2CH3). All data is in agreement with literature values.
128
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[Ethoxy(phenyl)methylidene]propanedinitrile, 188
150
 
 
Adapted from the procedure of Bontems et al.
150
 Triethyl orthobenzoate (10 mL, 44 mmol), 
malononitrile (2.99 g, 45 mmol) and acetic anhydride (85 mL) were combined and heated to reflux. A 
colour change was observed on heating, from yellow to dark brown. After 3 h. at reflux, the heat 
source was removed, and the reaction mixture concentrated in vacuo. Purification by column 
chromatography, eluting with EtOAc/petroleum ether (1:4) provided the pure product as yellow 
crystalline powder (4.26 g, 49%). Mp 88-92 °C [lit. 84-85 °C
150
]; Rf 0.30 (UV 254 nm, 
EtOAc/petroleum ether, 1:4); δH (CDCl3, 400 MHz) 7.65-7.49 (5H, PhH), 4.22 (2H, q, J 6.9, OCH2), 
1.39 (3H, t, J 6.9, OCH2CH3); m/z (NH3 CI+), 216 (M+NH4
+
). All data are in agreement with 
literature values.
150
 
 
5-Amino-1-(3-benzyloxy-1,1-dimethylpropyl)-1H-pyrazole-4-carbonitrile, 122
112
 
 
Adapted from the procedure of McCague.
112
 AcCl (2.72 mL, 38.3 mmol) was added to anhydrous 
EtOH (35 mL) at 0 °C. The solution was warmed to r.t., and hydrazine 120 (2.60 g, 6.4 mmol) added. 
The reaction was heated at reflux for 1.5 h., before cooling to 0 °C. Et3N (7.95 mL, 57.3 mmol) was 
added, followed by enol ether 121 (0.78 g, 6.4 mmol). The reaction was heated to reflux for 1.5 h., 
whereupon the heat source was removed, and the reaction allowed to cool to r.t. The solvent was 
removed in vacuo, before the addition of H2O (100 mL), and brine (100 mL) to the brown solid 
residue. The aqueous phase was extracted with EtOAc (3 x 100 mL), and the organic phases 
combined and dried over MgSO4. The solution was concentrated in vacuo to provide the crude 
product as brown oil (2.00 g). Purification by column chromatography eluting with EtOAc/petroleum 
ether (1:3) provided the pure product as yellow oil (1.35 g, 74%). Rf 0.15 (UV 254 nm, 
EtOAc/petroleum ether, 1:3); δH (CDCl3, 400 MHz) 7.39 (1H, s, pyrazole-H), 7.34-7.21 (5H, PhH), 
4.49 (2H, br s, NH2), 4.37 (2H, s, PhCH2), 3.43 (2H, t, J 6.4, CH2CH2O), 2.19 (2H, t, J 6.4, 
CH2CH2O), 1.62 (6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 151.1, 138.5, 137.8, 128.5, 127.9, 127.7, 
114.6, 78.1, 73.2, 66.4, 61.9, 40.6, 28.1. All data are in agreement with reported values.
112
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5-Amino-1-(1,1-dimethylbut-3-enyl)-1H-pyrazole-4-carbonitrile, 158 
 
Adapted from the procedure of McCague.
112
 AcCl (8.86 mL, 125 mmol) was added dropwise to 
anhydrous MeOH (125 mL) at 0 °C. The mixture was allowed to warm to r. t., and hydrazine 157 
(4.45 g, 21 mmol) was added in one portion. The mixture was heated to reflux for 1 h. The reaction 
was cooled to 0 °C, and basified with Et3N (26 mL, 187 mmol). Enol ether 121 (2.30 g, 21 mmol) was 
added in one portion. The reaction mixture was heated to reflux for 1 h. The heat source was removed, 
and the reaction allowed to cool to r. t. The solvent was removed in vacuo, before the addition of 
brine (5 mL) and H2O (5 mL). The aqueous phase was extracted with EtOAc (3 x 5 mL) and the 
organics combined and dried over MgSO4. The solvent was removed in vacuo to provide the crude 
product as a brown oil. Purification by column chromatography, eluting with EtOAc/petroleum ether 
(1:5) provided the pure product as an off-white powder (2.50 g, 63%). Mp 95-97 °C; Rf 0.15 (UV 254 
nm, EtOAc/petroleum ether, 1:5); νmax/cm
-1 3421 (NH), 3331 (NH), 3244 (NH), 2219 (C≡N), 1648; 
δH (CDCl3, 400 MHz) 7.41 (1H, s, pyrazole-H), 5.62-5.52 (1H, m, H2C=CH), 5.08 (1H, m, 
HHC=CH), 5.06-5.04 (1H, m, HHC=CH), 4.44 (2H, br s, NH2), 2.61 (2H, d, J 7.1, H2C=CHCH2), 
1.61 (6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 150.5, 138.5, 132.4, 119.5, 114.6, 78.0, 62.6, 45.3, 27.1; 
m/z HRMS (NH3 CI+), found: MH
+
, 191.1299. C10H15N4 requires 191.1297, Δ 1.0 ppm. 
 
5-Amino-1-(1,1-dimethylbut-3-enyl)-3-phenyl-1H-pyrazole-4-carbonitrile, 189 
 
Adapted from the procedure of McCague.
112
 AcCl (4.0 mL, 60 mmol) was added dropwise to 
anhydrous MeOH at 0 °C. Hydrazine 157 (2.0 g, 9.3 mmol) was added in one portion, and the mixture 
heated to reflux. After 70 min., the reaction was cooled to 0 °C, and basified with Et3N (11.7 mL, 83.7 
mmol). Enol ether 188 (1.8 g, 9.3 mmol) was added in one portion, and the reaction heated to reflux. 
After 2 h. 10 min., the heat source was removed, and the reaction allowed to cool to r. t. The solvent 
was removed in vacuo, before the addition of brine (80 mL) and H2O (80 mL). The aqueous phase 
was extracted with EtOAc (3 x 80 mL) and the organics combined and dried over MgSO4. The 
solvent was removed in vacuo to provide the crude product as brown oil (2.60 g). Purification by 
column chromatography, eluting with EtOAc/petroleum ether (1:10 then 1:5) provided the pure 
product as a yellow solid (1.3 g, 52%). Mp 98-100 °C; Rf 0.20 (UV 254 nm, EtOAc/petroleum ether, 
1:5); νmax/cm
-1 3474 (NH), 3355 (NH), 3017 (CH), 2988 (CH), 2212 (C≡N), 1623; δH (CDCl3, 
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400 MHz) 7.94-7.92 (2H, ArH), 7.44-7.34 (3H, ArH), 5.72-5.62 (1H, m, H2C=CH), 5.13-5.12 (1H, 
m, CHHCH), 5.09 (1H, m, CHHCH), 4.50 (2H, br s, NH2), 2.69 (2H, d, J 7.4, H2C=CHCH2), 1.66 
(6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 152.0, 148.3, 132.8, 131.7, 128.8, 128.7, 126.2, 119.4, 115.8, 
75.5, 62.8, 45.5, 27.2; m/z (NH3 CI+), found: MH
+
, 267.1608. C16H19N4 requires 267.1610, 
Δ 0.7 ppm. 
 
1-(3-Benzyloxy-1,1-dimethylpropyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine, 123
112
 
 
Adapted from the procedure of McCague.
112
 Pyrazole 122 (0.40 g, 1.4 mmol) and formamide (4 mL) 
were combined and heated to 180 °C. After 16 h., the heat source was removed, and the dark-brown 
reaction allowed to cool. The mixture was poured into brine (18 mL), and the aqueous phase extracted 
with EtOAc (3 x 18 mL). Emulsions were observed on extraction of the aqueous phase, which 
separated slowly. The organic phase was extracted with brine (2 x 18 mL) and dried over MgSO4, to 
provide the crude product as yellow oil (0.35 g). Purification by column chromatography eluting with 
EtOAc/petroleum ether (1:3, 1:1 then 1:0) provided the pure product as clear oil (0.34 g, 77%). Rf 
0.15 (UV 254 nm, EtOAc/petroleum ether, 1:3); νmax/cm
-1 
3330 (NH), 3138, 1643, 1596; δH (CDCl3, 
400 MHz) 8.32 (1H, s, pyrimidine-H), 7.80 (1H, s, pyrazole-H), 7.28-7.17 (5H, ArH), 6.15 (2H, br s, 
NH2), 4.33 (2H, s, PhCH2), 3.38 (2H, t, J 6.8, CH2CH2OBn), 2.57 (2H, t, J 6.8, CH2CH2OBn), 1.83 
(6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 157.8, 154.4, 153.5, 138.3, 128.9, 128.3, 127.5, 127.4, 102.0, 
72.8, 66.7, 62.1, 40.2, 27.8; m/z (NH3, CI+) found: MH
+
, 312.1827. C17H22N5O requires 312.1824, 
Δ 1.0 ppm. All data are in agreement with literature values.112 
 
1-(3-Benzyloxy-1,1-dimethylpropyl)-1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one, 123a
112
 
 
The title compound was synthesised according to the procedure used to synthesise pyrimidine 123. 
Purification by column chromatography eluting with EtOAc/petroleum ether (1:3, then 1:1) provided 
the pure product as a yellow oil (53 mg, 12%). Rf 0.18 (UV 254 nm, EtOAc/petroleum ether, 1:3); 
νmax/cm
-1 
2883 (CH), 1684 (C=O), 1603; δH (CDCl3, 400 MHz) 12.20 (1H, br s, pyrimidone-NH), 
8.06 (1H, s, pyrimidone-H), 7.92 (1H, s, pyrazole-H), 7.30-7.19 (5H, PhH), 4.34 (2H, s, PhCH2), 3.39 
(2H, t, J 6.5, CH2CH2OBn), 2.53 (2H, t, J 6.5, CH2CH2OBn), 1.82 (6H, s, 2 x CH3); δC (CDCl3, 101 
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MHz) 160.3, 152.0, 144.1, 138.2, 133.0, 128.6, 128.3, 127.5, 107.4, 72.9, 66.5, 62.8, 40.5, 27.9; m/z 
HRMS (NH3, CI+) found: MH
+
, 313.1669. C17H21N4O2 requires 313.1665, Δ 1.3 ppm. All data are in 
agreement with literature values.
112
 
 
1-(1,1-Dimethylbut-3-enyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine, 159 
  
Adapted from the procedure of McCague.
112
 Pyrazole 158 (2.5 g, 13 mmol) and formamide (20 mL) 
were combined and heated to reflux. After 16 h., the heat source was removed, and the dark-brown 
reaction allowed to cool to room temperature. Brine (50 mL) was added, followed by EtOAc (50 mL), 
forming a suspension that slowly separated. The aqueous phase extracted with further portions of 
EtOAc (2 x 60 mL). The organics were combined and dried over MgSO4 and the solvent removed in 
vacuuo. Purification by column chromatography, eluting with EtOAc/petroleum ether (1:1) provided 
the pure product as a white solid (1.89 g, 66%). Mp 117-120; Rf 0.20 (UV 254 nm, EtOAc/petroleum 
ether, 1:1); νmax/cm
-1 
3315 (NH), 3092 (CH), 2868 (CH), 1670, 1597; δH (CDCl3, 400 MHz) 8.34 (1H, 
s, pyrimidine-H), 7.86 (1H, s, pyrazole-H), 6.35 (2H, br s, NH2), 5.58-5.74 (1H, m, CH2CH), 4.97-
4.95 (1H, m, CHHCH), 4.92-4.90 (1H, m, CHHCH), 2.95 (2H, d, J 7.2, CH2CH), 1.79 (6H, s, 2 x 
CH3); δC (CDCl3, 101 MHz) 157.9, 154.3, 153.4, 133.4, 128.8, 118.4, 102.0, 62.7, 45.1, 27.1; m/z 
HRMS (NH3 CI+) found: MH
+
, 218.1399. C10H20NO4 requires 218.1406, Δ 3.2 ppm. 
 
1-(1,1-Dimethylbut-3-enyl)-1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one, 161 
 
The title compound was synthesised from pyrazole 158 (100 mg, 0.53 mmol), according to the 
procedure used to synthesise pyrimidine 159. Purification by column chromatography, eluting with 
EtOAc/petroleum ether (1:1) provided the pure product as white powder (36 mg, 31%). Mp 125-30 
°C; Rf 0.25 (UV 254 nm, EtOAc/petroleum ether, 1:1); νmax/cm
-1
 2284, 1696, 1605, 1319; δH (CDCl3, 
400 MHz) 12.06 (1H, br s, NH), 8.10 (1H, s, pyrimidone-H), 7.98 (1H, s, pyrazole-H), 5.63-5.52 (1H, 
m, CH2CH), 5.02-5.01  (1H, m, CHHCH), 4.98 (1H, m, CHHCH), 2.93 (2H, d, J 7.8, CH2CH), 1.81 
(6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 160.2, 151.9, 144.0, 133.1, 133.0, 118.7, 107.4, 63.5, 45.6, 
27.2; m/z HRMS (NH3 CI+) found: MH
+
, 219.1243. C11H15N4O requires 219.1246, Δ 1.4 ppm. 
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[1-(1,1-Dimethylbut-3-enyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-triethylsilanylamine, 173 
 
Pyrazolo[3,4-d]pyrimidine 159 (25 mg, 0.12 mmol) was dissolved in anhydrous THF (1 mL) and 
cooled to -30 °C. iPrMgCl.LiCl (1.24 M solution in THF, 0.25 mmol, 0.20 mL) was added dropwise 
over 1 min., and the solution turned from clear to yellow. The reaction was maintained between -35°C 
and -22°C for 2 h. Et3SiCl (13 μL, 0.12 mmol) was added at -32 °C, and the reaction was allowed to 
warm slowly to 25 °C for 40 min. NaHCO3 (sat., aq., 2 mL) was added, and the aqueous phase 
extracted with Et2O (3 x 5 mL). The organic phase was washed with brine (10 mL) and dried over 
MgSO4, to provide the crude product as a white solid (46 mg). Purification by column 
chromatography eluting with EtOAc/petroleum ether (1:1) provided the pure product as a white solid 
(25 mg, 53%). Mp 125-126 °C; Rf 0.15 (UV, 254 nm, EtOAc/petroleum ether, 1:1); νmax/cm
-1 
3286 
(NH), 2954 (CH), 1598, 1559; δH (CDCl3, 400 MHz) 8.34 (1H, s, pyrimidine-H), 7.83 (1H, s, 
pyrazole-H), 5.59-5.48 (1H, m, H2C=CH), 5.00-4.93 (2H, H2C=CH), 4.63 (1H, br s, NH), 2.96 (2H, 
d, J 7.3, H2C=CHCH2), 1.78 (6H, s, 2 x CH3), 1.02-0.98 (9H, m, 3 x SiCH2CH3), 0.93-0.87 (6H, m, 
SiCH2CH3); δC (CDCl3, 101 MHz) 160.1, 154.3, 153.5, 133.6, 128.5, 118.2, 103.8, 62.5, 45.1, 27.0, 
7.0, 4.3; m/z HRMS (NH3 CI+), found: MH
+
, 332.2270. C17H30N5Si requires 332.2270, Δ 0.0 ppm. 
 
[1-(1,1-Dimethylbut-3-enyl)-1H-pyrazolo[3,4,d]pyrimidin-4-yl]-dicarbamic acid di-tert-butyl 
ester, 182 
 
According to the procedure of Garner.
145
 Pyrazolo[3,4-d]pyrimidine 159 (100 mg, 0.46 mmol) and 
DMAP (5 mg, 9 μmol) were dissolved in anhydrous THF (2.5 mL), and (Boc)2O (400 mg, 1.84 
mmol) added at r.t.. On addition of the (Boc)2O, the reaction mixture turned from clear to yellow. The 
reaction was stirred at r.t. for 5 h. NH4Cl (sat. aq., 20 mL) was added, and the aqueous phase extracted 
with Et2O (3 x 20 mL). The organics were combined and dried over MgSO4 and the solvent removed 
in vacuo to provide the crude product as a clear oil. Purification by column chromatography eluting 
with EtOAc/petroleum ether (1:10) provided the pure product as white sticky crystals (142 mg, 74%). 
Mp 69-72 °C; Rf 0.30 (UV, 254 nm, EtOAc/petroleum ether, 1:10); νmax/cm
-1 
2984 (CH), 2937 (CH), 
1785, 1746 (C=O); δH (CDCl3, 400 MHz) 8.74 (1H, s, pyrimidine-H), 8.00 (1H, s, pyrazole-H), 5.57-
5.46 (1H, m, HC=CH2), 4.92 (1H, m, HC=CHH), 4.88 (1H, m, HC=CHH), 2.96 (2H, d, J 7.3, 
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H2C=CHCH2), 1.82 (6H, s, 2 x CH3), 1.50 (18H, s, 2 x C(CH3)3); δC (CDCl3, 101 MHz) 154.4, 
153.2, 152.9, 150.3, 133.2, 131.1, 118.5, 108.7, 84.4, 63.2, 45.1, 27.7, 27.1; m/z HRMS (ES+), found: 
MH
+
, 418.2447. C21H32N5O4 requires 418.2454, Δ 1.7 ppm. 
 
[1-(1,1-Dimethylbut-3-enyl)-1H-pyrazolo[3,4,d]pyrimidin-4-yl]-carbamic acid tert-butyl ester, 
186 
 
Pyrazolo[3,4-d]pyrimidine 159 (25 mg, 0.06 mmol) was dissolved in anhydrous THF (0.2 mL) and 
(TMP)2.2MgCl2.2LiCl
147
  (0.25 mL, 0.56 M in THF, 0.14 mmol) was added dropwise. The reaction 
was stirred for 2 h. at r.t. D2O was added, and the reaction stirred for a further 30 min. NH4Cl (sat. aq., 
5 mL) was added, and the aqueous phase extracted with Et2O (3 x 5 mL). The organics were dried 
over MgSO4 and the solvent removed in vacuo to provide the crude product as a brown oil. 
Purification by column chromatography eluting with EtOAc/petroleum ether (1:10, 1:5) provided the 
pure product as a white oil (3 mg, 16%). Rf 0.25 (UV, 254 nm, EtOAc/petroleum ether, 1:5); νmax/cm
-1
 
3171 (NH), 2988 (CH), 1755 (C=O), 1602
 ;  δH (CDCl3, 400 MHz) 8.59 (1H, s, pyrimidine-H), 8.53 
(1H, s, pyrazole-H), 8.47 (1H, br s, NH), 5.59-5.48 (1H, m, HC=CH2), 4.96-4.92 (2H, HC=CH2), 
2.98 (2H, d, J 7.1, H2C=CHCH2), 1.81 (6H, s, 2 x CH3), 1.57 (9H, s, C(CH3)3); δC (CDCl3, 101 MHz) 
154.3, 152.6, 152.4, 151.1, 134.4, 133.5, 118.4, 104.1, 82.5, 62.8, 44.9, 28.1, 27.0; m/z HRMS (ES+), 
found: MH
+
, 318.1928. C16H24N5O2 requires 318.1930, Δ 0.6 ppm. 
 
[5-Cyano-6-(1,1-dimethylbut-3-enylamino)-pyrimidin-4-yl]carbamic acid tert-butyl ester, 183 
 
The title compound was synthesised according to the procedure used to synthesise pyrimidine 186. 
White oil (4 mg, 21%). Rf 0.15 (UV, 254 nm, EtOAc/petroleum ether, 1:5); νmax/cm
-1 
3154 (NH), 
2975 (CH), 2222 (C≡N), 1746 (C=O);  δH (CDCl3, 400 MHz) 8.44 (1H, s, pyrimidine-H), 7.38 (1H, 
br s, amide-NH), 5.84-5.74 (1H, m, HC=CH2), 5.51 (1H, br s, amine-NH) 5.18-5.12 (2H, HC=CH2), 
2.59 (2H, d, J 6.8, H2C=CHCH2), 1.54 (9H, s, C(CH3)3) 1.49 (6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 
162.5, 159.3, 158.9, 149.8, 133.2, 119.7, 114.1, 83.0, 78.3, 55.5, 45.3, 27.9, 27.0; m/z HRMS (ES+), 
found: MH
+
, 318.1940. C16H24N5O2 requires 318.1930, Δ 3.1 ppm. 
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1-[(E)-1,1-Dimethyl-4-phenylbut-3-enyl]-1H-pyrazolo[3,4,d]pyrimidin-4-ylamine, 168 
 
A tapered microwave vial was charged with pyrazole 159 (26 mg, 0.12 mmol), KOAc (23 mg, 0.23 
mmol), Et4NCl (38 mg, 0.23 mmol) and Pd(OAc)2 (2 mg, 8 mol%). PhI (38 μL, 0.35 mmol) and 
anhydrous DMF (0.25 mL) were added, and the tube sealed and the reaction heated to 100 °C for 27 
h. After this time, the heat source was removed and the reaction allowed to cool. EtOAc (4 mL) was 
added, and the organic phase washed with brine (4 x 5 mL). A further portion of EtOAc (5 mL) was 
added to the organic phase, which was dried over MgSO4. The crude product was isolated as a brown 
solid (29 mg). Purification by column chromatography eluting with EtOAc/petroleum ether (1:1) 
provided the product as a white solid (21 mg, 62%). Mp 152-155 °C; Rf 0.20 (UV, 254 nm, 
EtOAc/petroleum ether, 1:1); νmax/cm
-1 
3333 (NH), 1644, 1602, 1564; δH (CDCl3, 400 MHz) 8.35 
(1H, s, pyrimidine-H), 7.85 (1H, s, pyrazole-H), 7.25-7.16 (5H, PhH), 6.32 (1H, d, J 16.2, ArCH), 
5.98 (1H, dt, J 16.2 and 7.7, PhCHCH), 5.89 (2H, br s, NH2), 3.10 (2H, d, J 7.7, CHCH2), 1.84 (6H, 
s, 2 x CH3); δC (CDCl3, 101 MHz) 157.6, 154.2, 153.5, 137.4, 133.4, 128.8, 128.4, 127.1, 126.1, 
125.3, 101.9, 63.2, 44.4, 27.2; m/z HRMS (ES+), found: MH
+
, 294.1717. C17H20N5 requires 294.1719, 
Δ 0.7 ppm.  
 
1-(1,1-Dimethylbut-3-enyl)-3-phenyl-1H-pyrazolo[3,4,d]pyrimidin-4-ylamine, 190 
 
Adapted from the method of McCague.
112
 Pyrazole 189 (1.16 g, 4.4 mmol) and formamide (12 mL) 
were combined and heated to reflux. After 20 h., the heat source was removed, and the brown reaction 
allowed to cool to room temperature. Brine (25 mL) was added, followed by EtOAc (25 mL), forming 
a suspension that slowly separated. The aqueous phase extracted with further portions of EtOAc (2 x 
25 mL). The organics were dried over MgSO4 and the solvent removed in vacuuo. Purification by 
column chromatography, eluting with EtOAc/petroleum ether (1:3) provided the pure product as 
white crystals (0.60 g, 47%). Mp 156-159 °C; Rf 0.15 (UV 254 nm, Petroleum ether/EtOAc, 3:1); 
νmax/cm
-1 
3464 (NH), 3073 (CH), 1645, 1598, 1560; δH (CDCl3, 400 MHz) 8.36 (1H, s, pyrimidine-
H), 7.70-7.67 (2H, ArH), 7.55-7.43 (3H, ArH), 5.69-5.58 (1H, m, H2C=CH), 5.36 (2H, br s, NH2), 
5.03-4.96 (2H, H2C=CH), 3.01 (2H, d, J 7.3, H2C=CHCH2), 1.83 (6H, s, 2 x CH3); δC (CDCl3, 101 
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MHz) 158.1, 154.4, 154.2, 142.3, 133.8, 129.3, 128.8, 128.6, 126.3, 118.3, 99.6, 62.8, 45.2, 27.1; m/z 
HRMS (NH3 CI+), found: MH
+
, 294.1709. C17H20N5 requires 294.1719, Δ 3.4 ppm. 
 
4-(4-Aminopyrazolo[3,4,d]pyrimidin-1-yl)-4-methylpentane-1,2-diol, 160 
 
Adapted from the method of Sharpless et al.
131
 AD-mix-α (4.34 g, 1.4 g/mmol) was added to 
tert-BuOH:H2O (1:1, 31 mL) and  cooled to 0 °C. Alkene 159 (0.67 g, 3.1 mmol) was added and the 
reaction warmed to r.t. and strired vigorously for 24 h, when the reaction was judged to be complete 
by TLC analysis. Vigorous stirring was necessary to allow for complete consumption of the starting 
alkene. The reaction was cooled to 0 °C and Na2SO3 (4.7 g) was added. The reaction mixture was 
warmed to r.t. and stirred for 30 min. The aqueous phase was extracted with CHCl3/EtOH (2:1) (3 x 
15 mL), dried over MgSO4 and the solvent removed in vacuo. The pure product was isolated as a 
white solid (0.78 g, quant.). Mp 187-9 °C; Rf 0.40 (UV 254 nm, CHCl3/EtOH, 2:1); νmax/cm
-1 
3423 
(Het-H), 3192 (CH), 2560, 1662, 1607; δH (d6-DMSO, 400 MHz) 8.17 (1H, s, pyrimidine-H), 8.07 
(1H, s, pyrazole-H), 7.61 (2H, br s, NH2), 4.47 (1H, t, J 5.8, CH2OH), 4.30 (1H, d, J 5.2 CHOH), 
3.36-3.28 (1H, m, CHOH), 3.16-3.09 (1H, m, CHHOH), 3.07-2.99 (1H, m, CHHOH), 2.46 (1H, dd, J 
14.6 and 2.2, CHHC(CH3)2N), 1.95 (1H, dd, J 14.6 and 8.3, CHHC(CH3)2N), 1.84 (3H, s, CH3), 1.76 
(3H, s, CH3); δC (d6-DMSO, 101 MHz) 158.6, 155.1, 153.4, 130.4, 101.9, 68.8, 66.9, 62.2, 44.3, 28.8, 
27.5; m/z HRMS (NH3 CI+), found: MH
+
, 252.1457. C11H18N5O2 requires 252.1461, Δ 1.6 ppm. 
 
4-(4-Amino-3-phenylpyrazolo[3,4,d]pyrimidin-1-yl)-4-methylpentane-1,2-diol, 191 
 
Adapted from the method of Sharpless et al.
131
 AD-mix-α (4.34 g) was added to tert-BuOH:H2O (1:1, 
31 mL) and  cooled to 0 °C.  Alkene 190 (0.92 g, 3.1 mmol) was added and the reaction warmed to r.t. 
and strired for 40 h., when the reaction was judged to be complete by TLC analysis. Vigorous stirring 
was necessary to allow for complete consumption of the starting alkene. The reaction was cooled to 0 
°C and Na2SO3 (4.8 g) was added. The reaction mixture was warmed to r.t. and stirred for 30 min. The 
aqueous phase was extracted with EtOAc (3 x 30 mL), dried over MgSO4 and the solvent removed in 
vacuo. The pure product was isolated as a white solid (0.48 g, 79%). Mp 55-58 °C. Rf 0.25 (UV 254 
nm, EtOAc); νmax/cm
-1 
3473 (Het-H), 3324 (Het-H), 3171 (CH), 1632; δH (d6-DMSO, 400 MHz) 8.25 
167 
 
(1H, s, pyrimidine-H), 7.69-7.67 (2H, ArH), 7.59-7.54 (2H, ArH), 7.52-7.47 (1H, ArH), 6.70 (2H, br 
s, NH2), 4.45 (1H, t, J 5.5, CH2OH), 4.31 (1H, d, J 5.5, CHOH), 3.39 (1H, m, CHOH), 3.20-3.13 (1H, 
m, CHHOH), 3.09-3.04 (1H, m, CHHOH), 2.50 (1H, dd, J 14.4 and 2.1, CHHC(CH3)2N), 2.01 (1H, 
m, CHHC(CH3)2N), 1.88 (3H, s, CH3) 1.80 (3H, s, CH3); δC (d6-DMSO, 101 MHz) 158.6, 154.9, 
142.0, 133.8, 129.5, 128.9, 99.1, 79.6, 68.8, 67.0, 62.7, 44.3, 28.7, 27.5, 19.0; m/z HRMS (ES+), 
found: MH
+
, 328.1761. C17H22N5O2 requires 328.1774, Δ 4.0 ppm. 
 
3-(4-Aminopyrazolo[3,4-d]pyrimidin-1-yl)-3-methylbutyraldehyde, 125
112
 
 
Diol 160 (0.78 g, 3.1 mmol) was dissolved in H2O:MeOH (60 mL, 1:1) and cooled to 0 °C in air. 
NaIO4 (0.66 g, 3.1 mmol) was added in one portion. The reaction was stirred at 0 °C for 25 min., 
when complete consumption of starting material was observed by TLC. EtOAc (60 mL) was added, 
followed by H2O (30 mL) and brine (30 mL). The organic phase was removed, and the aqueous phase 
extracted with further portions of EtOAc (2 x 60 mL). NaCl (s) was added to aid the separation of the 
emulsion that formed in the second extraction. The organics were combined and dried over MgSO4, 
and the solvent removed in vacuuo. Purification by column chromatography, eluting with 
EtOAc/petroleum ether (2:1 then 1:0) provided the pure product as white crystalline foam (0.56 g, 
82%). Mp 60-63 °C; Rf 0.25 (UV 254 nm, EtOAc); νmax/cm
-1 
3183, 1721 (C=O), 1602, 1564; δH 
(CDCl3, 400 MHz) 9.69 (1H, t, J 2.3 CHO), 8.30 (1H, s, pyrimidine-H), 7.85 (1H, s, pyrazole-H), 
6.08 (2H, br s, NH2), 3.25 (2H, d, J 2.3), 1.88 (6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 200.7, 157.7, 
154.8, 153.4, 129.3, 102.1, 60.7, 53.2, 27.6; m/z (ES+), 220 (M+H
+
). All data is in agreement with 
literature values.
112
 
 
3-(4-Amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)-3-methylbutyraldehyde, 192 
 
Diol 191 (411 mg, 1.26 mmol) was dissolved in H2O:MeOH (34 mL, 1:1) and cooled to 0 °C in air. 
NaIO4 (269 mg, 1.26 mmol) was added in one portion. The reaction was stirred at 0 °C for 1 h. 30 
min., when complete consumption of starting material was observed by TLC. EtOAc (35 mL) was 
added, followed by H2O (35 mL). The organic phase was removed, and the aqueous phase extracted 
with further portions of EtOAc (2 x 35 mL). NaCl (s) was added to aid the separation of the emulsion 
168 
 
that formed in the second extraction. The organics were combined and dried over MgSO4, and the 
solvent removed in vacuuo. Purification by column chromatography, eluting with EtOAc provided the 
pure product as white powdery solid (291 mg, 79%). Mp 164-166 °C; Rf 0.40 (UV 254 nm, EtOAc); 
νmax/cm
-1 
3472 (NH), 3111, 1717 (C=O), 1644; δH (CDCl3, 400 MHz) 9.77 (1H, t, J 2.3, CHO), 8.32 
(1H, s, pyrimidine-H), 7.68-7.66 (2H, ArH), 7.54-7.44 (3H, ArH), 5.82 (2H, br s, NH2), 3.28 (2H, d, 
J 2.3, CH2CHO), 1.93 (6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 200.7, 158.0, 154.8, 154.4, 142.8, 
133.3, 129.3, 129.0, 128.5, 99.8, 60.9, 53.3, 27.7; m/z HRMS (ES+), found: MH
+
, 296.1505. 
C16H18N5O requires 296.1511, Δ 2.0 ppm. 
 
1-(1,1-Dimethyl-3-prop-2-ynylaminopropyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine, 127
112
 
 
According to the procedure of McCague.
112
 Aldehyde 125 (191 mg, 0.87 mmol) was dissolved in 
MeOH (14 mL) and cooled to 0 °C. Propargylamine (112 μL, 1.74 mmol) and AcOH (150 μL, 2.62 
mmol) were added sequentially. The reaction was allowed to warm to r.t. and stirred for 50 min., 
before cooling to 0 °C. NaCNBH3 (164 mg, 2.62 mmol) was added in one portion, and the rection 
allowed to warm to r.t. and stirred for 17 h. The reaction was cooled to 0 °C and HCl (0.5M, aq., 40 
mL) added. The reaction was warmed to r.t. and neutralised with NaHCO3 (s). The aqueous phase 
extracted with EtOAc (3 x 50 mL), the organics were dried over MgSO4and the solvent removed in 
vacuo to provide the crude product as a white foam. Purification by column chromatography eluting 
with EtOAc/MeOH/Et3N (1:0:0 then 90:5:5) provided the pure product as clear oil (107 mg, 48%). Rf 
0.30 (UV, 254 nm, EtOAc/MeOH/Et3N, 90:5:5); νmax/cm
-1 
3482 (NH), 3304 (NH), 1635, 1584; δH 
(CDCl3, 400 MHz) 8.27 (1H, s, pyrimidine-H), 7.84 (1H, s, pyrazole-H), 6.23 (2H, br s, NH2), 3.28 
(2H, d, J 2.4, HCCCH2), 2.51-2.47 (2H, m, CH2CH2NH), 2.39-2.35 (2H, m, CH2CH2NH), 2.09 (1H, 
t, J 2.4, CCH), 1.77 (6H, s, 2 x CH3); δC (CDCl3, 101 MHz) 157.8, 154.5, 153.4, 129.1, 101.9, 81.9, 
71.3, 62.1, 44.0, 40.5, 38.0, 27.6; m/z HRMS (ES+), found: MH
+
, 259.1664. C13H19N6 requires 
259.1671, Δ 2.7 ppm. All data is in agreement with literature values.112 
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1-(1,1-Dimethyl-3-prop-2-ynylaminopropyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine, 
193 
 
Adapted from the procedure of McCague.
112
 Aldehyde 192 (203 mg, 0.69 mmol) was dissolved in 
MeOH (14 mL) and cooled to 0 °C. Propargylamine (88 μL, 1.37 mmol) and AcOH (118 μL, 2.08 
mmol) were added sequentially. The reaction was allowed to warm to r.t. and stirred for 50 min., 
before cooling to 0 °C. NaCNBH3 (131 mg, 2.08 mmol) was added in one portion, and the reaction 
allowed to warm to r.t. and stirred for 17 h. The reaction was cooled to 0 °C and HCl (0.5M, aq., 40 
mL) added. The reaction was warmed to r.t. and neutralised with NaHCO3 (s). The aqueous phase 
extracted with EtOAc (3 x 50 mL), the organics were dried over MgSO4 and the solvent removed in 
vacuo to provide the crude product as a white solid. Purification by column chromatography eluting 
with EtOAc/MeOH/Et3N (1:0:0 then 190:5:5) provided the product as clear oil (163 mg, in 1:1 ratio 
with tentatively assigned alcohol). Rf 0.40 (UV, 254 nm, EtOAc/MeOH/Et3N, 190:5:5); νmax/cm
-1 
3482 (NH), 3303 (NH), 1635, 1584; δH (CDCl3, 400 MHz) 8.28 (1H, s, pyrimidine-H), 7.69-7.64 
(2H, ArH), 7.52-7.44 (3H, ArH), 6.00 (2H, br s, NH2), 3.32 (2H, d, J 2.5, HCCCH2), 2.60-2.57 (2H, 
m, CH2CH2NH), 2.44-2.40 (2H, m, CH2CH2NH), 2.09 (1H, t, J 2.5, CCH), 1.83 (6H, s, 2 x CH3); δC 
(CDCl3, 101 MHz) 158.1, 154.5, 142.4, 133.7, 129.3, 129.2, 128.8, 128.6, 99.6, 82.1, 71.2, 62.3, 44.1, 
40.6, 38.1, 27.7; m/z HRMS (ES+), found: MH
+
, 335.1981. C19H23N6 requires 335.1984, Δ 0.9 ppm.  
 
4-(4-Amino-3-phenylpyrazolo[3,4,d]pyrimidin-1-yl)-4-methyl-2-prop-2-
ynylaminopentanenitrile, 195 
 
The title compound was synthesised according to the procedure used to synthesise alkyne 193. 
Purification by column chromatography eluting with EtOAc provided the product as gritty oil (24 mg, 
10%). Rf 0.50 (UV, 254 nm, EtOAc); νmax/cm
-1 3486 (NH), 3311 (NH), 2984 (CH), 2365 (C≡N), 
1624; δH (CDCl3, 400 MHz) 8.32 (1H, s, pyrimidine-H), 7.70-7.68 (2H, ArH), 7.55-7.45 (3H, ArH), 
5.69 (2H, br s, NH2), 3.80 (1H, br s, NCCH), 3.53 (1H, br d, J 17.0, HC≡CCHH), 3.41 (1H, br d, J 
17.0, HC≡CCHH), 2.89 (1H, dd, J 14.7 and 7.6, N≡CCHCHH), 2.70 (1H, dd, J 14.7 and 5.1, 
N≡CCHCHH), 2.10 (1H, t, J 2.6, alkyne-H), 1.95 (3H, s, CH3), 1.90 (3H, s, CH3), 1.50 (1H, br s, 
NH); δC (CDCl3, 101 MHz) 158.0, 154.9, 154.8, 143.1, 133.4, 129.3, 129.0, 128.6, 119.4, 100.0, 
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79.7, 72.6, 61.3, 45.4, 44.1, 36.3, 27.8, 27.6; m/z HRMS (NH3 CI+), found: MH
+
, 360.1938. C20H22N7 
requires 360.1937, Δ 0.3 ppm. 
 
(4-Azidophenyl)-acetic acid, 162a
112
 
 
Adapted from the procedure of McCague.
112
 4-aminophenylacetic acid (0.50 g, 3.3 mmol) was added 
to HCl (5 M, aq., 6.6 mL) and cooled to 0 °C. NaNO2 (0.34 g, 5.0 mmol) was added portionwise, with 
effervescence noted on each addition. NaN3 (0.86 g, 13.2 mmol) was added portionwise, with 
effervescence noted. The brown reaction mixture was stirred in an ice-bath warming slowly to room 
temperature over 3 h. NaHCO3 (s) was added until pH 3 was reached. The aqueous phase was 
extracted with EtOAc (3 x 15 mL), and the organic phase dried over MgSO4. The solvent was 
removed in vacuo to provide the required product as a yellow solid (0.49 g, 84%). Mp 89-91 °C; 
νmax/cm
-1 
3022 (CH), 2121 (N3), 1696 (C=O); δH (CDCl3, 400 MHz) 7.28 (2H, d, J 8.3, ArH), 7.01 
(2H, d, J 8.3, ArH), 3.63 (2H, s, ArCH2); δC (CDCl3, 101 MHz) 177.3, 139.3, 130.8, 129.9, 119.3, 
40.3; m/z HRMS (NH3 CI+), found: MNH3
+
, 195.0885. C8H11N4O2 requires 195.0882, Δ 1.5 ppm. All 
data are in agreement with reported values.
112
 
 
(3-Azidophenyl)-acetic acid, 162b
112
 
 
Adapted from the procedure of McCague.
112
 3-aminophenylacetic acid (1.00 g, 6.6 mmol) was added 
to HCl (5 M, aq., 12 mL) and cooled to 0 °C. NaNO2 (0.68 g, 9.9 mmol) was added portionwise, with 
effervescence noted on each addition. NaN3 (1.72 g, 26.4 mmol) was added portionwise, with 
effervescence noted. The brown reaction mixture was stirred in an ice-bath warming slowly to room 
temperature over 3 h. NaHCO3 (s) was added until pH 3 was reached. The aqueous phase was 
extracted with EtOAc (3 x 30 mL), and the organic phase dried over MgSO4. The solvent was 
removed in vacuo to provide the required product as a yellow solid (1.04 g, 89%). Mp 65-67 °C; 
νmax/cm
-1 
2894 (br s) (CH), 2117 (N3), 1695 (C=O); δH (CDCl3, 400 MHz) 11.24 (1H, br s, COOH), 
7.38 (1H, t, J 7.9, ArH), 7.11 (1H, d, J 7.9, ArH), 7.01-6.99 (2H, ArH), 3.68 (2H, CH2COOH); δC 
(CDCl3, 101 MHz) 177.7, 140.4, 135.1, 130.0, 126.0, 120.1, 118.1, 40.8; m/z HRMS (NH3 CI+), 
found: MNH4
+
, 195.0876. C8H11N4O2 requires 195.0882, Δ 3.1 ppm. All data are in agreement with 
literature values.
112
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N-[3-(4-Aminopyrazolo[3,4-d]pyrimidin-1-yl)-3-methylbutyl]-2-(4-azidophenyl)-N-prop-2-
ynylacetamide, 129a
112
 
 
Adapted from the procedure of McCague.
112
 Carboxylic acid 162a (39 mg, 0.22 mmol) was 
suspended in anhydrous CH2Cl2 (2.5 mL). The mixture was cooled to 0 °C and oxalyl chloride (23 μl, 
0.26 mmol) was added followed by DMF (1 drop). The reaction was warmed slowly to 23 °C. After 
40 mins, complete consumption of starting acid was observed by TLC analysis (MeOH quench of an 
aliquot). The volatiles were removed in vacuo and the resulting acid chloride, a red oil, was re-
dissolved in anhydrous CH2Cl2 (2.5 mL). In a separate vessel, amine 127 (52 mg, 0.20 mmol) was 
dissolved in anhydrous CH2Cl2 (2.5 mL), and the mixture was cooled to 0 °C. Et3N (112 μl, 0.81 
mmol) was added, followed by the acid chloride solution, dropwise. After the addition, the ice-bath 
was removed and the reaction stirred at 23 °C for 18 h. NaHCO3 (sat. aq., 10 mL) was added, and the 
aqueous phase extracted with EtOAc (3 x 10 mL). The organics were combined and dried over 
MgSO4 and the solvent removed in vacuo to provide the crude product as a yellow oil. Purification by 
column chromatography eluting with EtOAc/petroleum ether (1:1 then 1:0) provided the pure product 
as a clear foam (42 mg, 50%). Mp 59-62 °C [lit.50-52 °C
112
]; Rf 0.40 (UV, 254 nm, EtOAc); νmax/cm
-1 
3315 (NH), 2117 (N3), 1636 (C=O); δH (CDCl3, 400 MHz, mixture of rotamers) 8.30 (0.61 x 1H, s, 
pyrimidine-H), 8.29 (0.39 x 1H, s, pyrimidine-H), 7.96 (0.61 x 1H, s, pyrazole-H), 7.94 (0.39 x 2H, s, 
pyrazole-H), 7.19-7.16 (0.39 x 2H, ArH), 7.00-6.98 (0.61 x 2H, ArH), 6.94-6.92 (0.39 x 2H, ArH), 
6.88-6.86 (0.61 x 2H, ArH), 6.11 (0.61 x 2H, br s, NH2), 6.02 (0.39 x 2H, br s, NH2), 4.17 (0.61 x 
2H, d J 2.4, HC≡CCH2), 3.93 (0.39 x 2H, d J 2.4, HC≡CCH2), 3.68 (0.39 x 2H, s, ArCH2), 3.49 (0.61 
x 2H, s, ArCH2), 3.32-3.28 (0.39 x 2H, m, CCH2CH2), 3.24-3.19 (0.61 x 2H, m, CCH2CH2), 2.55-
2.48 (2H, m, CCH2CH2), 2.20 (0.39 x 1H, t, J 2.2, alkyne-H), 2.12 (0.61 x 1H, t, J 2.2, alkyne-H), 
1.79 (0.61 x 6H, s, 2 x CH3), 1.77 (0.39 x 6H, s, 2 x CH3); δC (CDCl3, 101 MHz, mixture of 
rotamers) 170.5, 170.5, 157.9, 157.8, 154.9, 154.6, 153.6, 153.5, 138.7, 138.6, 131.4, 131.4, 130.5, 
130.1, 129.7, 129.5, 119.3, 119.2, 102.0, 101.9, 78.8, 78.4, 72.8, 72.0, 61.9, 61.4, 43.3, 42.7, 40.0, 
39.4, 39.0, 37.7, 37.6, 34.6, 27.6, 27.5; m/z HRMS (ES+), found: MH
+
, 418.2105. C21H24N9O requires 
418.2104, Δ 0.2 ppm. Data is in agreement with literature values.112 
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N-[3-(4-Aminopyrazolo[3,4-d]pyrimidin-1-yl)-3-methylbutyl]-2-(3-azidophenyl)-N-prop-2-
ynylacetamide, 129b
112
 
 
Adapted from the procedure of McCague.
112
 Carboxylic acid 162b (42 mg, 0.24 mmol) was 
suspended in anhydrous CH2Cl2 (2.5 mL) and cooled to 0 °C. Oxalyl chloride (24 μl, 0.28 mmol) was 
added followed by DMF (1 drop). The reaction was warmed slowly to 23 °C. After 1 h., complete 
consumption of starting acid was observed by TLC analysis (MeOH quench of an aliquot). The 
volatiles were removed in vacuo and the resulting acid chloride, an orange oily solid, was re-dissolved 
in anhydrous CH2Cl2 (2.5 mL). In a separate vessel, amine 127 (56 mg, 0.22 mmol) was dissolved in 
anhydrous CH2Cl2 (2.5 mL), and the mixture was cooled to 0 °C. Et3N (120 μl, 0.87 mmol) was 
added, followed by the acid chloride solution, dropwise. After the addition, the ice-bath was removed 
and the reaction stirred at 23 °C for 18 h. NaHCO3 (sat. aq., 10 mL) was added, and the aqueous phase 
extracted with EtOAc (3 x 10 mL). The organics were dried over MgSO4 and the solvent removed in 
vacuo to provide the crude product as a yellow oil. Purification by column chromatography eluting 
with EtOAc/petroleum ether (1:1 then 1:0) provided the pure product as a cream foam (36 mg, 40%). 
Mp 27-30 °C [lit. 44-46 °C
112
]; Rf 0.25 (UV, 254 nm, EtOAc); νmax/cm
-1 
3315 (NH), 3197 (CH), 2988 
(CH), 2121 (N3), 1636 (C=O); δH (CDCl3, 400 MHz, mixture of rotamers) 8.31 (0.65 x 1H, s, 
pyrimidine-H), 8.30 (0.35 x 1H, s, pyrimidine-H), 7.88 (0.65 x 1H, s, pyrazole-H), 7.85 (0.35 x 1H, s, 
pyrazole-H), 7.28 (0.35 x 1H, t, J 7.2, ArH), 7.22 (0.65 x 1H, t, J 7.8, ArH), 6.98 (0.35 x 1H, d, J 8.2, 
ArH), 6.89-6.80 (2H, ArH), 6.70 (0.65 x 1H, s, ArH), 6.00 (0.65 x 2H, br s, NH2), 5.94 (0.35 x 2H, br 
s, NH2), 4.18 (0.65 x 2H, d J 2.4, HC≡CCH2), 3.94 (0.35 x 2H, d J 2.4, HC≡CCH2), 3.69 (0.65 x 2H, 
s, ArCH2), 3.51 (0.35 x 2H, s, ArCH2), 3.33-3.29 (0.35 x 2H, m, CCH2CH2), 3.26-3.21 (0.65 x 2H, m, 
CCH2CH2), 2.56-2.50 (2H, m, CCH2CH2), 2.21 (0.35 x 1H, t, J 2.4, alkyne-H), 2.13 (0.65 x 1H, t, J 
2.4, alkyne-H), 1.79 (0.65 x 6H, s, 2 x CH3), 1.77 (0.35 x 6H, s, 2 x CH3); δC (CDCl3, 101 MHz, 
mixture of rotamers) 170.2, 170.1, 157.8, 157.7, 154.9, 154.6, 153.6, 153.5, 140.3, 140.2, 136.7, 
136.6, 130.0, 129.9, 129.7, 129.5, 125.7, 125.4, 119.7, 119.4, 117.7, 117.5, 102.0, 101.9, 78.7, 78.4, 
72.8, 72.0, 61.9, 61.4, 43.4, 42.7, 40.4, 39.8, 39.1, 37.8, 37.6, 34.6, 27.5, 27.5; m/z HRMS (ES+), 
found: MH
+
, 418.2086. C21H24N9O requires 418.2104, Δ 4.3 ppm. Data is in agreement with literature 
values.
112
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N-[3-(4-Amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)-3-methylbutyl]-2-(4-azidophenyl)-N-
prop-2-ynylacetamide, 2a 
 
Adapted from the procedure of McCague.
112
 Carboxylic acid 162a (48 mg, 0.27 mmol) was dissolved 
in anhydrous CH2Cl2 (3 mL) and cooled to 0 °C. Oxalyl chloride (28 μl, 0.33 mmol) was added 
followed by DMF (1 drop). The reaction was warmed slowly to 23 °C. After 1 h., complete 
consumption of starting acid was observed by TLC analysis (MeOH quench of an aliquot). The 
volatiles were removed in vacuo and the resulting acid chloride, an orange oily solid, was re-dissolved 
in anhydrous CH2Cl2 (3 mL). In a separate vessel, amine 193 (83 mg, 0.25 mmol) was dissolved in 
anhydrous CH2Cl2 (3 mL), and the mixture cooled to 0 °C. Et3N (138 μl, 0.99 mmol) was added, 
followed by the acid chloride solution, dropwise. After the addition, the ice-bath was removed and the 
reaction stirred at 23 °C for 18 h. NaHCO3 (sat. aq., 10 mL) was added, and the aqueous phase 
extracted with EtOAc (3 x 10 mL). The organics were dried over MgSO4 and the solvent removed in 
vacuo to provide the crude product as a yellow oil. Purification by column chromatography eluting 
with EtOAc/petroleum ether (3:2) provided the pure product as a yellow foam (48 mg, 34% over 2 
steps from aldehyde 192). Mp 29-33 °C; Rf 0.15 (UV, 254 nm, EtOAc/petroleum ether, 3:2); νmax/cm
-1 
3477 (NH), 3249 (NH), 2929 (CH), 2116 (N3), 1624 (C=O); δH (CDCl3, 400 MHz, mixture of 
rotamers) 8.34 (0.68  x 1H, s, pyrimidine-H), 8.31 (0.32 x 1H, s, pyrimidine-H), 7.70-7.62 and 7.54-
7.44 (5H, ArH), 7.21-7.19 and 6.97-6.92 and 6.84-6.82 (4H, ArH), 5.78 (2H, br s, NH2), 4.21 (0.68 x 
2H, d J 2.4, HC≡CCH2), 3.98 (0.32 x 2H, d J 2.4, HC≡CCH2), 3.70 (0.32 x 2H, s, ArCH2), 3.50 (0.68 
x 2H, s, ArCH2), 3.45-3.41 (0.32 x 2H, m, CCH2CH2), 3.34-3.30 (0.68 x 2H, m, CCH2CH2), 2.58-
2.52 (2H, m, CCH2CH2), 2.20 (0.32 x 1H, t, J 2.4, C≡CH), 2.13 (0.68 x 1H, t, J 2.4, C≡CH), 1.84 
(0.68 x 6H, s, 2 x CH3), 1.82 (0.32 x 6H, s, 2 x CH3); δC (CDCl3, 101 MHz, mixture of rotamers) 
170.4, 170.3, 158.0, 158.0, 154.9, 154.9, 154.6, 154.5, 142.9, 142.7, 138.7, 138.4, 133.6, 133.3, 131.5, 
131.5, 130.4, 130.0, 129.4, 129.3, 129.1, 128.9, 128.5, 128.5, 119.3, 119.1, 99.6, 99.6, 78.9, 78.6, 
72.6, 71.9, 62.1, 61.6, 43.3, 42.7, 40.0, 39.5, 39.3, 37.7, 37.6, 34.5, 27.6, 27.5; m/z HRMS (ES+), 
found: MH
+
, 494.2404. C27H28N9O requires 494.2417, Δ 2.6 ppm.  
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N-[3-(4-Amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)-3-methylbutyl]-2-(3-azidophenyl)-N-
prop-2-ynylacetamide, 2b 
 
Adapted from the procedure of McCague.
112
 Carboxylic acid 162b (94 mg, 0.53 mmol) was dissolved 
in anhydrous CH2Cl2 (6 mL) and cooled to 0 °C. Oxalyl chloride (55 μl, 0.64 mmol) added followed 
by DMF (1 drop). The reaction was warmed slowly to 23 °C. After 1 h., complete consumption of 
starting acid was observed by TLC analysis (MeOH quench of an aliquot). The volatiles were 
removed in vacuo and the resulting acid chloride, an orange oily solid, was re-dissolved in anhydrous 
CH2Cl2 (6 mL). In a separate vessel, amine 193 (163 mg, 0.49 mmol) was dissolved in anhydrous 
CH2Cl2 (6 mL), and the mixture was cooled to 0 °C. Et3N (271 μl, 1.96 mmol) was added, followed 
by the acid chloride solution, dropwise. After the addition, the ice-bath was removed and the reaction 
stirred at 23 °C for 18 h. NaHCO3 (sat. aq., 20 mL) was added, and the aqueous phase extracted with 
EtOAc (3 x 20 mL). The organics were dried over MgSO4 and the solvent removed in vacuo to 
provide the crude product as a yellow oil. Purification by column chromatography eluting with 
EtOAc/petroleum ether (3:2) provided the pure product as a yellow foam (90 mg, 30% over 2 steps 
from aldehyde 192). Mp 38-42 °C; Rf 0.15 (UV, 254 nm, EtOAc/petroleum ether, 3:2); νmax/cm
-1 
3477 
(NH), 3294 (NH), 2971 (CH), 2108 (N3), 1624 (C=O); δH (CDCl3, 400 MHz) mixture of rotamers 
8.33 (0.61 x 1H, s, pyrimidine-H), 8.31 (0.39 x 1H, s, pyrimidine-H), 7.70 (0.39 x 2H, d, J 7.4, ArH), 
7.64 (0.61 x 2H, d, J 7.5, ArH), 7.53-7.43 (3H, m, ArH), (7.29-7.25, (ArH), 7.18 (t, J 7.9, ArH), 7.00 
(d, J 8.4, ArH), 6.91-6.89 (ArH), 6.84 (d, J 8.2, ArH), 6.74 (d, J 7.5, ArH), 6.66 (s, ArH) all peaks 
totalling 4H), 5.89 (2H, br s, NH2), 4.21 (0.61 x 2H, d, J 2.3, HC≡CCH2), 3.98 (0.39 x 2H, d, J 2.3, 
HC≡CCH2), 3.71 (0.39 x 2H, s, ArCH2), 3.53 (0.61 x 2H, s, ArCH2), 3.46-3.42 (0.39 x 2H, m, 
CCH2CH2), 3.37-3.32 (0.61 x 2H, m, CCH2CH2), 2.58-2.54 (2H, m, CCH2CH2), 2.21 (0.39 x 1H, t, J 
2.5, C≡CH), 2.14 (0.61 x 1H, t, J 2.5, C≡CH), 1.84 (0.61 x 6H, s,  2 x CH3), 1.82 (0.39 x 6H, s, 2 x 
CH3); δC (CDCl3, 101 MHz) 170.0, 170.0, 158.1, 158.1, 154.9, 154.6, 154.6, 154.5, 143.0, 142.7, 
140.3, 140.1, 136.8, 136.7, 133.6, 133.3, 130.0, 130.0, 129.3, 129.3, 129.1, 128.9, 128.6, 128.5, 125.7, 
125.3, 119.6, 119.3, 117.6, 117.4, 99.6, 99.6, 78.9, 78.6, 72.7, 71.9, 62.1, 61.6, 43.4, 42.7, 40.4, 39.9, 
39.3, 37.7, 37.7, 34.6, 27.6, 27.5; m/z HRMS (ES+), found: MH
+
, 494.2409. C27H28N9O requires 
494.2417, Δ 1.6 ppm.  
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Fig. A1 The crystal structure of 1a. 
 
 
Fig. A2 The crystal structure of 1a (50% probability ellipsoids). 
 
Table 1. Crystal data and structure refinement for 1a 
 
Identification code AA1001 
Formula C13 H17 N O2 
Formula weight 219.28 
Temperature 173 K 
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Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Monoclinic, P2(1)/n 
Unit cell dimensions a = 5.7745(3) Å  = 90° 
 b = 20.4714(8) Å  = 98.175(4)° 
 c = 10.5178(4) Å  = 90° 
Volume, Z 1230.70(9) Å3, 4 
Density (calculated) 1.183 Mg/m3 
Absorption coefficient 0.080 mm-1 
F(000) 472 
Crystal colour / morphology Colourless thin plates 
Crystal size 0.30 x 0.11 x 0.01 mm3 
 range for data collection 3.57 to 28.09° 
Index ranges -7<=h<=4, -18<=k<=26, -10<=l<=13 
Reflns collected / unique 4462 / 2454 [R(int) = 0.0295] 
Reflns observed [F>4 (F)] 1619 
Absorption correction Analytical 
Max. and min. transmission 0.999 and 0.989 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2454 / 56 / 167 
Goodness-of-fit on F2 0.993 
Final R indices [F>4 (F)] R1 = 0.0487, wR2 = 0.0961 
R indices (all data) R1 = 0.0876, wR2 = 0.1092 
Extinction coefficient 0.0074(18) 
Largest diff. peak, hole 0.198, -0.165 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
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Table 2. Bond lengths [Å] and angles [°] for AA1001. 
 
C(1)-C(2) 1.386(2) 
C(1)-C(6) 1.388(2) 
C(1)-C(7) 1.486(2) 
C(2)-C(3) 1.377(2) 
C(3)-C(4) 1.381(3) 
C(4)-C(5) 1.374(3) 
C(5)-C(6) 1.389(3) 
C(7)-N(8) 1.462(2) 
C(7)-C(9) 1.503(2) 
N(8)-C(9) 1.464(2) 
C(9)-C(10) 1.487(2) 
C(10)-O(10) 1.210(2) 
C(10)-O(11) 1.334(2) 
O(11)-C(12') 1.480(16) 
O(11)-C(12) 1.491(3) 
C(12)-C(15) 1.510(4) 
C(12)-C(13) 1.514(4) 
C(12)-C(14) 1.514(4) 
C(12')-C(14') 1.507(14) 
C(12')-C(13') 1.509(13) 
C(12')-C(15') 1.510(14) 
 
C(2)-C(1)-C(6) 118.45(16) 
C(2)-C(1)-C(7) 121.38(14) 
C(6)-C(1)-C(7) 120.17(17) 
C(3)-C(2)-C(1) 120.91(17) 
C(2)-C(3)-C(4) 120.3(2) 
C(5)-C(4)-C(3) 119.68(18) 
C(4)-C(5)-C(6) 120.07(18) 
C(1)-C(6)-C(5) 120.61(19) 
N(8)-C(7)-C(1) 116.94(15) 
N(8)-C(7)-C(9) 59.14(9) 
C(1)-C(7)-C(9) 121.23(15) 
C(7)-N(8)-C(9) 61.80(10) 
N(8)-C(9)-C(10) 117.26(15) 
N(8)-C(9)-C(7) 59.06(10) 
C(10)-C(9)-C(7) 115.47(15) 
179 
 
O(10)-C(10)-O(11) 125.31(17) 
O(10)-C(10)-C(9) 123.40(16) 
O(11)-C(10)-C(9) 111.27(16) 
C(10)-O(11)-C(12') 122.4(8) 
C(10)-O(11)-C(12) 120.7(2) 
O(11)-C(12)-C(15) 101.9(3) 
O(11)-C(12)-C(13) 109.2(4) 
C(15)-C(12)-C(13) 110.6(3) 
O(11)-C(12)-C(14) 111.6(3) 
C(15)-C(12)-C(14) 110.9(3) 
C(13)-C(12)-C(14) 112.1(3) 
O(11)-C(12')-C(14') 101.6(18) 
O(11)-C(12')-C(13') 113(2) 
C(14')-C(12')-C(13') 112.0(12) 
O(11)-C(12')-C(15') 105.3(16) 
C(14')-C(12')-C(15') 112.0(12) 
C(13')-C(12')-C(15') 112.4(12) 
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